WO2013136802A1 - Drug administration device - Google Patents

Drug administration device Download PDF

Info

Publication number
WO2013136802A1
WO2013136802A1 PCT/JP2013/001720 JP2013001720W WO2013136802A1 WO 2013136802 A1 WO2013136802 A1 WO 2013136802A1 JP 2013001720 W JP2013001720 W JP 2013001720W WO 2013136802 A1 WO2013136802 A1 WO 2013136802A1
Authority
WO
WIPO (PCT)
Prior art keywords
piston
cylinder
peripheral side
screw
inflow
Prior art date
Application number
PCT/JP2013/001720
Other languages
French (fr)
Japanese (ja)
Inventor
孝博 相馬
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Publication of WO2013136802A1 publication Critical patent/WO2013136802A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804Flow controllers
    • A61M5/16809Flow controllers by repeated filling and emptying of an intermediate volume
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/14244Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A61M5/14248Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type
    • A61M2005/14252Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body of the skin patch type with needle insertion means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M2005/14506Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons mechanically driven, e.g. spring or clockwork
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00Ancillary equipment
    • A61M2209/01Remote controllers for specific apparatus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142Pressure infusion, e.g. using pumps
    • A61M5/145Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/148Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags

Definitions

  • the present invention relates to a drug solution administration device, which is suitable for application when, for example, insulin is administered into the body.
  • type 1 diabetes is a chronic disease that requires treatment to inject an appropriate amount of insulin at an appropriate time.
  • manual administration using a syringe or manual administration using an injector has been performed.
  • an automatic drug solution administration system capable of programming the dose and administration time has been developed.
  • This system consists of an infusion pump, a dedicated infusion set, and a catheter.
  • a system in which a drug administration device is made portable is also used.
  • a small and lightweight infusion pump that is fixed to the body surface with a double-sided tape without using the infusion set.
  • a patch-type drug solution administration device has been introduced in which a catheter is directly inserted from the device (for example, see Patent Document 1).
  • the liquid medicine is delivered from the liquid medicine storage section filled with the liquid medicine into the patient's body using a pump.
  • a cylinder part is provided with a suction port for suctioning a chemical solution and a discharge port for discharging a chemical solution, and a check valve is provided at each of the suction port and the discharge port.
  • a piston type pump is known in which one of check valves provided at each of the suction port and the discharge port is opened by changing the internal pressure of the pump.
  • the present invention has been made in consideration of the above points, and intends to propose a small-sized chemical solution administration device capable of quantitatively delivering a chemical solution.
  • the drug administration device is used by being attached to the body surface of the user, the drug solution storage unit storing the drug solution, and the cylindrical inner peripheral side surface And a cylinder having a bottom surface of a predetermined shape, a reservoir for supplying a chemical solution, an inflow port formed on an inner peripheral side surface of the cylinder communicating with an inflow passage connected to the reservoir, and the chemical solution into the body of the user
  • An outflow port provided on an inner peripheral side surface of the cylinder that communicates with a hollow needle to be supplied through a predetermined outflow path, and formed at a position rotated from the inflow port by a predetermined angle about the central axis of the cylinder;
  • An outer peripheral side surface in contact with the inner peripheral side surface, an end surface in contact with the chemical solution, the other end surface facing the end surface, and an outer peripheral side surface port provided on the outer peripheral side surface and a flow passage connecting the end surface are provided.
  • a piston that slides in the cylinder inner space formed in the direction of the center axis of the cylinder, a piston screw portion that has a thread groove formed on the other end surface side of the piston, and a piston screw portion that are screwed together.
  • a rotating screw portion that is rotated about the central axis of the cylinder and that generates a screw friction force between the piston screw portion that is larger than a peripheral side friction force generated between the cylinder and the piston when rotating.
  • the piston azimuth that the outer peripheral side port faces is the inflow azimuth that connects the outer peripheral side port to the inlet, and the piston is rotated from the inflow azimuth.
  • a rotation restricting portion for restricting the rotation within a rotation range sandwiched between the outflow direction for connecting the outer peripheral side surface port to the outflow port is provided.
  • the piston pump moves the piston in a direction away from the bottom surface of the cylinder by screwing the rotating screw portion and the piston screw portion to generate negative pressure in the cylinder, and from the reservoir through the inflow pipe and the flow pipe.
  • the chemical solution can flow into the cylinder.
  • the piston When the rotating screw part is rotated in the opposite direction, first, the piston is rotated in the opposite direction by the action of the screw friction force, and the outer peripheral side port is connected to the outlet in accordance with the outflow direction. The rotation of the piston is restricted. Subsequently, the piston pump moves the piston in a direction close to the bottom surface of the cylinder by screwing the rotating screw portion and the piston screw portion to generate a positive pressure in the cylinder, and from the inside of the cylinder through the flow pipe and the outflow pipe. The drug solution can be drained into the body of the user.
  • the piston is first rotated by the action of the screw friction force, and the connection destination of the outer peripheral side surface port is set to either the inflow port or the outflow port.
  • the piston can be separated or close to the bottom surface of the cylinder by screwing between the rotating screw portion and the piston screw portion, so that the chemical liquid can flow into or out of the cylinder.
  • a drug solution administration system 1 wirelessly communicates a signal corresponding to a user's input instruction with a portable drug solution administration device 2 that is held and used by being affixed to the user's skin.
  • the controller 3 that transmits to the drug solution administration device 2 and the charger 4 (FIG. 21) that charges the rechargeable battery 206 (FIG. 11) provided inside the drug solution administration device 2 are configured.
  • the medicinal solution administration device 2 stores a medicinal solution (for example, insulin) therein, is set by the controller 3, is transmitted by radio, and is stored in the memory in the medicinal solution administration device 2, and the bolus administration time and dose.
  • the drug solution is administered into the user's body according to the administration time and the dose, or according to the bolus dose transmitted from the controller 3.
  • the drug solution administration device 2 includes a drug solution storage and delivery unit 10, a drive control unit 20, and a puncture channel unit 30 that are detachable from each other.
  • the puncture channel unit 30 is slid from the front with respect to the drug solution storage / delivery unit 10 and the drive control unit 20.
  • the medicinal solution administration device 2 is used by being attached to the skin of the user in such a state.
  • the size of the medicinal solution administration device 2 may be small enough to be attached to the user's skin, for example, a substantially rectangular parallelepiped shape having a width of 34 mm, a length of 43 mm, and a height of 12 mm.
  • the chemical storage / delivery unit 10 includes a lower casing part 101 that is open on the upper side and has a space inside, and an upper casing that is screwed into the opening of the lower casing part 101.
  • the portion 102 is formed into a flat and substantially rectangular parallelepiped shape.
  • the chemical solution storage and delivery unit 10 is provided with a chemical solution bag 110, a filter unit 120, a delivery unit 130, a compression unit 150, and the like in a space formed by the lower casing unit 101 and the upper casing unit 102.
  • the lower housing part 101 is provided with a sticking part 103 made of double-sided tape or the like on the bottom face 101A.
  • the medicinal solution administration device 2 is held by the user when the sticking portion 103 is stuck on the user's skin.
  • the bottom surface 101 ⁇ / b> A of the lower housing 101 is formed of a transparent material so that the amount of the chemical stored in the chemical bag 110 can be seen from the outside. This makes it possible to check the remaining amount of the drug solution from the lateral direction even after the drug solution administration device 2 is attached to the user's skin.
  • Engagement portions 101B to E which are protrusions extending in the direction in which the drive control unit 20 is arranged, are provided on the side surfaces along the longitudinal direction (hereinafter also referred to as the front-rear direction) of the lower housing unit 101. It has been.
  • the engaging portions 101B to E are brought into close contact with the chemical solution storage and delivery portion 10 and the drive control portion 20 by engaging with engagement receiving portions 201A to 201D (FIG. 11) described later.
  • the lower casing 101 is provided with a waterproof packing 101F on the surface that is in close contact with the upper casing 102.
  • the waterproof packing 101F is also extended to the lower surface of the projecting portions 102A and 102B of the upper casing portion 102 and the portion in contact with the end surface of the central portion 102C, and is provided between the lower housing portion 101 and the upper housing portion 102. It is possible to prevent liquid from entering the space.
  • a hole 101G for inserting the leaf spring release rod 154 is provided on the side surface of the lower casing portion 101 along the front-rear direction.
  • a duckbill-like valve packing (not shown) is inserted into the hole 101G, and the hole is closed when the leaf spring release rod 154 is removed.
  • a bottom 101 ⁇ / b> A of the lower housing part 101 is provided with a hole 101 ⁇ / b> K into which the injection part 104 is fitted to inject a chemical liquid into the chemical liquid bag 110.
  • the peripheral portion of the hole 101K realizes a waterproof function by fitting the injection portion 104, which is an elastic member fused to the chemical solution bag 110, and the lower housing portion 101.
  • the lower casing portion 101 is provided with a concave portion 101H on the front side, which is a space into which a part of the puncture channel portion 30 is fitted when the puncture channel portion 30 is engaged with the drug solution storage and delivery unit 10. . Further, the lower casing portion 101 is provided with projections 101I and 101J protruding in opposite directions to guide the puncture flow path portion 30 so as to be slid and engaged with the medicinal solution storage / delivery portion 10 from the front direction. It is provided along.
  • the upper housing part 102 is provided with projecting parts 102A and 102B protruding in the front-rear direction so as to be continuous with the projecting parts 101I and 101J of the lower housing part 101 in the front-rear direction.
  • the upper housing portion 102 is formed such that the central portion 102C sandwiched between the protrusion portions 102A and 102B is one step lower than the other portions in order to form the protrusion portions 102A and 102B.
  • the chemical solution bag 110 as a reservoir is formed of a rectangular sheet 111 made of, for example, polyurethane, vinyl chloride, or polyethylene, as shown in FIG.
  • the sheet 111 is a central portion in the longitudinal direction and is a portion (hereinafter also referred to as a central portion) 112 that becomes the bottom surface of the chemical solution bag 110 that is a flexible thermoplastic resin.
  • At least three odd or more (five in the present embodiment) fold lines 113 and 114 are provided at equal intervals on both sides of the sheet.
  • an even number of portions (hereinafter also referred to as folding portions) 115 and 116 having a predetermined width are formed on the sheet 111 between the adjacent folds 113 and 114, respectively.
  • the sheet 111 has portions (hereinafter also referred to as end portions) 117 and 118 that are longer than half of the length in the longitudinal direction in the central portion 112 on the further end side than the folds 113 and 114 from the most ends in the longitudinal direction. Provided.
  • the folds 113 and 114 are alternately folded into a mountain fold and a valley fold so that the fold portions 115 and 116 overlap the center portion 112, and as shown in FIG. Part of the end side overlaps.
  • the overlapping portions of the end portions 117 and 118 are fused, and the edges in the width direction are fused.
  • the edge in the width direction of the sheet 111 is fused, the edge is fused so that the nozzle 105 that connects the space surrounded by the sheet 111 and the external space is sandwiched between the edges.
  • an injecting portion 104 having a rubber stopper (not shown) formed of, for example, synthetic rubber or the like is provided to inject the chemical solution into the chemical solution bag 110 from the outside.
  • a chemical solution bag 110 as shown in FIG. 5C is formed.
  • the medical solution bag 110 formed in this way is folded so that the adjacent folding portions 115 and 116 are in contact with each other in a state where the medical solution is not filled, and the central portion 112 and the end portions 117 and 118 are Overlap.
  • the chemical solution bag 110 is not crushed so that the central portion 112 and the end portions 117 and 118 are in contact with each other without leaving the chemical solution inside when the chemical solution filled therein is sent to the outside through the nozzle 105. Can be sent to the outside.
  • the conventional chemical solution bag is generally formed by fusing the edges of two films, and the chemical solution is injected into the space formed by the two films. As the distance approaches, the distance between the two films becomes shorter.
  • the conventional chemical solution administration device using the chemical solution bag in the space where the chemical solution bag is stored, when the chemical solution is injected near the edge of the chemical solution bag, a useless space is formed in the portion where the chemical solution bag does not expand. Will be.
  • the conventional drug solution bag has a problem in that the drug solution administration device is enlarged.
  • the chemical solution bag 110 has the folding portions 115 and 116 in the longitudinal direction, the folding portions 115 and 116 separate the center portion 112 and the end portions 117 and 118 when the chemical solution is injected. It spreads in the direction (vertical direction).
  • the chemical solution bag 110 can expand in the vertical direction even when it is near the edge of the chemical solution bag 110 when the chemical solution is injected by expanding the folding parts 115 and 116.
  • the space formed with the casing 102 when the chemical solution is injected, a wasteful space is not formed even in a portion near the edge of the chemical solution bag 110, and the chemical solution administration device 2 can be downsized. Yes, thus improving usability.
  • the filter unit 120 is connected to a side surface of the upper lid 121 having an opening on the lower side and a space in the interior, and a nozzle 105 communicating the inner space and the chemical solution bag 110.
  • a channel pipe 106 communicating with the delivery unit 130 is connected.
  • the filter unit 120 is provided with an air vent filter 122 that allows gas to pass but not liquid to close the opening of the upper lid 121.
  • the air vent filter 122 is fixed between the upper lid 121 and the lower lid 123 that closes the opening of the upper lid 121 so as to be sandwiched between the O-rings 124 and 125 along the circumferential direction.
  • the upper lid 121 and the lower lid 123 are in close contact with each other by, for example, ultrasonic fusion.
  • the lower lid 123 is provided with a hole 123A penetrating in the vertical direction.
  • the filter unit 120 can discharge only the gas from the inner space of the upper lid 121 through the hole 123A provided in the lower lid 123 without discharging the chemical solution.
  • the delivery unit 130 is a valveless pump that does not have a valve, and is configured around a cylinder 131 and a piston 132.
  • FIG. 7 shows a perspective view
  • FIG. 8A is a cross-sectional view as viewed from above
  • FIG. 8B is a cross-sectional view as viewed from the right side of the A1-A2 plane in FIG. 8A.
  • a partial side view is shown in combination.
  • the cylinder 131 has a rectangular parallelepiped shape whose outer diameter is long in the left-right direction, and a cylindrical hole is drilled from the left side surface to the right direction around the central axis X that is a virtual straight line along the left-right direction. Thus, an internal space 131S is formed.
  • the inner space 131S is closed on the right side by a flat circular bottom surface 131A, surrounded by a cylindrical inner peripheral side surface 131B in the vertical direction or the front-rear direction, and only the left side is open.
  • the inner diameter of the internal space 131S is about 0.6 [mm].
  • the cylinder 131 has an inflow pipe 131C penetrating between the front side surface and the internal space 131S and an outflow pipe 131D penetrating between the rear side surface and the internal space 131S.
  • the inflow pipe 131C communicates with the flow path pipe 106 on the front side surface, and allows the chemical solution supplied from the chemical solution bag 110 via the filter unit 120 to flow into the internal space 131S.
  • the inlet 131E which is the end of the inflow pipe 131C on the inner space 131S side, is formed in a long hole shape that is short in the vertical direction and long in the horizontal direction.
  • the outflow pipe 131D communicates with the flow path pipe 107 on the rear side, and the chemical liquid flows out from the internal space 131S and is supplied to the valve body 108 (FIG. 3) via the flow path pipe 107.
  • outflow port 131F which is the edge part by the side of the internal space 131S of outflow pipe 131D is formed in the long hole shape short in the up-down direction and long in the left-right direction similarly to the inflow port 131E.
  • the piston 132 as a whole is formed in a columnar shape centered on the central axis X, and one end face port 132AH made of a round hole of a predetermined diameter is formed on the right flat end face 132A, and the outer peripheral side face 132B is also predetermined.
  • One outer peripheral side port 132BH made of a round hole with a diameter is formed.
  • a circulation pipe 132C that is bent in an L shape and communicates with the end surface port 132AH and the outer peripheral side surface port 132BH as the outer peripheral side surface port passes through the piston 132.
  • the outer diameter of the piston 132 is slightly smaller than the inner diameter of the internal space 131S of the cylinder 131. Therefore, when the piston 132 is inserted into the internal space 131S of the cylinder 131, the right end surface 132A is opposed to the bottom surface 131A of the cylinder 131, and the outer peripheral side surface 132B is in close contact with the inner peripheral side surface 131B of the cylinder 131.
  • the piston 132 forms a highly airtight space surrounded by the end surface 132A, the bottom surface 131A of the cylinder 131, and the inner peripheral side surface 131B in the internal space 131S.
  • this space is referred to as a storage space 131L.
  • the piston 132 can move in the left-right direction within the cylinder 131, that is, in the direction along the central axis X, and in the cylinder 131 around the central axis X in the circumferential direction. Can be rotated.
  • the rotation direction around the central axis X is referred to as a clockwise direction or a counterclockwise direction depending on the rotation direction when viewed from the right side as shown in FIG. 8B.
  • the direction in which the outer peripheral side surface port 132BH is located with respect to the central axis X is defined as the direction of the piston 132, and the position of the piston 132 with respect to the direction along the central axis X (namely, the left-right direction) Called the position.
  • a position corresponding to a so-called top dead center
  • a position corresponding to a so-called bottom dead center
  • a predetermined distance for example, about 3 [mm]
  • a lubricant such as silicon may be applied to the outer peripheral side surface 132B of the piston 132 and the inner peripheral side surface 131B of the cylinder 131 so as to improve the sealing performance and reduce the frictional force so that the sliding can be performed smoothly.
  • an O-ring groove may be provided around the inlet 131E and the outlet 131F, and an O-ring having a small sliding resistance covered with Teflon (registered trademark of DuPont) may be installed.
  • the piston 132 basically closes the inlet 131E and outlet 131F of the cylinder 131 by the outer peripheral side surface 132B, the outer peripheral side port 132BH is connected to the inlet 131E or outlet 131F when facing forward or rearward.
  • the inflow port 131E and the outflow port 131F include a location facing the outer peripheral side surface port 132BH when the piston 132 is in the contact position, and a location facing the outer peripheral side surface port 132BH when the piston 132 is in the separated position.
  • the position and shape are determined so as to be a long hole connecting the two.
  • the piston 132 is moved between the contact position and the separation position (hereinafter referred to as the piston movement range) along the central axis X while the outer peripheral side surface port 132BH faces the front direction or the rear direction.
  • the outer peripheral side surface port 132BH and the inflow port 131E or the outflow port 131F can be kept connected at any position within the range.
  • the delivery unit 130 sequentially communicates from the inlet pipe 131C to the storage space 131L via the inlet 131E and the outlet pipe 132C at any position in the piston movement range. Can do.
  • the delivery unit 130 sequentially communicates from the storage space 131L to the outflow pipe 131D via the flow pipe 132C and the outflow port 131F at any position in the piston movement range. Can do.
  • a groove 132D having a predetermined depth that goes around the outer peripheral side surface 132B is formed, and an annular O-ring 133 is fitted into the groove 132D.
  • the O-ring 133 is made of a resin material having elasticity, and is configured to maintain airtightness between the piston 132 and the cylinder 131.
  • a long and thin columnar column 134 is extended to the left on the left end surface of the piston 132. Further, a screw receiving portion 135 is attached to the left side of the column portion 134. That is, the piston 132, the column portion 134, and the screw receiving portion 135 are configured to move or rotate integrally in the internal space 131S of the cylinder 131.
  • the screw receiving portion 135 is formed in a rectangular parallelepiped shape that is elongated in the left-right direction as a whole, and has a shape penetrating vertically by making the inside hollow and omitting the upper side surface and the lower side surface.
  • a claw portion 135A as a piston-side protruding portion is erected outward in the vicinity of the right end of the side plate in the same direction as the outer peripheral side surface port 132BH of the piston 132 when viewed from the central axis X. .
  • a restriction portion 136 is attached to the cylinder 131 from the left side surface to the inner peripheral side surface 131B.
  • the restricting portion 136 is configured by an annular ring portion 136A serving as a substrate and two restricting plates 136B and 136C each having an elongated plate shape.
  • the annular portion 136 ⁇ / b> A has an inner diameter substantially equal to the inner peripheral side surface 131 ⁇ / b> B of the cylinder 131, and is attached to the left side surface of the cylinder 131 so that the inner peripheral side surface 131 ⁇ / b> B and the inner side surfaces of each other are aligned. .
  • the restricting plates 136B and 136C have their respective longitudinal directions aligned with the left-right direction, that is, the direction along the central axis X, and are located slightly below the front and rear sides of the inner surface of the annular portion 136A. Each is attached so as to protrude greatly from the annular portion 136A to the right. That is, the restriction plates 136B and 136C are erected from the inner peripheral surface 131B to the central axis X in the internal space 131S.
  • the regulation plates 136B and 136C are arranged in a direction from the inner peripheral side surface 131B toward the central axis X, that is, in a short direction so that the screw receiving portion 135 is rotated integrally with the piston 132 and the column portion 134 so as to come into contact with the claw portion 135A.
  • the length of is determined.
  • the restricting portion 136 brings the restricting plates 136B and 136C into contact with the claw portion 135A so that the rotation range of the screw receiving portion 135 and the piston 132 is about 180 ° from the front to the rear through the upper direction.
  • the range (hereinafter referred to as the piston rotation range) can be regulated.
  • regulation plates 136B and 136C define the length and the mounting position in the left and right direction so that the claw portion 135A moves in the left and right direction when the piston 132 moves in the piston movement range.
  • the restricting portion 136 can restrict the rotation range of the screw receiving portion 135 and the piston 132 within the piston rotation range even when the piston 132 is in any position within the piston movement range.
  • the left end face plate of the screw receiving portion 135 is provided with a screw hole 135B penetrating in the left-right direction.
  • a threaded portion 137A of the rotating threaded portion 137 is screwed into the threaded hole 135B.
  • the rotating screw portion 137 is configured around a screw portion 137A in which a thread groove is engraved on the peripheral side surface of a cylindrical column that is elongated in the left-right direction with the center axis X as the center, and is cylindrical from the screw portion 137A to the left.
  • the relay part 137B is extended.
  • relay portion 137B of the rotary screw portion 137 is supported by a rotary screw support portion having a slide bearing (not shown) so that it can freely rotate while maintaining positions in the left-right direction, the front-rear direction, and the vertical direction.
  • the threaded portion 137A of the rotating threaded portion 137 is configured so that a frictional force generated between the screw receiving portion 135 and the screw hole 135B (hereinafter referred to as a screwed frictional force)
  • a frictional force generated between the screw receiving portion 135 and the screw hole 135B hereinafter referred to as a screwed frictional force
  • the dimensions, materials, and the like of each part are optimized so as to be higher than the frictional force generated between the side 131B (hereinafter referred to as the peripheral side frictional force).
  • a gear portion 137C made up of a bevel gear centered on the central axis X is attached to the left end of the relay portion 137B.
  • the gear portion 137C meshes with the gear portion 138A of the rotation transmission portion 138.
  • the rotation transmitting portion 138 is configured around a central axis cylindrical relay portion 138B along the vertical direction, and a gear portion 138A made of a bevel gear similar to the gear portion 137C is attached to the lower end of the relay portion 138B. ing.
  • a driving magnet 138C made of a disk-shaped magnet is attached to the upper end of the relay portion 138B. Further, a rotation detection magnet 138D made of a small rectangular parallelepiped magnet is attached to one place on the outer periphery of the drive magnet 138C.
  • the driving magnet 138C is coupled to a power transmission magnet (described later) of the drive control unit 20 via a magnetic force. Further, the rotation transmitting unit 138 is supported by a support unit (not shown) so as to be able to rotate around a rotation axis along the vertical direction.
  • the rotation transmission unit 138 rotates by transmitting the rotation driving force via the driving magnet 138C, and the gear unit 138A and The rotating screw portion 137 can be rotated by the meshing of the gear portion 137C.
  • the delivery unit 130 when performing the inflow operation, first has the piston 132 in the contact position and facing backward. To do.
  • the delivery portion 130 applies an external force in the rotational direction to the piston 132 via the screw receiving portion 135 due to the screw friction force generated between the screw portion 137A and the screw hole 135B.
  • the claw portion 135A is brought into contact with the front regulation plate 136B by rotating about 180 ° clockwise.
  • the delivery unit 130 connects the outer peripheral side surface port 132BH and the inflow port 131E with the piston 132 facing forward, and connects the inflow port 131E and the flow tube 132C from the inflow tube 131C.
  • the outlet 131F is closed by the outer peripheral side surface 132B of the piston 132.
  • the delivery portion 130 cannot rotate due to the screw receiving portion 135 being restricted by the restriction plate 136B, and therefore the screw receiving portion 130 is screwed by the screw portion 137A and the screw hole 135B.
  • An external force in the moving direction is applied to the piston 132 via the portion 135, and the claw portion 135A is moved to the left while sliding on the restricting plate 136B, that is, using the restricting plate 136B as a guide rail.
  • the delivery unit 130 gradually expands the volume of the storage space 131L as the piston 132 moves in the left direction to increase the negative pressure, and is supplied to the inflow pipe 131C.
  • the delivery unit 130 can maintain the connection state between the outer peripheral side surface port 132BH and the inflow port 131E while the piston 132 moves over the piston movement range. It is possible to keep the chemical liquid flowing from the inflow pipe 131C into the storage space 131L.
  • the delivery part 130 can keep closing the outflow port 131F by the outer peripheral side surface 132B of the piston 132 at this time, the inflow of the chemical
  • the delivery unit 130 rotates the rotating screw part 137 clockwise a predetermined number of times, and at the stage where the piston 132 reaches the separated position, the rotating screw part 137 rotates clockwise. Stop rotation. As a result, about 1 [ ⁇ l] of the chemical solution is stored in the storage space 131L.
  • the delivery unit 130 rotates the piston 132 half a clockwise and then moves leftward as shown in FIGS. 9 (A) to (D). It can be moved and a chemical
  • the delivery unit 130 when performing the outflow operation, the delivery unit 130, as shown in FIG. 10 (A) showing a state equivalent to FIG. 9 (D), has the piston 132 in the separated position and facing forward. To do.
  • the delivery portion 130 causes an external force in the rotational direction to be exerted on the piston 132 via the screw receiving portion 135 by a screw friction force generated between the screw portion 137A and the screw hole 135B.
  • the claw portion 135A is brought into contact with the rear-side regulating plate 136C by rotating about 180 ° counterclockwise.
  • the delivery unit 130 connects the outer peripheral side surface port 132BH and the outlet 131F with the piston 132 facing rearward, and connects the flow pipe 132C and the outlet 131F from the storage space 131L. And the outflow pipe 131D are sequentially communicated with each other, and the inflow port 131E is closed by the outer peripheral side surface 132B of the piston 132.
  • the delivery portion 130 is screwed by screwing the screw portion 137A and the screw hole 135B.
  • An external force in the moving direction is applied to the piston 132 via the receiving portion 135, and the claw portion 135A is moved to the right while sliding on the restricting plate 136C, that is, using the restricting plate 136C as a guide rail.
  • the delivery unit 130 gradually reduces the volume of the storage space 131L as the piston 132 moves in the right direction to increase the pressure, and stores in the storage space 131L.
  • the chemical liquid being discharged is allowed to flow out to the outflow pipe 131D.
  • the outflow port 131F is formed in a long hole shape in the same manner as the inflow port 131E, the delivery unit 130 is connected to the outer peripheral side surface port 132BH and the outflow port 131F while the piston 132 moves over the piston movement range.
  • the chemical solution can continue to flow out from the storage space 131L to the outflow pipe 131D.
  • the delivery unit 130 can keep the inlet 131E closed by the outer peripheral side surface 132B of the piston 132, and thus can prevent the chemical solution from flowing out from the inlet 131E side.
  • the delivery unit 130 rotates the rotating screw unit 137 counterclockwise a predetermined number of times and reaches the piston 132 at the contact position, thereby counterclockwise the rotating screw unit 137. Stop rotating in the direction. Thereby, all the chemical
  • the delivery unit 130 rotates the piston 132 half-clockwise counterclockwise as shown in FIGS. 10 (A) to (D). It is possible to cause the chemical solution to flow out from the storage space 131L to the outflow pipe 131D.
  • the delivery unit 130 causes the chemical solution to flow into the storage space 131L from the inflow pipe 131C, and when the rotary screw portion 137 is rotated in the counterclockwise direction, the storage space 131L.
  • the chemical liquid can flow out from the inside to the outflow pipe 131D.
  • the delivery unit 130 can function as a pump that intermittently delivers the chemical solution by alternately switching the rotation direction of the rotary screw unit 137 under the control of the drive control unit 20 (FIG. 2).
  • the delivery unit 130 can make the volume of the storage space 131L constant when the piston 132 is at the separation position, so that the inflow amount by one inflow operation (FIG. 9) and the one outflow operation (FIG. 9).
  • the outflow amount according to 10) can be made constant.
  • medical solution can be kept constant by keeping the rotation speed of the rotation screw part 137 constant, and the change degree can be changed by changing the rotation speed of the rotation screw part 137. Accordingly, the delivery speed of the chemical solution can be changed.
  • the delivery unit 130 because of the structure of the delivery unit 130, only one of the inflow pipe 131C or the outflow pipe 131D can be communicated with the storage space 131L at a time, and therefore the delivery section 130 communicates with both the inflow pipe 131C and the outflow pipe 131D at the same time. This prevents the back flow of the chemical solution and fluctuations in the delivery speed.
  • the compression unit 150 includes a press plate 151, a support unit 152, and a plate spring 153.
  • the holding plate 151 is a plate material having an area larger than the central portion 112 of the chemical solution bag 110 and is provided on the upper side of the chemical solution bag 110.
  • the holding plate 151 is supported by a support portion 152 fixed to the lower casing portion 101 so as to be rotatable in a direction away from and approaching the chemical solution bag 110 around the connecting portions 151A and 152A formed of, for example, a hinge mechanism.
  • the plate spring 153 is a plate material provided in a state of being bent in a substantially V shape between the holding plate 151 and the upper housing portion 102, and the plate portions that are bent in a substantially V shape and are opposed to each other are separated from each other.
  • the force works in the direction to open (the direction to open). Therefore, when the leaf spring 153 is disposed between the holding plate 151 and the upper housing portion 102, the holding plate 151 is always pressed against the chemical solution bag 110 side with a constant force.
  • the compression portion 150 is a plate spring release rod between the holding plate 151 and the plate spring 153 through the hole 101G of the lower housing portion 101 before the chemical solution is injected into the chemical solution bag 110 (FIG. 4A). 154 is inserted. At this time, in the compression unit 150, the presser plate 151 can freely rotate without the plate spring 153 pressing the presser plate 151.
  • the compression portion 150 presses the holding plate 151 against the chemical solution bag 110 side.
  • the pressing plate 151 sandwiches the chemical solution bag 110 with the lower housing 101 and the presser plate 151 applies a constant positive pressure to the chemical solution bag 110 (FIG. 4B).
  • the compression unit 150 can discharge the bubbles to the outside via the filter unit 120 when bubbles are present in the chemical solution bag 110.
  • the compression unit 150 presses the chemical solution bag 110 in a direction to be crushed, so that the chemical solution stored in the chemical solution bag 110 is pushed out without leaving inside. Thus, it can be sent out.
  • the drive control unit 20 is formed in a substantially U-shape having a recess 20 ⁇ / b> A that matches the shape of the puncture flow channel portion 30 so that the puncture flow channel portion 30 is inserted from the front direction. Is done.
  • the drive control unit 20 is a space formed between an upper housing part 201 that is open on the lower side and has a space inside, and a lower housing part 202 that is screwed into the opening of the upper housing part 201.
  • a charging antenna 203 a substrate 204, a communication antenna 205, a rechargeable battery 206, a motor 207, a gear head 208, a power transmission magnet 209, magnetic sensors 210 and 211, and the like.
  • the outer surface along the front-rear direction of the upper housing part 201 is provided with engagement receiving parts 201A to 201D that are grooves for engaging with the engagement parts 101B to E provided in the chemical solution storage and delivery part 10, respectively.
  • a bolus switch 201E that is pressed down by the user when a certain amount of chemical solution is temporarily administered (bolus administration) is provided.
  • the bolus switch 201E is provided at a position recessed from the upper surface of the upper housing portion 201, and can be prevented from being accidentally pressed by the user, for example, by turning over.
  • the lower casing 202 is provided with a waterproof packing 202A on the surface that is in close contact with the upper casing 201, and the upper casing 201 is screwed to the lower casing 202 via the waterproof packing 202A (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the upper casing portion 201 and the lower casing portion 202.
  • the charging antenna 203 is affixed on the upper surface of the lower housing
  • a CPU Central A board unit 204 on which a communication antenna 205 for transmitting and receiving signals to and from an electrical circuit such as a processing unit (RAM), a random access memory (RAM), and a read only memory (ROM) and the controller 3 is disposed above the charging antenna 203. It is provided to overlap.
  • RAM processing unit
  • RAM random access memory
  • ROM read only memory
  • a rechargeable battery 206 is provided on the upper surface of the lower casing unit 202, which is charged by electricity supplied from the charging antenna 203 and supplies electricity to each unit during driving.
  • the motor 207, the gear head 208, and the power transmission magnet 209 are provided on the upper surface of the lower casing unit 202 so as to overlap with each other in order from the top at a position facing the driving magnet 138C of the drug solution storage and delivery unit 10.
  • a magnetic sensor 210 is provided on the upper surface of the lower housing unit 202.
  • the motor 207 rotates the power transmission magnet 209 via the gear head 208. As shown in FIG. 12, the power transmission magnet 209 faces the drive magnet 138C so as to have a polarity that attracts the drive magnet 138C in a state where the chemical storage / delivery unit 10 and the drive control unit 20 are in close contact with each other. To be placed.
  • the power transmission magnet 209 When the power transmission magnet 209 is rotated by the motor 207 via the gear head 208, the power transmission magnet 209 rotates with its rotation while attracting the driving magnet 138C by magnetic force.
  • the motor 207 rotates the piston 132 by rotating the rotation transmission portion 138 and rotating the rotation screw portion 137 in a non-contact manner via the gear head 208, the power transmission magnet 209, and the driving magnet 138C. Move to.
  • the motor 207 rotates the rotation transmission unit 138 in a non-contact manner through the magnetic force of the power transmission magnet 209 and the driving magnet 138C, it is determined whether or not the rotation transmission unit 138 rotates following the rotation of the motor 207. It needs to be detected. Therefore, the magnetic sensor 210 that detects that the rotation transmitting unit 138 is rotating is disposed on the circumference where the rotation detecting magnet 138D moves.
  • the magnetic sensor 210 detects the magnetic force of the rotation detection magnet 138D, it detects that the rotation transmitting unit 138 has made one rotation by detecting the magnetic force again.
  • the magnetic sensor 210 can detect the rotation and movement of the piston 132 by detecting that the rotation transmitting unit 138 is rotating.
  • the number of rotations is detected in units of one rotation, but the number of magnetic sensors 210 may be increased to detect the number of rotations more finely.
  • the microcomputer 220 (FIG. 21) is a magnetic sensor 210 provided in the same space formed by the upper housing portion 201 and the lower housing portion 202 and is a different space. It is possible to check the drive of the sending unit 130 provided in the space formed by the lower housing unit 101 and the upper housing unit 102 without contact.
  • a connector unit 212 for transmitting and receiving various signals is provided. As shown in FIGS. 13A and 13B, the connector portion 212 has a structure in which a waterproof rubber 212B covers the outside of the electrical connector portion 212A in which a plurality of spring connectors 212C for transmitting and receiving electricity and various signals are collected. It becomes.
  • the connector part 350 (FIG. 15) of the puncture flow path part 30 connected to the connector part 212 also has a waterproof rubber outside the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected. The structure is covered with 350B.
  • the waterproof rubber 212B and 350B can prevent the liquid from touching the electrical connector units 212A and 350B.
  • the length is not contacted at the limit where insertion is permitted (when sufficient insertion is not performed).
  • This pin is provided and connected to the ground potential on the puncture flow path section 30 side, and it is checked whether the potential of this pin is the ground potential or not on the drive control section 20 side. In this case, the insertion of the puncture channel 30 is monitored by displaying an alarm indicating that the puncture channel 30 is insufficiently inserted.
  • the puncture channel portion 30 is fitted in the space between the recess 101H and the recess 20A formed in a state where the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged. It has an elongated shape.
  • the puncture flow path part 30 is provided with each part in the internal space of the housing part 301 that forms the outer shell. 14A shows an external configuration, and FIG. 14B shows an internal configuration. Further, in FIG. 15, for convenience of explanation, a part is shown in cross section.
  • the housing unit 301 When the puncture flow path unit 30 is fitted to the drug solution storage and delivery unit 10, the housing unit 301 includes a bottom surface 301 ⁇ / b> A located on the same plane as the bottom surface 101 ⁇ / b> A of the lower housing unit 101 and the center of the upper housing unit 102. A bottom surface 301B located at a height facing and adjacent to the portion 102C.
  • the housing portion 301 is provided at a position where a convex portion 301C that fits into the concave portion 102D of the upper housing portion 102 when the puncture flow path portion 30 is fitted to the drug solution storage and delivery portion 10 faces the concave portion 102D in the bottom surface 301B. .
  • the casing 301 includes a protrusion 101I of the lower casing 101 and a protrusion 102A of the upper casing 102, a protrusion 101J of the lower casing 101, and a protrusion of the upper casing 102.
  • Guide grooves 301D and 301E that respectively engage with the portion 102B are formed on the side surfaces along the front-rear direction.
  • the casing 301 is provided with a recess 301Q on the upper surface 301F for hooking a user's finger when removing the puncture channel 30 from the drug solution storage / delivery unit 10 and the drive controller 20 that are fitted.
  • the casing 301 is curved from the upper surface 301F to the front surface 301G, and an angle adjustment mechanism 340, which will be described in detail later, is provided on the curved surface 301H.
  • the casing 301 is provided with a hole 301I at a position facing the valve body 108 of the chemical liquid storage / delivery section 10 in a state where the puncture flow path section 30 is fitted to the chemical liquid storage / delivery section 10.
  • the nozzle 302 to be inserted is fixed so as to penetrate the hole 301I.
  • the nozzle 302 is fixed without providing a gap with the hole 301I.
  • One end of the nozzle 302 is inserted into the valve body 108 in a state where the puncture flow path section 30 is fitted to the drug solution storage and delivery section 10 and communicates with the flow path pipe 107.
  • the nozzle 302 is connected to a running water sensor 303 at the other end.
  • the flowing water sensor 303 is for detecting whether or not the passing chemical solution is flowing.
  • the thermistor is heated at a constant current to detect a temperature change of the thermistor due to the continuous flow of the chemical solution.
  • the heating source and the temperature sensor are used separately.
  • the heating source is a resistor, heater wire, semiconductor, and the temperature sensor is a thermo file, platinum resistor, semiconductor, etc. Things are adaptable.
  • the flowing water sensor 303 has a puncture channel needle 304 connected to the end opposite to the end to which the nozzle 302 is connected, and allows the nozzle 302 and the puncture channel needle 304 to communicate with each other.
  • the puncture flow path needle 304 is bent so that one end side connected to the running water sensor 303 is folded back on the S-shape, is arranged along the front-rear direction therefrom, and reaches the bottom surface 301A on the other end side.
  • the puncture channel needle 304 is made of a metal member, but is a 28 gauge hollow tube, for example, which can be easily bent.
  • the puncture channel needle 304 is fixed by a fixing portion 305 that protrudes inward from the housing portion 301 at a position immediately after being folded back on the S-shape.
  • the puncture flow path needle 304 is spirally wound with a part (hereinafter also referred to as an elastic portion) 304A on the front side from the position fixed to the fixing portion 305.
  • the elastic portion 304A is extendable in the front-rear direction.
  • the puncture channel needle 304 has a sharply sharp shape at a tip portion (hereinafter also referred to as a tip portion) 304B that is bent so as to reach the bottom surface 301A.
  • the puncture flow path needle 304 having such a shape sends the drug solution flowing from the flowing water sensor 303 to the outside through the inner space from the distal end portion 304B.
  • the puncture channel needle 304 is covered with, for example, the sheath portion 310 from the distal end portion 304B to the elastic portion 304A.
  • the sheath portion 310 is made of, for example, Teflon (registered trademark of DuPont) (polytetrafluoroethylene) or polyethylene, and is made of a flexible sheath 311 and, for example, Teflon (registered trademark of DuPont), polyolefin, or polyurethane. It is composed of an elongated portion 312 that is soft and has a characteristic (permanent deformation, plastic deformation) that maintains the shape as it is once deformed and does not return to the original shape. Examples of the material that is soft and easily deformable and has an irreversible property as the extending portion 312 include a material that is crosslinked by ultraviolet rays at a high temperature such as a heat shrinkable tube. Polyolefin, Teflon (registered by DuPont) Trademark), silicon, polyvinyl chloride, polyvinylidene fluoride, and the like can be used.
  • the sheath 311 covers most of the puncture channel needle 304 from the distal end 304B to the front of the elastic portion 304A, and is not fixed to the puncture channel needle 304.
  • the extending portion 312 covers the puncture channel needle 304 from a position overlapping one end side of the elastic portion 304A side of the sheath 311 to just before the elastic portion 304A, and one end on the fixed portion 305 side is the puncture channel needle. The other end is fixed to the sheath 311.
  • the extending portion 312 is fixed so as to seal the gap between the puncture flow path needle 304 and the sheath 311 along the circumferential direction so that the liquid does not leak from the gap at both fixed ends.
  • a caulking 306 that fixes the puncture flow path needle 304 and the sheath 311 together is provided at a predetermined position closer to the distal end portion 304B than the elastic portion 304A of the puncture flow path needle 304.
  • the caulking 306 is made of a material that deforms when a certain force is applied, such as aluminum or copper.
  • the caulking 306 is crushed from the left and right direction after the puncture flow path needle 304 and the sheath 311 are inserted into the ring hole from the state of the ring shape, and a part of the vertical direction overlaps, and the puncture flow path needle 304 and the sheath 311 are overlapped. Tighten and fix. Thereby, the sheath 311 is fixed so as not to slip with respect to the puncture flow path needle 304.
  • the caulking 306 is bonded to the sheath 311 and does not leave the sheath 311 even when the caulking 306 is loosened.
  • the puncture flow path part 30 is provided in front of the caulking 306 and a movement restricting part 307 at a position away from the caulking 306 by a predetermined distance.
  • the predetermined distance is a distance at which the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, that is, a depth at which the puncture flow path needle 304 and the sheath 311 are punctured to the user. It is the same distance as the distance, and is set to 10 mm in the present embodiment.
  • the movement restricting portion 307 is fixed to the housing portion 301 and is arranged so that the puncture flow path needle 304 and the sheath portion 310 can be inserted into a hole provided in the center without contacting.
  • the puncture flow path section 30 is provided with a puncture mechanism 320 at a position behind the caulking 306 and ahead of the extension section 312.
  • the puncture mechanism 320 includes a fixed plate 321, a spring 322, a support plate 323, and a pressing portion 324.
  • the fixing plate 321 is fixed to the housing part 301 and is arranged so that the puncture flow path needle 304 and the sheath part 310 can be inserted into a hole provided in the center without contact.
  • a spring 322 is disposed in front of the fixed plate 321.
  • the spring 322 is arranged so as to pass through the inner space without contact between the puncture flow path needle 304 and the sheath portion 310, and is arranged in a state where it is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length. Is done.
  • the support plate 323 is arranged so that the puncture flow path needle 304 and the sheath portion 310 are inserted without contacting each other, and is a surface on the opposite side to the surface where the spring 322 is in contact with the puncture flow path needle 304 and the sheath portion.
  • the push portion 324 is supported below 310.
  • the support plate 323 is held so as not to move forward by the puncture release mechanism 330 at a position lower than a position where the pressing portion 324 is supported on the same surface as the surface supporting the pressing portion 324.
  • the pressing portion 324 has a substantially cylindrical shape, and has a negative shape (one character type) whose tip is long in the vertical direction and short in the horizontal direction.
  • the pressing portion 324 is supported by the support plate 323 so that the tip is located between members overlapping on the lower side of the portion of the caulking 306 extending in the vertical direction.
  • the puncture release mechanism 330 includes a limiting portion 331, a spring 332, and an actuator 333.
  • the restricting portion 331 has a portion extending in the front-rear direction and a portion extending in the up-down direction so that the cross section has a substantially L shape, and is provided near the center of the portion extending in the front-rear direction.
  • the rotary shaft 331A is held rotatably.
  • the restricting portion 331 is disposed so as to support the support plate 323 with the surface on the rotating shaft 331A side of the portion extending in the vertical direction, and restricts the support plate 323 from moving in the forward direction.
  • the restriction portion 331 has a spring 332 connected to the lower surface on the front side of the rotation shaft 331A of the portion extending in the front-rear direction, and the protrusion 333A of the actuator 333 is in contact with the upper surface on the rear side of the rotation shaft 331A.
  • the spring 332 has one end connected to the restricting portion 331 and the other end connected to the bottom surface 301B side of the housing portion 301, and is arranged in a state in which a force is always applied in the direction of contraction.
  • the actuator 333 is configured to move the protruding portion 333A in the front-rear direction when electric power is supplied, and is disposed in a state where the protruding portion 333A is in contact with the limiting portion 331.
  • the spring 322 is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length, the limiting portion 331 is in contact with the support plate 323, and the projection 333A of the actuator 333 is disposed in contact with the limiting portion 331.
  • the state is also referred to as an initial state (FIGS. 15 and 17A).
  • the puncture flow path needle 304 and the sheath 311 are illustrated in a straight state that is not bent, but in reality, a part thereof is bent as described above.
  • the contracted spring 322 extends to return to the natural length and pushes the support plate 323 and the pressing portion 324 in the forward direction.
  • the pushing portion 324 pushed in the forward direction pushes the caulking 306 forward together with the puncture channel needle 304 and the sheath 311 until the caulking 306 comes into contact with the movement restricting portion 307.
  • the caulking 306 moves in the forward direction while sandwiching the puncture channel needle 304 and the sheath 311 along the caulking guide 308 in which the upper portion of the portions extending in the vertical direction overlaps on the upper side.
  • the cross section of the caulking guide 308 has a U-shape with an opening at the bottom, and the caulking 306 fits from the direction in which the caulking guide 308 is opened in the overlapping portion on the upper side. Is retained.
  • the elastic portion 304A of the puncture channel needle 304 is extended (FIG. 17B).
  • the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, and the distal end 304B punctures the user and enters the user's body together with the sheath 311.
  • the spring 322 continues to extend even after the caulking 306 comes into contact with the movement restricting portion 307, and the tip of the pressing portion 324 enters between the members overlapping below the caulking 306. At this time, the pusher 324 opens the overlapping members below the caulking 306 on both sides, and loosens the tightening of the caulking 306 with respect to the puncture channel needle 304 and the sheath 311.
  • the sheath 311 is fixed to the caulking 306 and cannot move, so the extension portion 312 having one end fixed to the puncture channel needle 304 extends as the elastic portion 304A contracts.
  • the sheath portion 310 is maintained in a state in which the distal end portion of the sheath 311 protrudes from the bottom surface 301A because the elongated portion 312 that extends at one end does not return to the original shape (FIG. 17C).
  • the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then inserts only the flexible sheath 311 into the body. Subsequently, the puncture channel needle 304 made of metal can be returned to the outside of the body.
  • the medicinal solution administration device 2 does not leave the metal puncture channel needle 304 in the body while the user is using it, and can continue to insert only the flexible sheath 311 into the body. It is possible to reduce pain and discomfort to the user, thus improving usability.
  • one end of the sheath is connected to the needle through a packing, and after the needle and the sheath are punctured into the skin, the sheath is inserted into the packing portion when the needle is pulled out of the body. It was made to slide and stay in that position.
  • the gap between the needle and the sheath is sealed with the packing, so that the drug solution leaks, or when the seal is strengthened, the friction between the needle and the packing increases and the needle reaches a sufficient depth. There was a possibility not to sting.
  • the medicinal solution administration device 2 since the medicinal solution administration device 2 is fixed without providing a gap with the puncture channel needle 304 at one end of the extending portion 312, the medicinal solution does not leak. In addition, there is no hindrance to the puncturing operation due to the friction between the packing and the needle.
  • the puncture flow path section 30 (FIGS. 14 and 15) is forward of the movement restricting section 307 and on the curved surface 301H of the housing section 301, the angle at which the puncture flow path needle 304 and the sheath 311 project with respect to the bottom surface 301A (
  • an angle adjustment mechanism 340 for adjusting the projection angle is also provided. Since the bottom surface 301A is in contact with the user's skin, the protruding angle is the same as the angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's skin (hereinafter also referred to as the puncture angle).
  • the angle adjustment mechanism 340 is supported by a support portion 341 made of an L-shaped column whose one end is fixed to the housing portion 301.
  • the support portion 341 is a concentric circular shape at the end surface arranged to be orthogonal to the left-right direction on the side opposite to the one end fixed to the housing portion 301, and a plurality of (four in this embodiment) concave portions at a predetermined angle. 341A is provided.
  • the concave portion 341A is provided at a position where the puncture angle of the puncture channel needle 304 and the sheath 311 is 20 ° to 90 °, as will be described in detail later.
  • the angle adjusting mechanism 340 is provided with a central portion 342 having a convex portion 342A projecting so as to be concentric with the concave portion 341A and fitted into the concave portion 341A at a position facing the end surface of the support portion 341.
  • the central portion 342 is supported by the support portion 341 at a position where the protruding convex portion 342A fits into the concave portion 341A while being pressed toward the support portion 341 by the screw 345 through the spring 343 and the spring pressing plate 344.
  • the central portion 342 is provided with a shaft portion 346 in a direction orthogonal to the rotation axis when the center portion 342 rotates.
  • the shaft portion 346 has a cylindrical shape, one end is connected to the holding portion 347 that holds the puncture channel needle 304 and the sheath 311, and the other end is connected to the knob portion 348 that is held when the angle is adjusted by the user. Is done.
  • the holding portion 347 is a tube having an inner diameter that is thicker than the outer shape of the sheath 311, and the puncture flow path needle 304 and the sheath 311 are inserted therethrough, and the puncture flow path needle 304 and the sheath 311 are held without being fixed.
  • the knob portion 348 includes a knob 348A held by the user and a knob support portion 348B that supports the knob 348A.
  • the knob portion 348 is placed so that both ends of the knob support portion 348B are hooked on rail portions 301K and 301M whose left and right sides of the opening 301J provided on the curved surface 301H of the housing portion 301 are L-shaped in cross section.
  • the knob support portion 348B is placed so as to be sandwiched between the housing portion 301 and the panel portion 349 provided on the curved surface 301H of the housing portion 301.
  • the panel portion 349 opens so that the knob 348A can move in a direction along the curved surface 301H (hereinafter also referred to as a curved direction), and has a shape that is longer in the curved direction than the rail portions 301K and 301M. is doing.
  • a waterproof packing 348C is provided on the edge of the upper surface of the knob support portion 348B, and prevents liquid from entering the housing portion 301 from between the knob support portion 348B and the panel portion 349.
  • the holding portion 347 is rotated according to the rotation of the shaft portion 346 around the center portion 342 when the knob portion 348 is moved in the bending direction by the user. .
  • the angle adjusting mechanism 340 sets the protrusion angle of the puncture flow path needle 304 held by the holding portion 347 and the bottom surface 301A of the sheath 311 to 20 ° to 90 °.
  • Change in range. 20A shows a case where the protrusion angle is 90 °
  • FIG. 20B shows a case where the protrusion angle is 20 °.
  • the angle adjusting mechanism 340 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis arranged in parallel with the bottom surface 301A in the range of 20 ° to 90 °.
  • the puncture flow path needle 304 and the sheath 311 are set so that the tip 304B does not come out of the bottom 301A when the distance between the tip 304B and the bottom 301A changes depending on the puncture angle.
  • distal end portion 304B of the puncture channel needle 304 and the distal end of the sheath 311 are arranged so as to close the opening 301N provided in the bottom surface 301A and come into contact with the outer periphery of the sheath 311. Held by the unit 309.
  • the tip holding portion 309 is fitted to an L-shaped rib provided inside the bottom surface 301A, and both sides are shifted in the front-rear direction along the inside of the front surface 301G and the back surface 301V of the 301. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 340, they can follow it and continue to close the opening 301N. Accordingly, liquid can be prevented from entering the housing portion 301.
  • the tip holding portion 309 includes an air vent filter 309A that covers the tip portion 304B of the puncture channel needle 304 and the tip of the sheath 311 at a position further ahead of the tip portion 304B of the puncture channel needle 304. Provided.
  • the air vent filter 309A can discharge only the air present in the puncture channel needle 304 to the outside without leaking the drug solution flowing through the puncture channel needle 304 before use by the user. .
  • the angle adjustment mechanism 340 can change the protrusion angle of the puncture flow path needle 304 and the bottom surface 301A of the sheath 311 with respect to the bottom surface 301A within a range of 20 ° to 90 ° according to the operation of the user.
  • the human body has skins such as epidermis and dermis from about 1.5 mm to 4 mm from the body surface, and there is subcutaneous tissue at a depth of about 4 mm to 9 mm from the body surface inside, and further inside Have muscles.
  • insulin when administered from the outside, it is generally administered to a subcutaneous tissue at a depth of about 4 mm to 9 mm from the surface in consideration of burden on the user, pain, absorption rate of insulin, and the like.
  • the medicinal-solution administration device 2 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis within the range of 20 ° to 90 ° by the angle adjusting mechanism 340.
  • the angle adjusting mechanism 340 By adjusting, it is possible to puncture to an arbitrary depth, and it is possible to reliably puncture the subcutaneous tissue that is optimal for all users.
  • by administering a drug solution to the dermis layer it is possible to obtain the same medicinal effect with a small amount of drug solution compared to when administered subcutaneously, and therefore it is possible to set the puncture distance to the dermis.
  • the medicinal solution administration device 2 can improve usability.
  • the connector unit 350 is adhered to the hole 301P provided at a position facing the connector unit 212 of the drive control unit 20 without a gap.
  • the connector portion 350 covers the outside of the electrical connector portion 350A in which a plurality of connector portions 350C for transmitting and receiving electricity and various signals are collected with a waterproof rubber 350B. Constructed.
  • the medicinal solution administration device 2 includes the puncture channel unit 30 provided with the puncture channel needle 304 for puncturing the user's skin, the medicinal solution storage and delivery unit 10 provided with the medicinal solution bag 110 for storing the medicinal solution, and the delivery.
  • the drive control unit 20 provided with the motor 207 for operating the unit 130 and the substrate unit 204 is provided separately.
  • the liquid medicine bag for storing the liquid medicine, the motor, etc. are all provided in the same housing, for example, when puncture fails Had to replace the entire device, which was not only convenient, but also increased the economic burden.
  • the controller 3 includes a microcomputer 361, a battery 362, a battery monitoring unit 363, a mode switch 364, a numerical value setting switch 365, a display unit 366, a transmission unit 367, a reception unit 368, and a communication antenna 369.
  • the microcomputer 361 is a computer including a CPU, a RAM, a ROM, and the like.
  • the CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM.
  • Various processes are executed by reading various programs into the RAM and executing them.
  • the battery 362 supplies power to each unit.
  • the battery monitoring unit 363 monitors the presence / absence and remaining amount of the battery 362 and notifies the microcomputer 361 of it.
  • the mode switch 364 is a switch for setting a basal mode in which a chemical solution is continuously administered for a long time and a bolus mode in which a chemical solution is temporarily administered.
  • the numerical value setting switch 365 is a switch for setting the dose per hour and the administration time of the drug solution.
  • the microcomputer 361 displays the contents corresponding to the operation on the mode switch 364 and the numerical value setting switch 365 on the display unit 366 and transmits a signal indicating the contents to the drug solution administration device 2 via the transmission unit 367 and the communication antenna 369. To do.
  • the microcomputer 361 when the microcomputer 361 receives the signal transmitted from the medicinal solution administration device 2 via the communication antenna 369, the microcomputer 361 acquires the signal via the receiving unit 368, and displays a content corresponding to the signal such as an occlusion alarm or a drive unit abnormality. In addition to notifying the user by displaying on 366, processing corresponding to the content is executed.
  • the electric circuit is operated by the power supply supplied from the rechargeable battery 206, and the microcomputer 220 provided in the drive control unit 20 performs overall control.
  • the microcomputer 220 is a computer including a CPU, a RAM, a ROM, and the like.
  • the CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM.
  • Various processes are executed by reading various programs into the RAM and executing them.
  • the microcomputer 220 receives the administration time and the dose which are set in advance by the controller 3 and is stored in the RAM by the communication antenna 205 and the reception unit 222, and operates each part according to the administration time and the dose. Alternatively, each unit is operated directly according to the dose received from the controller 3 via the receiving unit 222.
  • the microcomputer 220 operates the flowing water sensor 303 in synchronization with the liquid feeding of the delivery unit 130 to monitor whether the administration is normally delivered, and monitors whether the delivery unit 130 is operating as controlled by the magnetic sensor 210. If it is determined that there is an abnormality, the occurrence of a blockage, a drive unit abnormality, or the like is transmitted to the controller 3.
  • the bolus administration time and dose, and the basal administration time and dose are set in the controller 3 and transmitted to the drug solution administration device 2, thereby the drug solution administration device. 2 is set.
  • an amount of the chemical solution corresponding to the set content is injected into the chemical solution bag 110 so that bubbles do not enter the chemical solution.
  • the puncture angle of the drug solution administration device 2 is adjusted by causing the user to operate the filling angle adjustment mechanism 340 under the guidance of the doctor, and the drug solution administration device 2 is attached to the user via the application unit 103.
  • the microcomputer 220 confirms whether or not the puncture flow path unit 30 is connected to the drive control unit 20 by connecting the connector units 212 and 350.
  • the microcomputer 220 drives the puncture release mechanism 330 to puncture the user with the puncture channel needle 304 and the sheath 311.
  • the microcomputer 220 sends a prescribed amount of liquid to fill the cavity in the sheath punctured by the living body. Specifically, the microcomputer 220 monitors whether or not the basal administration time or the bolus administration time stored in advance in the RAM has been reached, and administers a drug solution of a set dose when any administration time is reached. . Further, when the microcomputer 220 receives a bolus administration instruction from the controller 3, the microcomputer 220 immediately administers the received dose of drug solution. In any case, the microcomputer 220 administers the drug solution into the user's body by rotating the motor 207 and driving the delivery unit 130 in order to administer the drug solution at the set drug solution dosage and administration speed.
  • the drug solution stored in advance in the drug solution bag 110 via the injection unit 104 is used via the filter unit 120, the delivery unit 130, the running water sensor 303, the puncture channel needle 304, the sheath 311, and the like. It is administered to the body of a person.
  • the microcomputer 220 monitors the rotation speed of the motor 207 via the encoder 223 and detects whether or not the chemical solution is flowing via the flow detection control unit 224.
  • the flow detection control unit 224 heats the thermistor of the flowing water sensor 303 and monitors the temperature change of the thermistor.
  • microcomputer 220 detects whether or not the sending unit 130 is driven based on the magnetic force detected by the magnetic sensor 210.
  • the microcomputer 220 performs again when the motor 207 is not rotating normally, when the delivery unit 130 is not normally driven, or when no chemical is flowing, and when the state does not change, Each unit is stopped, and a message such as a blocking alarm is transmitted to the controller 3 via the transmission unit 221 and the communication antenna 205.
  • the microcomputer 220 controls the receiving / charging circuit 225 to receive the electricity supplied from the charger 4 through the charging antenna 203 to charge the rechargeable battery 206.
  • the rechargeable battery 206 is provided with a battery safety circuit unit 226.
  • the battery safety circuit unit 226 monitors overcharge during charging and temperature change, prevents overcharge and thermal runaway, and prevents overdischarge during use. .
  • the charger 4 includes an outlet 401, an AC / DC converter 402, a high frequency converter 403, and a transmission antenna 404.
  • the charger 4 converts alternating current sent from the outlet 401 into direct current by the AC / DC converter 402, converts it to high frequency by the high frequency conversion unit 403 for transmission by the transmission antenna 404, and then passes through the transmission antenna 404. Then, electric energy is transmitted to the drug solution administration device 2.
  • the drug solution storage and delivery unit 10 including the drug solution bag 110 and the puncture channel unit 30 including the puncture channel needle 304 and the sheath 311 are used only once from the hygiene viewpoint that the drug solution is used.
  • the drive control unit 20 that does not use the chemical solution can be used many times by attaching and detaching the chemical solution storage and delivery unit 10 and the puncture flow path unit 30. At this time, since the rechargeable battery 206 of the drive control unit 20 is charged by the charger, it can be used multiple times.
  • the screw friction force generated between the screw portion 137A of the rotary screw portion 137 and the screw hole 135B of the screw receiving portion 135 is optimized by optimizing the dimensions and materials of each portion.
  • the case where the peripheral side frictional force generated between the outer peripheral side surface 132B and the inner peripheral side surface 131B of the cylinder 131 is increased is described.
  • the screw friction force is applied to the peripheral side surface friction by urging the screw portion 137A of the rotating screw portion 137 to the screw hole 135B of the screw receiving portion 135 using an urging means such as a spring. You may make it raise rather than power.
  • the present invention is not limited to this, and the rotating screw portion 137 can be rotated freely while maintaining positions in the left-right direction, the front-rear direction, and the up-down direction by a rotating screw support portion formed of various known mechanisms or combinations thereof. May be supported.
  • a sending unit 630 that replaces the sending unit 130 can be configured.
  • the delivery unit 630 includes a screw receiver 635 and a rotary screw 637 that replace the screw receiver 135 and the rotary screw 137, and further includes a relay gear 638 and a rotary screw support 640. Although the point which has is different, it is comprised similarly about another part.
  • the screw receiving portion 635 has a claw portion 635A and a screw hole 635B similar to the claw portion 135A and the screw hole 135B of the screw receiving portion 135, and an annular mounting portion on the inner surface side of the left side plate. 635C is erected.
  • a spring 635D made of a coil spring is attached to the outer periphery of the attachment portion 635C.
  • the spring 635D is wound in the right direction, and a cap 635E is attached to the right end thereof.
  • the cap 635E is attached to the spring 635D by an annular 635EA similar to the attachment portion 635C, and a protrusion 635EB protruding leftward is formed at the center of the right side surface.
  • the spring 635D is attached to the screw receiving portion 635 in a state extended from the natural length.
  • the spring coefficient, the number of turns, the pitch, and the like of the spring 635D are appropriately selected so that the natural length is not returned even when the piston 132 is at the separation position and is shortened the most.
  • a ruby bearing 637AB is embedded in the right end portion of the screw portion 637A corresponding to the screw portion 137A of the rotating screw portion 137.
  • the ruby bearing 637AB is configured to receive the protrusion 635EB of the cap 635E by forming a recess in the center portion of the right side surface.
  • the spring 635D applies an elastic force that always tries to return to the natural length, that is, shortens, and causes the screw portion 637A of the rotary screw portion 637 to move to the left via the cap 635E. Since the biasing is performed, the screw friction force between the screw portion 637A and the screw hole 635B can be increased.
  • the screw friction force is made higher than the circumferential friction force by urging the screw portion 637A of the rotating screw portion 637 to the screw hole 635B of the screw receiving portion 635 by the elastic action of the spring 635D. Can do.
  • the rotating screw portion 637 is provided with a gear portion 637C made of a spur gear instead of the gear portion 137C made of a bevel gear of the rotating screw portion 137 of FIG.
  • the gear portion 637C meshes with the gear portion 638A of the relay gear 638.
  • a gear portion 638A made of a spur gear is attached to one end of a cylindrical columnar portion 638B, and a gear portion 638C made of a bevel gear is attached to the other end.
  • the gear portion 638 ⁇ / b> C meshes with the gear portion 138 ⁇ / b> A of the rotation transmission portion 138, similarly to the gear portion 137 ⁇ / b> C of the rotation screw portion 137.
  • the relay gear 638 can be rotated by transmitting the rotational driving force from the rotation transmitting portion 138, and the rotational driving force can be transmitted to the rotating screw portion 637 to be rotated.
  • the rotating screw support portion 640 (FIG. 23) is configured around a plate-like substrate 641 that faces the plate surface in the left-right direction.
  • the substrate 641 has holes 641A and 641B drilled in two places, and resin bearings 642 and 643 are fitted in the holes 641A and 641B, respectively.
  • the relay portion 637B of the rotary screw portion 637 and the columnar portion 638B of the relay gear 638 are inserted through bearings 642 and 643, respectively.
  • a separation plate 644 is attached to the left side of the substrate 641.
  • the separation plate 644 has a shape in which a plate-like member is bent so as to have a U-shaped cross section, and a bottom portion 644A substantially parallel to the substrate 641 is formed at a predetermined distance from the substrate 641 in the left direction. Has been.
  • a hole 644B is formed in a portion corresponding to the hole 641A in the bottom 644A, that is, on the left side of the hole 641A.
  • Thrust ball bearings 645 and 646 are respectively attached to the left and right sides of the hole 644B, and a disc 637D is in contact with the left side of the thrust ball bearing 646.
  • the rotating screw support portion 640 can support the rotating screw portion 637 so that it can rotate smoothly without displacing its position in any of the left-right direction, the front-rear direction, and the up-down direction.
  • a sending unit 730 may be configured in place of the sending units 130 and 630.
  • the delivery unit 730 has a screw receiving unit 635, a screw receiving unit 135 instead of the screw receiving unit 635, the rotating screw supporting unit 640, a rotating screw supporting unit 740, and a rotating screw supporting unit 740.
  • the point of having a spring 735 is different, other parts are configured similarly.
  • the ruby bearing 637AB (FIG. 24) is omitted from the rotating screw portion 637 of FIG. 23, and the screw portion 737A configured similarly to the screw portion 637A, the relay portion 637B, the gear portion 637C, and the disc 637D. , Relay portion 737B, gear portion 737C and disk 737D, and further, nylon washer 737E.
  • a nylon washer 737E is sandwiched between the left side surface of the screw receiving portion 135 and the gear portion 737C of the rotating screw portion 737 so as to leave a space so as not to contact the periphery of the screw portion 737A and the relay portion 737B.
  • the spring 735 which consists of a coil spring is pinched
  • the spring 735 is in a state of being contracted from the natural length even when the piston 132 is in the abutting position and is most extended in the right direction, and is not completely shortened even when the piston 132 is in the separated position.
  • the spring coefficient, the number of turns, etc. are selected as appropriate.
  • the spring 735 always applies an elastic force to return to the natural length regardless of the position of the piston 132, that is, to extend and urge the screw portion 737A of the rotating screw portion 737 to the left.
  • the screw friction force between the screw portion 737A and the screw hole 135B can be increased.
  • the screw friction force is made higher than the peripheral side friction force by urging the screw portion 637A of the rotary screw portion 637 to the screw hole 135B of the screw receiving portion 135 by the elastic action of the spring 735. Can do.
  • the rotating screw support portion 740 (FIG. 26) is different from the rotating screw support portion 640 of FIG. 23 in that it has a bearing 745 instead of the thrust ball bearings 645 and 646, but the other portions are almost the same. It is constituted similarly.
  • the bearing 745 is made of a resin material like the bearings 642 and 643, and the sliding friction of the rotating screw portion 737 with respect to the relay portion 737B is small.
  • the rotating screw support portion 740 is rotated so as to be able to rotate smoothly without displacing its position in any of the left-right direction, the front-rear direction, and the up-down direction, similarly to the rotating screw support portion 640 of FIG.
  • the threaded portion 637 can be supported.
  • the inlet 131E and the outlet 131F are each formed in a long hole shape that is long in the left-right direction, so that the outer peripheral side surface port 132BH and the inlet 131E are located at any position within the piston movement range. Or the case where the connection state with the outflow port 131F was maintained and the chemical solution was allowed to flow in or out between the flow pipe 132C and the inflow pipe 131C or the outflow pipe 131D was described.
  • the present invention is not limited to this, and by forming at least one of the outer peripheral side surface port 132BH and the inflow port 131E and the outflow port 131F in the shape of a long hole, the outer peripheral side surface port 132BH
  • the inlet 131E or the outlet 131F may be connected.
  • the piston 132 when the piston 132 is in the contact position and the separation position, even if there is a deviation between the outer peripheral side surface port 132BH and the inflow port 131E or the outflow port 131F, it suffices if it is in an overlapping position.
  • a cylinder 831 instead of the cylinder 131 has an inflow port 831E and an outflow port 831F made of round holes.
  • the piston 832 has a hole portion 832BH formed of a long hole instead of the outer peripheral side surface port 132BH formed of a round hole.
  • This delivery part 830 connects the hole part 832BH and the inflow port 831E or the outflow port 831F at any position within the piston movement range as in the above-described delivery part 130, and connects the flow pipe 132C and the inflow pipe 131C or the outflow line.
  • a chemical solution can flow in or out from the tube 131D.
  • the present invention is not limited to this, and the claw portion 135A and the restricting plates 136B and 136C only need to be in a position where the piston 132 is in the contact position and the separation position in the left-right direction.
  • the sending unit 930 includes a screw receiving unit 935 and a regulating unit 936 that replace the screw receiving unit 135 and the regulating unit 136 of the sending unit 730.
  • the length in the left-right direction of the claw portion 935A corresponding to the claw portion 135A of the delivery portion 730 is longer than the piston movement range.
  • the restricting plates 936B and 936C of the restricting portion 936 are as short as the length of the claw portion 135A in the left-right direction.
  • the sending portion 930 can restrict the rotation range of the piston 132 to about 180 ° by bringing the claw portion 935A into contact with the restriction plate 936B or 936C, and also when moving the piston 132 in the left-right direction. While using the claw portion 935A as a guide rail, the rotation range can be maintained by sliding the claw portion 935A on the restriction plate 936B or 936C.
  • the present invention is not limited to this, and two claw portions 1035A and 1035B are provided in the screw receiving portion 1035, and one restriction portion 1036 is provided, for example, as in the delivery portion 1030 shown in FIGS.
  • the restriction plate 1036B may be provided.
  • the delivery unit 1030 regulates the rotation range of the piston 132 to about 180 °, and can continue to regulate the rotation range even when the piston 132 moves over the piston movement range. it can.
  • the present invention is not limited to this, and the inflow pipe 131C and the inflow port 131E are provided in an arbitrary direction in the cylinder 131, and the outflow pipe 131D and the outflow port 131F are provided in different directions, and correspond to these in the internal space 131S.
  • the restriction plates 136 ⁇ / b> B and 136 ⁇ / b> C may be provided in the direction in which the rotation of the piston 132 is restricted to an arbitrary angle.
  • the direction in which the inlet pipe 131C and the inlet 131E are provided and the direction in which the outlet pipe 131D and the outlet 131F are provided to some extent so that the outer peripheral side surface port 132BH of the piston 132 is not connected simultaneously with the inlet 131E and outlet 131F. It is desirable to pull apart.
  • the inflow pipe 1231C and the inflow port 1231E are provided on the upper side of the cylinder 1231, and the restriction plate 1236B of the restriction part 1236 is provided on the upper side of the internal space 131S.
  • the rotation range may be restricted to about 90 °.
  • the present invention is not limited to this, and each may have an arbitrary shape.
  • the rotational driving force of the motor 207 may be transmitted to the rotating screw portion 137 by contact with a predetermined gear.
  • an X ring may be provided instead of the O ring, an O ring or an X ring may be provided on the inner peripheral side surface 131B of the cylinder 131, and a piston may be provided.
  • a piston made of silicon rubber, butadiene rubber or the like may be attached to 132.
  • the present invention is not limited to this, and various objects (so-called fluids) having fluidity such as various liquids and various gases may be transmitted by the delivery unit 130.
  • the present invention can be applied to the medical field, for example.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Achieved is a drug administration device that enables the delivery of a fixed quantity of a drug while being compact. When a rotating screw section (137) is turned in the clockwise direction or counterclockwise direction, a delivery section (130) causes a piston (132) to make a half-turn in the clockwise direction or counterclockwise direction by means of screw friction, causing an outer peripheral surface opening (132BH) to connect to an inflow tube (131C) or an outflow tube (131D), causes a claw section (135A) to contact a regulation plate (136B or 136C), regulating rotation, causes the piston (132) to move to the left or to the right by means of the threading between screw section (137A) and screw section (135B), causes the drug to flow in from the inflow tube (131C) into a storage space (131L), and causes the drug to flow out from within the storage space (131L) to the outflow tube (131D). Also, the delivery section (130) can function as a pump that alternately causes the inflow and outflow of the drug by means of cyclically switching the direction of rotation of the rotating screw section (137).

Description

薬液投与装置Chemical solution administration device
 本発明は、薬液投与装置に関し、例えばインスリンを体内に投与する場合に適用して好適なものである。 The present invention relates to a drug solution administration device, which is suitable for application when, for example, insulin is administered into the body.
 近年、糖尿病は日本を始め世界中で患者数が増大の傾向を示している。また、これに伴う治療費用の増大が懸念されている。糖尿病の中でも、1型糖尿病は、適切な時間に適切量のインスリンの注入する治療が必要となる慢性疾患である。古くからシリンジを用いた手動投与か、インジェクタを用いた手動投与が行われてきた。これらに対してより簡便に安全に、適切な治療を行うために、投与量および投与時期をプログラムが可能な自動の薬液投与システムが開発されてきた。 In recent years, diabetes has shown an increasing trend in the number of patients worldwide, including Japan. In addition, there is a concern about the associated increase in treatment costs. Among diabetes, type 1 diabetes is a chronic disease that requires treatment to inject an appropriate amount of insulin at an appropriate time. For a long time, manual administration using a syringe or manual administration using an injector has been performed. In order to carry out appropriate treatment more simply, safely, and automatically, an automatic drug solution administration system capable of programming the dose and administration time has been developed.
 このシステムは輸液ポンプ、専用の輸液セット、カテ-テルからなり、現在、薬液投与装置を携帯可能にしたシステムも使用されてきている。最近、この携帯型のシステムにおいて、輸液セットのチューブのわずらわしさを排除し、扱い勝手を向上するため輸液セットを用いずに、体表に両面テ-プで貼り付け固定した小型軽量な輸液ポンプから直接カテ-テルを挿入して投与を行うパッチタイプの薬液投与装置が登場している(例えば、特許文献1参照)。 This system consists of an infusion pump, a dedicated infusion set, and a catheter. At present, a system in which a drug administration device is made portable is also used. Recently, in this portable system, in order to eliminate the troublesomeness of the tube of the infusion set and to improve handling, a small and lightweight infusion pump that is fixed to the body surface with a double-sided tape without using the infusion set. A patch-type drug solution administration device has been introduced in which a catheter is directly inserted from the device (for example, see Patent Document 1).
特表2010-501283公報Special table 2010-501283
 ところで、従来の薬液投与装置では、薬液が充填された薬液貯蔵部から薬液をポンプを使って患者の体内に送出する。 By the way, in the conventional liquid medicine administration device, the liquid medicine is delivered from the liquid medicine storage section filled with the liquid medicine into the patient's body using a pump.
 薬液投与装置では、患者の体内に定量の薬液を投与する必要があるため、薬液の定量吸引及び定量排出が可能なポンプを用いなくてはならない。 Since a chemical solution administration device needs to administer a fixed amount of chemical solution into the body of a patient, a pump capable of quantitative suction and discharge of the chemical solution must be used.
 このようなポンプとしては、シリンダ部に薬液吸引用の吸引口と薬液排出用の排出口とを設けると共に、吸引口と排出口のそれぞれに逆止弁を設け、ピストンを摺動させてシリンダ部の内圧を変化させることで、吸引口と排出口のそれぞれに設けられた逆止弁のうちの一方を開くようにしたピストン式のポンプが知られている。 As such a pump, a cylinder part is provided with a suction port for suctioning a chemical solution and a discharge port for discharging a chemical solution, and a check valve is provided at each of the suction port and the discharge port. A piston type pump is known in which one of check valves provided at each of the suction port and the discharge port is opened by changing the internal pressure of the pump.
 しかしながら、このような従来のポンプは、逆止弁として受動型のバルブを使用しており、リークや、大きい開弁圧、また、開弁圧のばらつきがポンプの性能に大きな影響を与えていた。また、対応として能動型のバルブを用いた場合には、その構成が複雑になり小型化が難しかった。 However, such a conventional pump uses a passive valve as a check valve, and leakage, a large valve opening pressure, and variations in the valve opening pressure have had a great influence on the pump performance. . Further, when an active type valve is used as a countermeasure, the configuration becomes complicated and it is difficult to reduce the size.
 本発明は以上の点を考慮してなされたもので、小型で薬液の定量送出が可能な薬液投与装置を提案しようとするものである。 The present invention has been made in consideration of the above points, and intends to propose a small-sized chemical solution administration device capable of quantitatively delivering a chemical solution.
 かかる課題を解決するため本発明の薬液投与装置においては、使用者の体表に貼着されて使用される薬液投与装置であって、薬液を貯蔵する薬液貯蔵部と、円筒状の内周側面及び所定形状の底面を有するシリンダと、薬液を供給するリザーバーと、リザーバーに接続される流入路を介して連通する、シリンダの内周側面に形成された流入口と、薬液を使用者の体内へ供給する中空の針まで所定の流出路を介して連通する、シリンダの内周側面に設けられ、シリンダの中心軸を中心に流入口から所定角度だけ回転した位置に形成された流出口と、シリンダの内周側面と接する外周側面と、薬液と接する端面と、該端面と対向する他端面と、外周側面に設けられた外周側面口及び端面とを接続する流通路とが設けられ、シリンダの内周側面と底面とで形成されるシリンダ内部空間をシリンダの中心軸方向に摺動するピストンと、ピストンの他端面側にねじ溝が形成されたピストンねじ部と、ピストンねじ部と螺合し、回転駆動部によりシリンダの中心軸を中心として回転されると共に、当該回転される際にシリンダとピストンとの間に生じる周側面摩擦力よりも大きいねじ摩擦力をピストンねじ部との間に生じる回転ねじ部と、シリンダ内においてピストンがシリンダの中心軸を中心として回転する際に外周側面口が向く方位であるピストン方位を、外周側面口を流入口に接続させる流入方位と、当該流入方位からピストンを回転され、外周側面口を流出口に接続させる流出方位とに挟まれた回転範囲内に規制する回転規制部とを設けるようにした。 In order to solve such a problem, in the drug administration device of the present invention, the drug administration device is used by being attached to the body surface of the user, the drug solution storage unit storing the drug solution, and the cylindrical inner peripheral side surface And a cylinder having a bottom surface of a predetermined shape, a reservoir for supplying a chemical solution, an inflow port formed on an inner peripheral side surface of the cylinder communicating with an inflow passage connected to the reservoir, and the chemical solution into the body of the user An outflow port provided on an inner peripheral side surface of the cylinder that communicates with a hollow needle to be supplied through a predetermined outflow path, and formed at a position rotated from the inflow port by a predetermined angle about the central axis of the cylinder; An outer peripheral side surface in contact with the inner peripheral side surface, an end surface in contact with the chemical solution, the other end surface facing the end surface, and an outer peripheral side surface port provided on the outer peripheral side surface and a flow passage connecting the end surface are provided. Perimeter and bottom A piston that slides in the cylinder inner space formed in the direction of the center axis of the cylinder, a piston screw portion that has a thread groove formed on the other end surface side of the piston, and a piston screw portion that are screwed together. A rotating screw portion that is rotated about the central axis of the cylinder and that generates a screw friction force between the piston screw portion that is larger than a peripheral side friction force generated between the cylinder and the piston when rotating. In the cylinder, when the piston rotates around the central axis of the cylinder, the piston azimuth that the outer peripheral side port faces is the inflow azimuth that connects the outer peripheral side port to the inlet, and the piston is rotated from the inflow azimuth. A rotation restricting portion for restricting the rotation within a rotation range sandwiched between the outflow direction for connecting the outer peripheral side surface port to the outflow port is provided.
 これにより、回転ねじ部が所定方向へ回転される場合、まずねじ摩擦力の作用によりピストンをこの所定方向へ回転させて流入方位に合わせて外周側面口を流入口に接続し、この状態で回転規制部により当該ピストンの回転を規制する。続いてピストンポンプは、回転ねじ部とピストンねじ部との螺合によりピストンをシリンダの底面から離隔する方向へ移動させてシリンダ内に負圧を生じさせ、リザーバーから流入管及び流通管を介して薬液をシリンダ内に流入させることができる。また回転ねじ部が反対方向へ回転される場合、まずねじ摩擦力の作用によりピストンを反対方向へ回転させて流出方位に合わせて外周側面口を流出口に接続し、この状態で回転規制部により当該ピストンの回転を規制する。続いてピストンポンプは、回転ねじ部とピストンねじ部との螺合によりピストンをシリンダの底面へ近接する方向へ移動させてシリンダ内に正圧を生じさせ、シリンダ内から流通管及び流出管を介して薬液を使用者の体内先へ流出させることができる。 As a result, when the rotating screw portion is rotated in a predetermined direction, first, the piston is rotated in this predetermined direction by the action of the screw friction force, and the outer peripheral side surface port is connected to the inflow port according to the inflow direction, and the rotation is performed in this state The restriction part restricts the rotation of the piston. Subsequently, the piston pump moves the piston in a direction away from the bottom surface of the cylinder by screwing the rotating screw portion and the piston screw portion to generate negative pressure in the cylinder, and from the reservoir through the inflow pipe and the flow pipe. The chemical solution can flow into the cylinder. When the rotating screw part is rotated in the opposite direction, first, the piston is rotated in the opposite direction by the action of the screw friction force, and the outer peripheral side port is connected to the outlet in accordance with the outflow direction. The rotation of the piston is restricted. Subsequently, the piston pump moves the piston in a direction close to the bottom surface of the cylinder by screwing the rotating screw portion and the piston screw portion to generate a positive pressure in the cylinder, and from the inside of the cylinder through the flow pipe and the outflow pipe. The drug solution can be drained into the body of the user.
 本発明によれば、回転ねじ部を所定方向又は反対方向へ回転させるだけで、最初にねじ摩擦力の作用によりピストンを回転させて外周側面口の接続先を流入口又は流出口のいずれかに切り換えてから、回転ねじ部とピストンねじ部との螺合によりピストンをシリンダの底面に対し離隔又は近接させて薬液をシリンダ内へ流入させ又はシリンダ内から流出させることができる。かくして小型で薬液の定量送出が可能な薬液投与装置を実現できる。 According to the present invention, only by rotating the rotating screw part in a predetermined direction or in the opposite direction, the piston is first rotated by the action of the screw friction force, and the connection destination of the outer peripheral side surface port is set to either the inflow port or the outflow port. After switching, the piston can be separated or close to the bottom surface of the cylinder by screwing between the rotating screw portion and the piston screw portion, so that the chemical liquid can flow into or out of the cylinder. Thus, it is possible to realize a small-sized chemical solution administration device capable of quantitatively delivering the chemical solution.
薬液投与システムの構成を示す略線図である。It is a basic diagram which shows the structure of a chemical | medical solution administration system. 薬液投与装置の構成を示す略線図である。It is a basic diagram which shows the structure of a chemical | medical solution administration apparatus. 薬液貯蔵送出部の分解斜視図である。It is a disassembled perspective view of a chemical | medical solution storage delivery part. 薬液の貯蔵前及び貯蔵後を示す略線図である。It is a basic diagram which shows before and after storage of a chemical | medical solution. 薬液バッグの形成工程を示す略線図である。It is a basic diagram which shows the formation process of a chemical | medical solution bag. フィルタ部の構成を示す略線図である。It is a basic diagram which shows the structure of a filter part. 送出部の構成を示す略線図である。It is a basic diagram which shows the structure of a sending part. 送出部の構成を示す略線図である。It is a basic diagram which shows the structure of a sending part. 送出部の流入動作の説明に供する略線図である。It is a basic diagram with which it uses for description of the inflow operation of a sending part. 送出部の流出動作の説明に供する略線図である。It is a basic diagram with which it uses for description of the outflow operation | movement of a sending part. 駆動制御部の分解斜視図である。It is a disassembled perspective view of a drive control part. 動力伝達の機構を示す略線図である。It is a basic diagram which shows the mechanism of power transmission. コネクタの構成を示す略線図である。It is a basic diagram which shows the structure of a connector. 穿刺流路部の構成を示す略線図である。It is a basic diagram which shows the structure of a puncture flow path part. 穿刺流路部の構成を示す略線図である。It is a basic diagram which shows the structure of a puncture flow path part. カシメ及び押部の構成を示す略線図である。It is a basic diagram which shows the structure of a crimping and a press part. 穿刺の様子を示す略線図である。It is a basic diagram which shows the mode of puncture. 角度調整機構の構成を示す略線図である。It is a basic diagram which shows the structure of an angle adjustment mechanism. 角度調整機構におけるツマミ部の載置を示す略線図である。It is a basic diagram which shows mounting of the knob part in an angle adjustment mechanism. 角度調整機構における突出角度の変更を示す略線図である。It is a basic diagram which shows the change of the protrusion angle in an angle adjustment mechanism. 薬液投与システムの回路構成及び機能的構成を示す略線図である。It is a basic diagram which shows the circuit structure and functional structure of a chemical | medical solution administration system. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態におけるねじ受部の構成を示す略線図である。It is a basic diagram which shows the structure of the screw receiving part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment. 他の実施の形態における送出部の構成を示す略線図である。It is a basic diagram which shows the structure of the sending part in other embodiment.
 以下に、図面について、本発明の一実施の形態を詳述する。 Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings.
〔1.薬液投与システムの構成〕
 図1に示すように、薬液投与システム1は、使用者の皮膚に貼り付けられることにより保持されて使用される携帯型の薬液投与装置2と、使用者の入力指示に応じた信号を無線通信で薬液投与装置2に送信するコントローラ3と、薬液投与装置2の内部に設けられる充電池206(図11)を充電する充電器4(図21)とを含む構成とされる。
[1. Configuration of chemical solution administration system]
As shown in FIG. 1, a drug solution administration system 1 wirelessly communicates a signal corresponding to a user's input instruction with a portable drug solution administration device 2 that is held and used by being affixed to the user's skin. The controller 3 that transmits to the drug solution administration device 2 and the charger 4 (FIG. 21) that charges the rechargeable battery 206 (FIG. 11) provided inside the drug solution administration device 2 are configured.
〔2.薬液投与装置の構成〕
 薬液投与装置2は、内部に薬液(例えばインスリン)が貯蔵されており、コントローラ3により設定され、無線により送信され薬液投与装置2内のメモリに記憶されているボーラス投与時間及び投与量、並びにベーサル投与時間及び投与量に応じて、またはコントローラ3から送信されるボーラス投与量に応じて、薬液を使用者の体内に投与する。薬液投与装置2は、図2に示すように、互いに着脱可能な薬液貯蔵送出部10、駆動制御部20及び穿刺流路部30により構成される。
[2. Configuration of chemical administration device]
The medicinal solution administration device 2 stores a medicinal solution (for example, insulin) therein, is set by the controller 3, is transmitted by radio, and is stored in the memory in the medicinal solution administration device 2, and the bolus administration time and dose. The drug solution is administered into the user's body according to the administration time and the dose, or according to the bolus dose transmitted from the controller 3. As shown in FIG. 2, the drug solution administration device 2 includes a drug solution storage and delivery unit 10, a drive control unit 20, and a puncture channel unit 30 that are detachable from each other.
 薬液投与装置2は、薬液貯蔵送出部10と駆動制御部20が上下方向から係合された後、薬液貯蔵送出部10及び駆動制御部20に対して前方向から穿刺流路部30がスライドされて嵌合することにより一体となる。薬液投与装置2は、このような状態で使用者の皮膚に貼り付けられて使用される。 In the drug solution administration device 2, after the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged from above and below, the puncture channel unit 30 is slid from the front with respect to the drug solution storage / delivery unit 10 and the drive control unit 20. To be integrated. The medicinal solution administration device 2 is used by being attached to the skin of the user in such a state.
 薬液投与装置2の大きさは、使用者の皮膚に貼り付けることができる程度にまで小型化されていればよいが、例えば横34mm、縦43mm、高さ12mmの略直方体形状とされる。 The size of the medicinal solution administration device 2 may be small enough to be attached to the user's skin, for example, a substantially rectangular parallelepiped shape having a width of 34 mm, a length of 43 mm, and a height of 12 mm.
〔2-1.薬液貯蔵送出部の構成〕
 薬液貯蔵送出部10は、図3及び図4に示すように、上側が開口し内部に空間が設けられた下筐体部101と該下筐体部101の開口に螺着される上筐体部102により扁平な略直方体形状に形成される。
[2-1. (Configuration of chemical storage and delivery unit)
As shown in FIG. 3 and FIG. 4, the chemical storage / delivery unit 10 includes a lower casing part 101 that is open on the upper side and has a space inside, and an upper casing that is screwed into the opening of the lower casing part 101. The portion 102 is formed into a flat and substantially rectangular parallelepiped shape.
 薬液貯蔵送出部10は、下筐体部101と上筐体部102とで形成される空間に薬液バッグ110、フィルタ部120、送出部130及び圧迫部150等が設けられる。 The chemical solution storage and delivery unit 10 is provided with a chemical solution bag 110, a filter unit 120, a delivery unit 130, a compression unit 150, and the like in a space formed by the lower casing unit 101 and the upper casing unit 102.
 下筐体部101には、底面101Aに両面テープ等でなる貼付部103が設けられる。薬液投与装置2は、貼付部103が使用者の皮膚に貼り付けられることにより該使用者に保持される。なお下筐体部101の底面101Aは透明な材質の部材で形成されており、薬液バッグ110に貯蔵される薬液の量が外から見えるようになされている。これにより、薬液投与装置2を該使用者の皮膚に貼り付けた後でも横方向から薬液残量を確認することが可能となる。 The lower housing part 101 is provided with a sticking part 103 made of double-sided tape or the like on the bottom face 101A. The medicinal solution administration device 2 is held by the user when the sticking portion 103 is stuck on the user's skin. The bottom surface 101 </ b> A of the lower housing 101 is formed of a transparent material so that the amount of the chemical stored in the chemical bag 110 can be seen from the outside. This makes it possible to check the remaining amount of the drug solution from the lateral direction even after the drug solution administration device 2 is attached to the user's skin.
 下筐体部101の長手方向(以下、これを前後方向とも呼ぶ)に沿った側面には、駆動制御部20が配される方向に延設された突起でなる係合部101B~Eが設けられている。この係合部101B~Eは、後述する係合受部201A~D(図11)と係合することにより薬液貯蔵送出部10と駆動制御部20とを密着させる。 Engagement portions 101B to E, which are protrusions extending in the direction in which the drive control unit 20 is arranged, are provided on the side surfaces along the longitudinal direction (hereinafter also referred to as the front-rear direction) of the lower housing unit 101. It has been. The engaging portions 101B to E are brought into close contact with the chemical solution storage and delivery portion 10 and the drive control portion 20 by engaging with engagement receiving portions 201A to 201D (FIG. 11) described later.
 下筐体部101は、上筐体部102と密着する面に防水パッキン101Fが設けられている。この防水パッキン101Fは、上筺体部102の突起部102A及び102Bの下面並びに中央部102Cの端面と接する部分にも延設されており、下筐体部101及び上筐体部102の間から内部空間に液体が侵入することを防止することができる。 The lower casing 101 is provided with a waterproof packing 101F on the surface that is in close contact with the upper casing 102. The waterproof packing 101F is also extended to the lower surface of the projecting portions 102A and 102B of the upper casing portion 102 and the portion in contact with the end surface of the central portion 102C, and is provided between the lower housing portion 101 and the upper housing portion 102. It is possible to prevent liquid from entering the space.
 下筐体部101の前後方向に沿った側面には、板バネリリースロッド154が挿入されるための孔101Gが設けられる。孔101Gにはダックビル様の弁パッキン(図示せず)が挿入されていて板バネリリースロッド154を抜いた場合に穴が閉じるようになっている。また下筐体部101の底面101Aには、薬液バッグ110に薬液を注入するため注入部104が嵌合する孔101Kが設けられる。 A hole 101G for inserting the leaf spring release rod 154 is provided on the side surface of the lower casing portion 101 along the front-rear direction. A duckbill-like valve packing (not shown) is inserted into the hole 101G, and the hole is closed when the leaf spring release rod 154 is removed. Further, a bottom 101 </ b> A of the lower housing part 101 is provided with a hole 101 </ b> K into which the injection part 104 is fitted to inject a chemical liquid into the chemical liquid bag 110.
 孔101Kの周辺部は薬液バッグ110に融着されている弾性部材である注入部104と下筐体部101のはめ合わせにて防水機能を実現している。 The peripheral portion of the hole 101K realizes a waterproof function by fitting the injection portion 104, which is an elastic member fused to the chemical solution bag 110, and the lower housing portion 101.
 さらに下筐体部101は、薬液貯蔵送出部10に穿刺流路部30が係合される際に該穿刺流路部30の一部がはめ込まれる空間である凹部101Hが前方向側に設けられる。また下筐体部101は、穿刺流路部30が前方向から薬液貯蔵送出部10にスライドして係合されるように案内する、互いに向かい合う方向に突出された突起部101I及び101Jが前後方向に沿って設けられる。 Further, the lower casing portion 101 is provided with a concave portion 101H on the front side, which is a space into which a part of the puncture channel portion 30 is fitted when the puncture channel portion 30 is engaged with the drug solution storage and delivery unit 10. . Further, the lower casing portion 101 is provided with projections 101I and 101J protruding in opposite directions to guide the puncture flow path portion 30 so as to be slid and engaged with the medicinal solution storage / delivery portion 10 from the front direction. It is provided along.
 上筐体部102は、下筐体部101の突起部101I及び101Jと前後方向に連続するように互いに向かい合う方向に突出された突起部102A及び102Bが前後方向に沿って設けられる。なお上筐体部102は、突起部102A及び102Bを形成するため、該突起部102A及び102Bに挟まれる中央部102Cがその他の部分より一段低くなるように形成される。 The upper housing part 102 is provided with projecting parts 102A and 102B protruding in the front-rear direction so as to be continuous with the projecting parts 101I and 101J of the lower housing part 101 in the front-rear direction. The upper housing portion 102 is formed such that the central portion 102C sandwiched between the protrusion portions 102A and 102B is one step lower than the other portions in order to form the protrusion portions 102A and 102B.
 上筐体部102は、薬液貯蔵送出部10に穿刺流路部30が係合される際に穿刺流路部30の凸部301C(図15)がはまり込む凹部102Dが中央部102Cの所定位置に設けられる。 In the upper housing portion 102, a concave portion 102D into which a convex portion 301C (FIG. 15) of the puncture flow channel portion 30 is fitted when the puncture flow channel portion 30 is engaged with the drug solution storage and delivery portion 10 is a predetermined position of the central portion 102C. Provided.
 リザーバーとしての薬液バッグ110は、図5に示すように、例えばポリウレタン、塩化ビニル、ポリエチレンでなる長方形のシート111から形成される。シート111は、図5(A)に示すように、長手方向における中央部分であって可撓性の熱可塑性樹脂である薬液バッグ110の底面となる部分(以下、これを中央部とも呼ぶ)112の両側に、少なくとも3以上の奇数個(本実施の形態では5個)の折り目113及び114が等間隔にそれぞれ設けられる。これによりシート111には、それぞれ隣接する折り目113及び114の間に所定幅の部分(以下、これを折畳部とも呼ぶ)115及び116が偶数個形成される。 The chemical solution bag 110 as a reservoir is formed of a rectangular sheet 111 made of, for example, polyurethane, vinyl chloride, or polyethylene, as shown in FIG. As shown in FIG. 5 (A), the sheet 111 is a central portion in the longitudinal direction and is a portion (hereinafter also referred to as a central portion) 112 that becomes the bottom surface of the chemical solution bag 110 that is a flexible thermoplastic resin. At least three odd or more (five in the present embodiment) fold lines 113 and 114 are provided at equal intervals on both sides of the sheet. As a result, an even number of portions (hereinafter also referred to as folding portions) 115 and 116 having a predetermined width are formed on the sheet 111 between the adjacent folds 113 and 114, respectively.
 またシート111は、長手方向における最も端よりの折り目113及び114よりさらに端側に、中央部112における長手方向の長さの半分より長い部分(以下、これを端部とも呼ぶ)117及び118が設けられる。 Further, the sheet 111 has portions (hereinafter also referred to as end portions) 117 and 118 that are longer than half of the length in the longitudinal direction in the central portion 112 on the further end side than the folds 113 and 114 from the most ends in the longitudinal direction. Provided.
 このシート111は、折畳部115及び116が中央部112と重なるように折り目113及び114が山折及び谷折に交互に折り畳まれ、図5(B)に示すように、端部117及び118の端側の一部が重なる。 In this sheet 111, the folds 113 and 114 are alternately folded into a mountain fold and a valley fold so that the fold portions 115 and 116 overlap the center portion 112, and as shown in FIG. Part of the end side overlaps.
 シート111は、端部117及び118のうちの互いに重なった部分が融着され、また幅方向の縁が融着される。シート111の幅方向の縁が融着される際、該シート111に囲まれた空間と外部空間とを連通させるノズル105を一方の縁に挟むようにして該縁が融着される。 In the sheet 111, the overlapping portions of the end portions 117 and 118 are fused, and the edges in the width direction are fused. When the edge in the width direction of the sheet 111 is fused, the edge is fused so that the nozzle 105 that connects the space surrounded by the sheet 111 and the external space is sandwiched between the edges.
 またシート111の中央部112の所定位置には、外部から薬液バッグ110に薬液を注入するために例えば合成ゴムなどで形成されるゴム栓(不図示)を備えた注入部104が設けられる。このようにして図5(C)に示すような薬液バッグ110が形成される。 Also, at a predetermined position of the central portion 112 of the sheet 111, an injecting portion 104 having a rubber stopper (not shown) formed of, for example, synthetic rubber or the like is provided to inject the chemical solution into the chemical solution bag 110 from the outside. In this way, a chemical solution bag 110 as shown in FIG. 5C is formed.
 このようにして形成された薬液バッグ110は、薬液が充填されていない状態では隣接する折畳部115及び116同士が接するようにして折畳まれており、中央部112と端部117及び118とが重なり合う。 The medical solution bag 110 formed in this way is folded so that the adjacent folding portions 115 and 116 are in contact with each other in a state where the medical solution is not filled, and the central portion 112 and the end portions 117 and 118 are Overlap.
 従って薬液バッグ110は、内部に充填された薬液をノズル105を介して外部に送出する際に、中央部112と端部117及び118とが接するように潰されることで薬液を内部に残すことなく外部に送出することができる。 Therefore, the chemical solution bag 110 is not crushed so that the central portion 112 and the end portions 117 and 118 are in contact with each other without leaving the chemical solution inside when the chemical solution filled therein is sent to the outside through the nozzle 105. Can be sent to the outside.
 ところで従来の薬液バッグは、2枚のフィルムの縁を融着されて形成されたものが一般的であり、2枚のフィルムにより形成される空間に薬液が注入されるが、その際には縁に近づくに連れて2枚のフィルムが離間する距離が短くなってしまう。 By the way, the conventional chemical solution bag is generally formed by fusing the edges of two films, and the chemical solution is injected into the space formed by the two films. As the distance approaches, the distance between the two films becomes shorter.
 従って従来の薬液バッグを使った薬液投与装置では、薬液バッグを格納される空間において、薬液バッグの縁に近い部分で薬液が注入された際に該薬液バッグが膨らまない部分に無駄な空間が形成されてしまう。かくして従来の薬液バッグでは薬液投与装置が大型化してしまうといった問題があった。 Therefore, in the conventional chemical solution administration device using the chemical solution bag, in the space where the chemical solution bag is stored, when the chemical solution is injected near the edge of the chemical solution bag, a useless space is formed in the portion where the chemical solution bag does not expand. Will be. Thus, the conventional drug solution bag has a problem in that the drug solution administration device is enlarged.
 一方、薬液バッグ110は、長手方向に折畳部115及び116を有しているので、薬液が注入される際には折畳部115及び116が、中央部112と端部117及び118を離間させる方向(上下方向)に広がる。 On the other hand, since the chemical solution bag 110 has the folding portions 115 and 116 in the longitudinal direction, the folding portions 115 and 116 separate the center portion 112 and the end portions 117 and 118 when the chemical solution is injected. It spreads in the direction (vertical direction).
 従って薬液バッグ110は、折畳部115及び116が広がることによって、薬液が注入される際に薬液バッグ110の縁付近であっても上下方向に広がることができるので、下筐体部101と上筐体部102とで形成される空間において、薬液が注入される際に薬液バッグ110の縁に近い部分でも無駄な空間が形成されてしまうことがなく、薬液投与装置2を小型化することができ、かくして使い勝手を向上することができる。 Therefore, the chemical solution bag 110 can expand in the vertical direction even when it is near the edge of the chemical solution bag 110 when the chemical solution is injected by expanding the folding parts 115 and 116. In the space formed with the casing 102, when the chemical solution is injected, a wasteful space is not formed even in a portion near the edge of the chemical solution bag 110, and the chemical solution administration device 2 can be downsized. Yes, thus improving usability.
 フィルタ部120は、図6に示すように、下側が開口し内部に空間が設けられた上蓋121の側面に、内部空間と薬液バッグ110とを連通するノズル105が接続されると共に、内部空間と送出部130とを連通する流路管106が接続される。 As shown in FIG. 6, the filter unit 120 is connected to a side surface of the upper lid 121 having an opening on the lower side and a space in the interior, and a nozzle 105 communicating the inner space and the chemical solution bag 110. A channel pipe 106 communicating with the delivery unit 130 is connected.
 フィルタ部120は、上蓋121の開口を塞ぐように、気体を通過させ液体を通過させないエアベントフィルタ122が設けられる。エアベントフィルタ122は、上蓋121と該上蓋121の開口を塞ぐ下蓋123との間に、周方向に沿って上下方向からOリング124及び125に挟まれるようにして固定される。なお、上蓋121と下蓋123とは例えば超音波融着などにより密着される。下蓋123は、上下方向に貫通した孔123Aが設けられる。 The filter unit 120 is provided with an air vent filter 122 that allows gas to pass but not liquid to close the opening of the upper lid 121. The air vent filter 122 is fixed between the upper lid 121 and the lower lid 123 that closes the opening of the upper lid 121 so as to be sandwiched between the O-rings 124 and 125 along the circumferential direction. The upper lid 121 and the lower lid 123 are in close contact with each other by, for example, ultrasonic fusion. The lower lid 123 is provided with a hole 123A penetrating in the vertical direction.
 これによりフィルタ部120は、上蓋121の内部空間から下蓋123に設けられる孔123Aを介して、薬液を排出することなく気体だけを外部に排出することができる。 Thus, the filter unit 120 can discharge only the gas from the inner space of the upper lid 121 through the hole 123A provided in the lower lid 123 without discharging the chemical solution.
 送出部130は、図7、図8(A)及び(B)に示すように、弁を有さないバルブレスポンプであり、シリンダ131及びピストン132を中心に構成されている。 As shown in FIGS. 7, 8 </ b> A and 8 </ b> B, the delivery unit 130 is a valveless pump that does not have a valve, and is configured around a cylinder 131 and a piston 132.
 因みに図7は斜視図を表しているものの、説明の都合上、一部を透過させることにより本来隠れる部分を明示している。また図8(A)は上方向から見た断面図であり、図8(B)は図8(A)におけるA1-A2平面を右側から見た断面図であるものの、説明の都合上、一部側面図を組み合わせて示している。 Incidentally, although FIG. 7 shows a perspective view, for the convenience of explanation, a part that is originally hidden by making a part transparent is clearly shown. FIG. 8A is a cross-sectional view as viewed from above, and FIG. 8B is a cross-sectional view as viewed from the right side of the A1-A2 plane in FIG. 8A. A partial side view is shown in combination.
 シリンダ131は、その外径が左右方向に長い直方体状でなり、左右方向に沿った仮想的な直線である中心軸Xを中心として左側面から右方向へ向けて円筒状の穴が穿設されることにより、内部空間131Sが形成されている。 The cylinder 131 has a rectangular parallelepiped shape whose outer diameter is long in the left-right direction, and a cylindrical hole is drilled from the left side surface to the right direction around the central axis X that is a virtual straight line along the left-right direction. Thus, an internal space 131S is formed.
 内部空間131Sは、平坦な円形の底面131Aにより右側が閉塞され、また円筒状の内周側面131Bにより上下方向ないし前後方向が囲まれており、左側のみが開放されている。因みに内部空間131Sの内径は、約0.6[mm]となっている。 The inner space 131S is closed on the right side by a flat circular bottom surface 131A, surrounded by a cylindrical inner peripheral side surface 131B in the vertical direction or the front-rear direction, and only the left side is open. Incidentally, the inner diameter of the internal space 131S is about 0.6 [mm].
 さらにシリンダ131は、前側面と内部空間131Sとの間を貫通する流入管131C及び後側面と内部空間131Sとの間を貫通する流出管131Dがそれぞれ穿設されている。 Further, the cylinder 131 has an inflow pipe 131C penetrating between the front side surface and the internal space 131S and an outflow pipe 131D penetrating between the rear side surface and the internal space 131S.
 流入管131Cは、前側面において流路管106と連通されており、薬液バッグ110からフィルタ部120を介して供給される薬液を内部空間131Sへ流入させるようになされている。 The inflow pipe 131C communicates with the flow path pipe 106 on the front side surface, and allows the chemical solution supplied from the chemical solution bag 110 via the filter unit 120 to flow into the internal space 131S.
 また流入管131Cにおける内部空間131S側の端部である流入口131Eは、上下方向に短く左右方向に長い長孔状に形成されている。 Further, the inlet 131E, which is the end of the inflow pipe 131C on the inner space 131S side, is formed in a long hole shape that is short in the vertical direction and long in the horizontal direction.
 流出管131Dは、後側面において流路管107と連通されており、内部空間131S内から薬液を流出させ当該流路管107経由で弁体108(図3)へ供給するようになされている。 The outflow pipe 131D communicates with the flow path pipe 107 on the rear side, and the chemical liquid flows out from the internal space 131S and is supplied to the valve body 108 (FIG. 3) via the flow path pipe 107.
 また流出管131Dの内部空間131S側の端部である流出口131Fは、流入口131Eと同様、上下方向に短く左右方向に長い長孔状に形成されている。 Moreover, the outflow port 131F which is the edge part by the side of the internal space 131S of outflow pipe 131D is formed in the long hole shape short in the up-down direction and long in the left-right direction similarly to the inflow port 131E.
 ピストン132は、全体として中心軸Xを中心とした円柱状に形成されており、右側の平坦な端面132Aに所定径の丸孔でなる端面口132AHが1箇所形成され、外周側面132Bにも所定径の丸孔でなる外周側面口132BHが1箇所形成されている。またピストン132の内部には、L字状に屈曲され端面口132AHと外周側面口としての外周側面口132BHとを連通させる流通管132Cが貫通されている。 The piston 132 as a whole is formed in a columnar shape centered on the central axis X, and one end face port 132AH made of a round hole of a predetermined diameter is formed on the right flat end face 132A, and the outer peripheral side face 132B is also predetermined. One outer peripheral side port 132BH made of a round hole with a diameter is formed. In addition, a circulation pipe 132C that is bent in an L shape and communicates with the end surface port 132AH and the outer peripheral side surface port 132BH as the outer peripheral side surface port passes through the piston 132.
 ピストン132の外径は、シリンダ131の内部空間131Sにおける内径よりも僅かに小さくなっている。このためピストン132は、シリンダ131の内部空間131S内に挿入されると、右側の端面132Aをシリンダ131の底面131Aと対向させると共に、外周側面132Bをシリンダ131の内周側面131Bと全面的に密接させる。 The outer diameter of the piston 132 is slightly smaller than the inner diameter of the internal space 131S of the cylinder 131. Therefore, when the piston 132 is inserted into the internal space 131S of the cylinder 131, the right end surface 132A is opposed to the bottom surface 131A of the cylinder 131, and the outer peripheral side surface 132B is in close contact with the inner peripheral side surface 131B of the cylinder 131. Let
 またピストン132は、内部空間131S内において、端面132A、シリンダ131の底面131A及び内周側面131Bにより囲まれた気密性の高い空間を形成する。以下、この空間を貯留空間131Lと呼ぶ。 The piston 132 forms a highly airtight space surrounded by the end surface 132A, the bottom surface 131A of the cylinder 131, and the inner peripheral side surface 131B in the internal space 131S. Hereinafter, this space is referred to as a storage space 131L.
 さらにピストン132は、所定方向へ外力が加えられると、シリンダ131内で左右方向に、すなわち中心軸Xに沿った方向に移動することができ、また中心軸Xを中心としてシリンダ131内を周方向に回転することができる。なお以下では、中心軸Xを中心とした回転方向を、図8(B)のように右側から見たときの回転方向により時計方向又は反時計方向と呼ぶ。 Further, when an external force is applied in a predetermined direction, the piston 132 can move in the left-right direction within the cylinder 131, that is, in the direction along the central axis X, and in the cylinder 131 around the central axis X in the circumferential direction. Can be rotated. Hereinafter, the rotation direction around the central axis X is referred to as a clockwise direction or a counterclockwise direction depending on the rotation direction when viewed from the right side as shown in FIG. 8B.
 また説明の都合上、以下では、中心軸Xに対し外周側面口132BHが位置する方向をピストン132の方向とし、中心軸Xに沿った方向(すなわち左右方向)に関するピストン132の位置を単にピストン132の位置と呼ぶ。さらに以下では、ピストン132がシリンダ131内を最も右方向へ移動して端面132Aを底面131Aに当接させたときの位置(いわゆる上死点に相当)を当接位置と呼び、当該ピストン132が当接位置から所定距離(例えば約3[mm])だけ左方向へ離れたときの位置(いわゆる下死点に相当)を離隔位置と呼ぶ。 Further, for convenience of explanation, in the following, the direction in which the outer peripheral side surface port 132BH is located with respect to the central axis X is defined as the direction of the piston 132, and the position of the piston 132 with respect to the direction along the central axis X (namely, the left-right direction) Called the position. Further, hereinafter, a position (corresponding to a so-called top dead center) when the piston 132 moves rightward in the cylinder 131 and the end surface 132A contacts the bottom surface 131A is referred to as a contact position. A position (corresponding to a so-called bottom dead center) when it is leftward from the contact position by a predetermined distance (for example, about 3 [mm]) is called a separation position.
 なお、ピストン132の外周側面132B及びシリンダ131の内周側面131Bには、シリコンなどの潤滑材を塗布することにより、シール性を高めると共に摩擦力を低減し円滑に摺動できるようにしても良い。また、流入口131E及び流出口131Fの周囲にOリング溝を設け、テフロン(デュポン株式会社の登録商標)で被覆した摺動抵抗の小さいOリングを設置しても良い。 Note that a lubricant such as silicon may be applied to the outer peripheral side surface 132B of the piston 132 and the inner peripheral side surface 131B of the cylinder 131 so as to improve the sealing performance and reduce the frictional force so that the sliding can be performed smoothly. . Further, an O-ring groove may be provided around the inlet 131E and the outlet 131F, and an O-ring having a small sliding resistance covered with Teflon (registered trademark of DuPont) may be installed.
 ピストン132は、基本的には外周側面132Bによりシリンダ131の流入口131E及び流出口131Fを閉塞するものの、前方向又は後方向を向いたときには外周側面口132BHを流入口131E又は流出口131Fと接続させる。 Although the piston 132 basically closes the inlet 131E and outlet 131F of the cylinder 131 by the outer peripheral side surface 132B, the outer peripheral side port 132BH is connected to the inlet 131E or outlet 131F when facing forward or rearward. Let
 ここで流入口131E及び流出口131Fは、ピストン132が当接位置にあるときに外周側面口132BHと対向する箇所と、当該ピストン132が離隔位置にあるときに外周側面口132BHと対向する箇所とを結ぶ長孔となるよう、その位置及び形状が定められている。 Here, the inflow port 131E and the outflow port 131F include a location facing the outer peripheral side surface port 132BH when the piston 132 is in the contact position, and a location facing the outer peripheral side surface port 132BH when the piston 132 is in the separated position. The position and shape are determined so as to be a long hole connecting the two.
 このためピストン132は、外周側面口132BHが前方向又は後方向を向いたまま中心軸Xに沿って当接位置と離隔位置との間(以下これをピストン移動範囲と呼ぶ)で移動された場合、その範囲内におけるいずれの位置においても、外周側面口132BHと流入口131E又は流出口131Fとを接続した状態を維持することができる。 For this reason, the piston 132 is moved between the contact position and the separation position (hereinafter referred to as the piston movement range) along the central axis X while the outer peripheral side surface port 132BH faces the front direction or the rear direction. The outer peripheral side surface port 132BH and the inflow port 131E or the outflow port 131F can be kept connected at any position within the range.
 すなわち送出部130は、ピストン132が前方向を向いている場合、ピストン移動範囲におけるいずれの位置においても、流入管131Cから流入口131E及び流通管132Cを介して貯留空間131Lまでを順次連通させることができる。 That is, when the piston 132 is directed forward, the delivery unit 130 sequentially communicates from the inlet pipe 131C to the storage space 131L via the inlet 131E and the outlet pipe 132C at any position in the piston movement range. Can do.
 また送出部130は、ピストン132が後方向を向いている場合、ピストン移動範囲におけるいずれの位置においても、貯留空間131Lから流通管132C及び流出口131Fを介して流出管131Dまでを順次連通させることができる。 Further, when the piston 132 is directed backward, the delivery unit 130 sequentially communicates from the storage space 131L to the outflow pipe 131D via the flow pipe 132C and the outflow port 131F at any position in the piston movement range. Can do.
 ピストン132における左端近傍には、外周側面132Bを一周する所定深さの溝132Dが形成されており、この溝132Dに円環状のOリング133が嵌め込まれている。Oリング133は、弾性を有する樹脂材料で構成されており、ピストン132とシリンダ131との間における気密性を保つようになされている。 Near the left end of the piston 132, a groove 132D having a predetermined depth that goes around the outer peripheral side surface 132B is formed, and an annular O-ring 133 is fitted into the groove 132D. The O-ring 133 is made of a resin material having elasticity, and is configured to maintain airtightness between the piston 132 and the cylinder 131.
 ピストン132の左側端面には、細長い円柱状の柱部134が左方向へ向けて延設されている。さらに柱部134の左側には、ねじ受部135が取り付けられている。すなわちピストン132、柱部134及びねじ受部135は、シリンダ131の内部空間131S内において一体に移動又は回転するようになされている。 A long and thin columnar column 134 is extended to the left on the left end surface of the piston 132. Further, a screw receiving portion 135 is attached to the left side of the column portion 134. That is, the piston 132, the column portion 134, and the screw receiving portion 135 are configured to move or rotate integrally in the internal space 131S of the cylinder 131.
 ねじ受部135は、全体として左右方向に細長い直方体状に形成されており、内部が中空になされると共に上側面及び下側面が省略されることにより、上下に貫通された形状となっている。 The screw receiving portion 135 is formed in a rectangular parallelepiped shape that is elongated in the left-right direction as a whole, and has a shape penetrating vertically by making the inside hollow and omitting the upper side surface and the lower side surface.
 ねじ受部135には、中心軸Xから見てピストン132の外周側面口132BHと同じ方向の側板における右端近傍に、外方へ向けてピストン側突出部としての爪部135Aが立設されている。 In the screw receiving portion 135, a claw portion 135A as a piston-side protruding portion is erected outward in the vicinity of the right end of the side plate in the same direction as the outer peripheral side surface port 132BH of the piston 132 when viewed from the central axis X. .
 一方、シリンダ131には、その左側面から内周側面131Bにかけて規制部136が取り付けられている。 On the other hand, a restriction portion 136 is attached to the cylinder 131 from the left side surface to the inner peripheral side surface 131B.
 規制部136は、基板となる円環状の円環部136Aと、それぞれ細長い板状でなる2枚の規制板136B及び136Cとにより構成されている。 The restricting portion 136 is configured by an annular ring portion 136A serving as a substrate and two restricting plates 136B and 136C each having an elongated plate shape.
 円環部136Aは、シリンダ131の内周側面131Bとほぼ同等の内径を有しており、当該シリンダ131の左側面に対し当該内周側面131Bと互いの内側面を揃えるように取り付けられている。 The annular portion 136 </ b> A has an inner diameter substantially equal to the inner peripheral side surface 131 </ b> B of the cylinder 131, and is attached to the left side surface of the cylinder 131 so that the inner peripheral side surface 131 </ b> B and the inner side surfaces of each other are aligned. .
 規制板136B及び136Cは、それぞれの長手方向を左右方向、すなわち中心軸Xに沿った方向に合わせており、円環部136Aの内側面における前側及び後側のやや下寄りとなる箇所に、当該円環部136Aから右方向へ大きく突出するようにそれぞれ取り付けられている。すなわち規制板136B及び136Cは、内部空間131S内において、内周側面131Bからおおむね中心軸Xへ向けて立設されたようになっている。 The restricting plates 136B and 136C have their respective longitudinal directions aligned with the left-right direction, that is, the direction along the central axis X, and are located slightly below the front and rear sides of the inner surface of the annular portion 136A. Each is attached so as to protrude greatly from the annular portion 136A to the right. That is, the restriction plates 136B and 136C are erected from the inner peripheral surface 131B to the central axis X in the internal space 131S.
 また規制板136B及び136Cは、ピストン132及び柱部134と一体にねじ受部135が回転した際に爪部135Aと当接するよう、内周側面131Bから中心軸Xへ向かう方向、すなわち短手方向の長さが定められている。 Further, the regulation plates 136B and 136C are arranged in a direction from the inner peripheral side surface 131B toward the central axis X, that is, in a short direction so that the screw receiving portion 135 is rotated integrally with the piston 132 and the column portion 134 so as to come into contact with the claw portion 135A. The length of is determined.
 このため規制部136は、規制板136B及び136Cを爪部135Aと当接させることにより、ねじ受部135及びピストン132の回転範囲を、前方向から上方向を経て後方向へ至る約180°の範囲(以下これをピストン回転範囲と呼ぶ)に規制することができる。 For this reason, the restricting portion 136 brings the restricting plates 136B and 136C into contact with the claw portion 135A so that the rotation range of the screw receiving portion 135 and the piston 132 is about 180 ° from the front to the rear through the upper direction. The range (hereinafter referred to as the piston rotation range) can be regulated.
 また規制板136B及び136Cは、左右方向に関する長さ及び取付位置を、ピストン132がピストン移動範囲を移動する際に爪部135Aが左右方向に移動する範囲に合わせるよう定めている。 Further, the regulation plates 136B and 136C define the length and the mounting position in the left and right direction so that the claw portion 135A moves in the left and right direction when the piston 132 moves in the piston movement range.
 このため規制部136は、ピストン132がピストン移動範囲内におけるいずれの位置にあるときにおいても、ねじ受部135及びピストン132の回転する範囲をピストン回転範囲内に規制することができる。 For this reason, the restricting portion 136 can restrict the rotation range of the screw receiving portion 135 and the piston 132 within the piston rotation range even when the piston 132 is in any position within the piston movement range.
 ところでねじ受部135の左端面板には、左右方向に貫通するねじ孔135Bが穿設されている。このねじ孔135Bには、回転ねじ部137のねじ部137Aが螺合されている。 Incidentally, the left end face plate of the screw receiving portion 135 is provided with a screw hole 135B penetrating in the left-right direction. A threaded portion 137A of the rotating threaded portion 137 is screwed into the threaded hole 135B.
 回転ねじ部137は、中心軸Xを中心とした左右方向に細長い円柱の周側面にねじ溝が刻まれたねじ部137Aを中心に構成されており、当該ねじ部137Aから左方向へ円柱状の中継部137Bが延設されている。 The rotating screw portion 137 is configured around a screw portion 137A in which a thread groove is engraved on the peripheral side surface of a cylindrical column that is elongated in the left-right direction with the center axis X as the center, and is cylindrical from the screw portion 137A to the left. The relay part 137B is extended.
 また回転ねじ部137の中継部137Bは、図示しないすべり軸受を有する回転ねじ支持部により、左右方向、前後方向及び上下方向に関する位置を保ったまま自在に回転し得るように支持されている。 Further, the relay portion 137B of the rotary screw portion 137 is supported by a rotary screw support portion having a slide bearing (not shown) so that it can freely rotate while maintaining positions in the left-right direction, the front-rear direction, and the vertical direction.
 さらに回転ねじ部137のねじ部137Aは、ねじ受部135のねじ孔135Bとの間に生じる摩擦力(以下これをねじ摩擦力と呼ぶ)を、ピストン132の外周側面132Bとシリンダ131の内周側面131Bとの間に生じる摩擦力(以下これを周側面摩擦力と呼ぶ)よりも高めるよう、各部の寸法や材料等が最適化されている。 Further, the threaded portion 137A of the rotating threaded portion 137 is configured so that a frictional force generated between the screw receiving portion 135 and the screw hole 135B (hereinafter referred to as a screwed frictional force) The dimensions, materials, and the like of each part are optimized so as to be higher than the frictional force generated between the side 131B (hereinafter referred to as the peripheral side frictional force).
 一方、中継部137Bの左端には、中心軸Xを中心としたかさ歯車でなる歯車部137Cが取り付けられている。この歯車部137Cは、回転伝達部138の歯車部138Aと歯合している。 On the other hand, a gear portion 137C made up of a bevel gear centered on the central axis X is attached to the left end of the relay portion 137B. The gear portion 137C meshes with the gear portion 138A of the rotation transmission portion 138.
 回転伝達部138は、上下方向に沿った中心軸円柱状の中継部138Bを中心に構成されており、当該中継部138Bの下端に歯車部137Cと同様のかさ歯車でなる歯車部138Aが取り付けられている。 The rotation transmitting portion 138 is configured around a central axis cylindrical relay portion 138B along the vertical direction, and a gear portion 138A made of a bevel gear similar to the gear portion 137C is attached to the lower end of the relay portion 138B. ing.
 中継部138Bの上端には、円板状の磁石でなる駆動用磁石138Cが取り付けられている。また駆動用磁石138Cの外周における1箇所には、小さな直方体状の磁石でなる回転検出用磁石138Dが取り付けられている。 A driving magnet 138C made of a disk-shaped magnet is attached to the upper end of the relay portion 138B. Further, a rotation detection magnet 138D made of a small rectangular parallelepiped magnet is attached to one place on the outer periphery of the drive magnet 138C.
 駆動用磁石138Cは、駆動制御部20の動力伝達磁石(後述する)との間で磁力を介して結合されている。また回転伝達部138は、図示しない支持部により、上下方向に沿った回転軸を中心に回転し得るように支持されている。 The driving magnet 138C is coupled to a power transmission magnet (described later) of the drive control unit 20 via a magnetic force. Further, the rotation transmitting unit 138 is supported by a support unit (not shown) so as to be able to rotate around a rotation axis along the vertical direction.
 このため回転伝達部138は、駆動制御部20の動力伝達磁石(後述する)が回転されると、その回転駆動力が駆動用磁石138Cを介して伝達されることにより回転し、歯車部138A及び歯車部137Cの歯合により回転ねじ部137を回転させることができる。 Therefore, when the power transmission magnet (described later) of the drive control unit 20 is rotated, the rotation transmission unit 138 rotates by transmitting the rotation driving force via the driving magnet 138C, and the gear unit 138A and The rotating screw portion 137 can be rotated by the meshing of the gear portion 137C.
 以上の構成において、送出部130は、回転伝達部138を介して回転ねじ部137が回転されると、これに応じてピストン132を回転させ、さらに移動させることにより、薬液の流入動作及び流出動作を行う。 In the above configuration, when the rotary screw part 137 is rotated via the rotation transmission part 138, the delivery part 130 rotates and moves the piston 132 in accordance with this, thereby causing the chemical liquid inflow operation and the outflow operation. I do.
 送出部130は、流入動作を行う場合、まず図8(A)及び(B)と対応する図9(A)に示すように、ピストン132が当接位置にあり後方向を向いているものとする。 As shown in FIG. 9A corresponding to FIGS. 8A and 8B, the delivery unit 130, when performing the inflow operation, first has the piston 132 in the contact position and facing backward. To do.
 送出部130は、回転ねじ部137が時計方向に回転されると、ねじ部137Aとねじ孔135Bとの間に生じるねじ摩擦力により、ねじ受部135を介してピストン132に回転方向の外力を加え、時計方向に約180°回転させて爪部135Aを前側の規制板136Bに当接させる。 When the rotary screw portion 137 is rotated in the clockwise direction, the delivery portion 130 applies an external force in the rotational direction to the piston 132 via the screw receiving portion 135 due to the screw friction force generated between the screw portion 137A and the screw hole 135B. In addition, the claw portion 135A is brought into contact with the front regulation plate 136B by rotating about 180 ° clockwise.
 これにより送出部130は、図9(B)に示すように、ピストン132を前方向に向けて外周側面口132BHと流入口131Eとを接続し、流入管131Cから流入口131E及び流通管132Cを介して貯留空間131Lまでを順次連通させると共に、流出口131Fをピストン132の外周側面132Bにより閉塞する。 Thereby, as shown in FIG. 9B, the delivery unit 130 connects the outer peripheral side surface port 132BH and the inflow port 131E with the piston 132 facing forward, and connects the inflow port 131E and the flow tube 132C from the inflow tube 131C. The outlet 131F is closed by the outer peripheral side surface 132B of the piston 132.
 さらに送出部130は、引き続き回転ねじ部137が時計方向に回転されると、ねじ受部135が規制板136Bに規制されて回転できないため、ねじ部137Aとねじ孔135Bとの螺合によりねじ受部135を介してピストン132に移動方向の外力を加え、爪部135Aを規制板136Bに摺動させながら、すなわち規制板136Bをガイドレールとして用いながら、左方向へ移動させる。 Further, when the rotary screw portion 137 continues to rotate in the clockwise direction, the delivery portion 130 cannot rotate due to the screw receiving portion 135 being restricted by the restriction plate 136B, and therefore the screw receiving portion 130 is screwed by the screw portion 137A and the screw hole 135B. An external force in the moving direction is applied to the piston 132 via the portion 135, and the claw portion 135A is moved to the left while sliding on the restricting plate 136B, that is, using the restricting plate 136B as a guide rail.
 このとき送出部130は、図9(C)に示すように、ピストン132の左方向への移動に伴って貯留空間131Lの容積を徐々に拡大して負圧を高め、流入管131Cに供給される薬液を当該貯留空間131L内へ流入させていく。 At this time, as shown in FIG. 9C, the delivery unit 130 gradually expands the volume of the storage space 131L as the piston 132 moves in the left direction to increase the negative pressure, and is supplied to the inflow pipe 131C. The chemical solution to be flowed into the storage space 131L.
 ここで送出部130は、流入口131Eを長孔状に形成したため、ピストン132がピストン移動範囲に渡って移動する間、外周側面口132BHと当該流入口131Eとの接続状態を保つことができ、流入管131Cから薬液を貯留空間131L内へ流入させ続けることができる。 Here, since the inflow port 131E is formed in a long hole shape, the delivery unit 130 can maintain the connection state between the outer peripheral side surface port 132BH and the inflow port 131E while the piston 132 moves over the piston movement range. It is possible to keep the chemical liquid flowing from the inflow pipe 131C into the storage space 131L.
 また送出部130は、このとき流出口131Fをピストン132の外周側面132Bにより閉塞し続けることができるため、当該流出口131F側からの薬液の流入を防止できる。 Moreover, since the delivery part 130 can keep closing the outflow port 131F by the outer peripheral side surface 132B of the piston 132 at this time, the inflow of the chemical | medical solution from the said outflow port 131F side can be prevented.
 その後送出部130は、図9(D)に示すように、回転ねじ部137を時計方向へ所定回数だけ回転させピストン132を離隔位置に到達させた段階で当該回転ねじ部137の時計方向への回転を停止する。これにより貯留空間131L内には約1[μl]の薬液が貯蔵される。 Thereafter, as shown in FIG. 9 (D), the delivery unit 130 rotates the rotating screw part 137 clockwise a predetermined number of times, and at the stage where the piston 132 reaches the separated position, the rotating screw part 137 rotates clockwise. Stop rotation. As a result, about 1 [μl] of the chemical solution is stored in the storage space 131L.
 このように送出部130は、回転ねじ部137が時計方向に回転されると、図9(A)~(D)に示したように、ピストン132を時計回りに半回転させてから左方向へ移動させ、流入管131Cから貯留空間131L内へ薬液を流入させることができる。 As described above, when the rotary screw portion 137 is rotated clockwise, the delivery unit 130 rotates the piston 132 half a clockwise and then moves leftward as shown in FIGS. 9 (A) to (D). It can be moved and a chemical | medical solution can be poured in into the storage space 131L from the inflow pipe 131C.
 また送出部130は、流出動作を行う場合、まず図9(D)と同等の状態を表した図10(A)に示すように、ピストン132が離隔位置にあり前方向を向いているものとする。 In addition, when performing the outflow operation, the delivery unit 130, as shown in FIG. 10 (A) showing a state equivalent to FIG. 9 (D), has the piston 132 in the separated position and facing forward. To do.
 送出部130は、回転ねじ部137が反時計方向に回転されると、ねじ部137Aとねじ孔135Bとの間に生じるねじ摩擦力により、ねじ受部135を介してピストン132に回転方向の外力を加え、反時計方向に約180°回転させて爪部135Aを後側の規制板136Cに当接させる。 When the rotary screw portion 137 is rotated counterclockwise, the delivery portion 130 causes an external force in the rotational direction to be exerted on the piston 132 via the screw receiving portion 135 by a screw friction force generated between the screw portion 137A and the screw hole 135B. And the claw portion 135A is brought into contact with the rear-side regulating plate 136C by rotating about 180 ° counterclockwise.
 これにより送出部130は、図10(B)に示すように、ピストン132を後方向に向けて外周側面口132BHと流出口131Fとを接続させ、貯留空間131Lから流通管132C及び流出口131Fを介して流出管131Dまでを順次連通させると共に、流入口131Eをピストン132の外周側面132Bにより閉塞する。 Thus, as shown in FIG. 10B, the delivery unit 130 connects the outer peripheral side surface port 132BH and the outlet 131F with the piston 132 facing rearward, and connects the flow pipe 132C and the outlet 131F from the storage space 131L. And the outflow pipe 131D are sequentially communicated with each other, and the inflow port 131E is closed by the outer peripheral side surface 132B of the piston 132.
 さらに送出部130は、引き続き回転ねじ部137が反時計方向に回転されると、ねじ受部135が規制板136Cにより規制されて回転できないため、ねじ部137Aとねじ孔135Bとの螺合によりねじ受部135を介してピストン132に移動方向の外力を加え、爪部135Aを規制板136Cに摺動させながら、すなわち規制板136Cをガイドレールとして用いながら、右方向へ移動させる。 Furthermore, since the screw receiving portion 135 is restricted by the restricting plate 136C and cannot be rotated when the rotating screw portion 137 is continuously rotated counterclockwise, the delivery portion 130 is screwed by screwing the screw portion 137A and the screw hole 135B. An external force in the moving direction is applied to the piston 132 via the receiving portion 135, and the claw portion 135A is moved to the right while sliding on the restricting plate 136C, that is, using the restricting plate 136C as a guide rail.
 このとき送出部130は、図10(C)に示すように、ピストン132の右方向への移動に伴って貯留空間131Lの容積を徐々に縮小して圧力を高め、当該貯留空間131L内に貯留している薬液を流出管131Dへ流出させていく。 At this time, as shown in FIG. 10 (C), the delivery unit 130 gradually reduces the volume of the storage space 131L as the piston 132 moves in the right direction to increase the pressure, and stores in the storage space 131L. The chemical liquid being discharged is allowed to flow out to the outflow pipe 131D.
 ここで送出部130は、流入口131Eと同様に流出口131Fも長孔状に形成したため、ピストン132がピストン移動範囲に渡って移動する間、外周側面口132BHと当該流出口131Fとの接続状態を保つことができ、貯留空間131L内から薬液を流出管131Dへ流出させ続けることができる。 Here, since the outflow port 131F is formed in a long hole shape in the same manner as the inflow port 131E, the delivery unit 130 is connected to the outer peripheral side surface port 132BH and the outflow port 131F while the piston 132 moves over the piston movement range. Thus, the chemical solution can continue to flow out from the storage space 131L to the outflow pipe 131D.
 また送出部130は、このとき流入口131Eをピストン132の外周側面132Bにより閉塞し続けることができるため、当該流入口131E側からの薬液の流出を防止できる。 Further, at this time, the delivery unit 130 can keep the inlet 131E closed by the outer peripheral side surface 132B of the piston 132, and thus can prevent the chemical solution from flowing out from the inlet 131E side.
 その後送出部130は、図10(D)に示すように、回転ねじ部137を反時計方向へ所定回数だけ回転させピストン132を当接位置に到達させた段階で当該回転ねじ部137の反時計方向への回転を停止する。これにより貯留空間131L内の全ての薬液が流出される。 Thereafter, as shown in FIG. 10D, the delivery unit 130 rotates the rotating screw unit 137 counterclockwise a predetermined number of times and reaches the piston 132 at the contact position, thereby counterclockwise the rotating screw unit 137. Stop rotating in the direction. Thereby, all the chemical | medical solutions in the storage space 131L flow out.
 このように送出部130は、回転ねじ部137が反時計方向に回転されると、図10(A)~(D)に示したように、ピストン132を反時計回りに半回転させてから右方向へ移動させ、貯留空間131L内から流出管131Dへ薬液を流出させることができる。 As described above, when the rotary screw portion 137 is rotated counterclockwise, the delivery unit 130 rotates the piston 132 half-clockwise counterclockwise as shown in FIGS. 10 (A) to (D). It is possible to cause the chemical solution to flow out from the storage space 131L to the outflow pipe 131D.
 すなわち送出部130は、回転ねじ部137が時計方向に回転されると、流入管131Cから貯留空間131L内へ薬液を流入させ、回転ねじ部137が反時計方向に回転されると、貯留空間131L内から流出管131Dへ薬液を流出させることができる。 That is, when the rotary screw portion 137 is rotated in the clockwise direction, the delivery unit 130 causes the chemical solution to flow into the storage space 131L from the inflow pipe 131C, and when the rotary screw portion 137 is rotated in the counterclockwise direction, the storage space 131L. The chemical liquid can flow out from the inside to the outflow pipe 131D.
 このため送出部130は、駆動制御部20(図2)の制御によって回転ねじ部137の回転方向が交互に切り換えられることにより、薬液を断続的に送出するポンプとして機能することができる。 For this reason, the delivery unit 130 can function as a pump that intermittently delivers the chemical solution by alternately switching the rotation direction of the rotary screw unit 137 under the control of the drive control unit 20 (FIG. 2).
 このとき送出部130は、ピストン132が離隔位置にあるときの貯留空間131Lの容積を一定とすることができるので、1回の流入動作(図9)による流入量及び1回の流出動作(図10)による流出量を一定量とすることができる。 At this time, the delivery unit 130 can make the volume of the storage space 131L constant when the piston 132 is at the separation position, so that the inflow amount by one inflow operation (FIG. 9) and the one outflow operation (FIG. 9). The outflow amount according to 10) can be made constant.
 このため送出部130では、回転ねじ部137の回転速度を一定に保つことにより薬液の送出速度を一定に保つことができ、また回転ねじ部137の回転速度を変化させることにより、その変化度合いに応じて薬液の送出速度を変化させることもできる。 For this reason, in the delivery part 130, the delivery speed of a chemical | medical solution can be kept constant by keeping the rotation speed of the rotation screw part 137 constant, and the change degree can be changed by changing the rotation speed of the rotation screw part 137. Accordingly, the delivery speed of the chemical solution can be changed.
 さらに送出部130は、その構造上、貯留空間131Lに対し一時に流入管131C又は流出管131Dのいずれか一方のみを連通させ得るため、流入管131C及び流出管131Dの双方と同時に連通してしまうことによる薬液の逆流や送出速度の変動を生じることがない。 Furthermore, because of the structure of the delivery unit 130, only one of the inflow pipe 131C or the outflow pipe 131D can be communicated with the storage space 131L at a time, and therefore the delivery section 130 communicates with both the inflow pipe 131C and the outflow pipe 131D at the same time. This prevents the back flow of the chemical solution and fluctuations in the delivery speed.
 こうすることで、逆止弁を設けることなく簡易な構成でありながら薬液の定量送出が可能となり、かくして、薬液の定量送出と小型化を同時に満たす送出部130を実現できる。 By doing so, it is possible to deliver a fixed amount of the chemical solution with a simple configuration without providing a check valve, and thus it is possible to realize a delivery unit 130 that satisfies the fixed amount of the chemical solution and miniaturization at the same time.
 圧迫部150は、図3に示すように、押え板151、支持部152、板バネ153を含む構成とされる。押え板151は、薬液バッグ110の中央部112より大きな面積を有する板材でなり、薬液バッグ110の上側に設けられる。押え板151は、下筐体部101に固定された支持部152に、例えばヒンジ機構でなる連結部151A及び152Aを中心として薬液バッグ110に離間する方向及び接近する方向に回動可能に支持される。 As shown in FIG. 3, the compression unit 150 includes a press plate 151, a support unit 152, and a plate spring 153. The holding plate 151 is a plate material having an area larger than the central portion 112 of the chemical solution bag 110 and is provided on the upper side of the chemical solution bag 110. The holding plate 151 is supported by a support portion 152 fixed to the lower casing portion 101 so as to be rotatable in a direction away from and approaching the chemical solution bag 110 around the connecting portions 151A and 152A formed of, for example, a hinge mechanism. The
 板バネ153は、押え板151と上筐体部102との間に略V字状に折り曲げられた状態で設けられる板材であり、略V字状に曲げられて対向する板部同士が互いに離間する方向(開こうとする方向)に力が働く。従って板バネ153は、押え板151と上筐体部102との間に配された場合、押え板151を薬液バッグ110側へ常に一定の力で押え付ける。 The plate spring 153 is a plate material provided in a state of being bent in a substantially V shape between the holding plate 151 and the upper housing portion 102, and the plate portions that are bent in a substantially V shape and are opposed to each other are separated from each other. The force works in the direction to open (the direction to open). Therefore, when the leaf spring 153 is disposed between the holding plate 151 and the upper housing portion 102, the holding plate 151 is always pressed against the chemical solution bag 110 side with a constant force.
 ところで圧迫部150は、薬液バッグ110に薬液が注入される前(図4(A))において、下筐体部101の孔101Gから、押え板151と板バネ153との間に板バネリリースロッド154が挿入される。このとき圧迫部150では、板バネ153が押え板151を押え付けることなく、押え板151が自由に回動可能な状態である。 By the way, the compression portion 150 is a plate spring release rod between the holding plate 151 and the plate spring 153 through the hole 101G of the lower housing portion 101 before the chemical solution is injected into the chemical solution bag 110 (FIG. 4A). 154 is inserted. At this time, in the compression unit 150, the presser plate 151 can freely rotate without the plate spring 153 pressing the presser plate 151.
 そして圧迫部150は、薬液バッグ110に薬液が注入された後に板バネリリースロッド154が取り外されると、板バネ153が押え板151を薬液バッグ110側に押え付ける。これにより圧迫部150は、押え板151が薬液バッグ110を下筐体部101との間で挟み込み、該薬液バッグ110に一定の陽圧を与える(図4(B))。 When the leaf spring release rod 154 is removed after the chemical solution is injected into the chemical solution bag 110, the compression portion 150 presses the holding plate 151 against the chemical solution bag 110 side. As a result, the pressing plate 151 sandwiches the chemical solution bag 110 with the lower housing 101 and the presser plate 151 applies a constant positive pressure to the chemical solution bag 110 (FIG. 4B).
 これにより圧迫部150は、薬液バッグ110に気泡が存在している場合には、フィルタ部120を介して外部に気泡を排出することができる。 Thereby, the compression unit 150 can discharge the bubbles to the outside via the filter unit 120 when bubbles are present in the chemical solution bag 110.
 また圧迫部150は、送出部130により薬液バッグ110に貯蔵された薬液を送出する際に、該薬液バッグ110を潰れる方向に押し付けるので、薬液バッグ110に貯蔵された薬液を内部に残すことなく押し出すようにして送出させることができる。 In addition, when the medical solution stored in the chemical solution bag 110 is sent out by the delivery unit 130, the compression unit 150 presses the chemical solution bag 110 in a direction to be crushed, so that the chemical solution stored in the chemical solution bag 110 is pushed out without leaving inside. Thus, it can be sent out.
〔2-2.駆動制御部の構成〕
 駆動制御部20は、図11に示すように、穿刺流路部30が前方向から挿入されるよう、該穿刺流路部30の形状に合わせた凹部20Aを有する略コの字型形状に形成される。
[2-2. Configuration of drive control unit]
As shown in FIG. 11, the drive control unit 20 is formed in a substantially U-shape having a recess 20 </ b> A that matches the shape of the puncture flow channel portion 30 so that the puncture flow channel portion 30 is inserted from the front direction. Is done.
 駆動制御部20は、下側が開口し内部に空間が設けられた上筐体部201と、該上筐体部201の開口に螺着される下筐体部202との間で形成される空間に充電アンテナ203、基板部204、通信アンテナ205、充電池206、モータ207、ギヤヘッド208、動力伝達磁石209、磁気センサ210及び211等が設けられる。 The drive control unit 20 is a space formed between an upper housing part 201 that is open on the lower side and has a space inside, and a lower housing part 202 that is screwed into the opening of the upper housing part 201. Are provided with a charging antenna 203, a substrate 204, a communication antenna 205, a rechargeable battery 206, a motor 207, a gear head 208, a power transmission magnet 209, magnetic sensors 210 and 211, and the like.
 上筐体部201の前後方向に沿った外側面は、薬液貯蔵送出部10に設けられる係合部101B~Eとそれぞれ係合するための溝である係合受部201A~Dが設けられる。 The outer surface along the front-rear direction of the upper housing part 201 is provided with engagement receiving parts 201A to 201D that are grooves for engaging with the engagement parts 101B to E provided in the chemical solution storage and delivery part 10, respectively.
 また上筐体部201の上面には、薬液を一時的に一定量だけ投与する(ボーラス投与)際に使用者に押下操作されるボーラススイッチ201Eが設けられる。このボーラススイッチ201Eは、上筐体部201の上面より窪んだ位置に設けられ、例えば寝返り等により誤って使用者に押下されることを防止することができる。 Also, on the upper surface of the upper housing part 201, a bolus switch 201E that is pressed down by the user when a certain amount of chemical solution is temporarily administered (bolus administration) is provided. The bolus switch 201E is provided at a position recessed from the upper surface of the upper housing portion 201, and can be prevented from being accidentally pressed by the user, for example, by turning over.
 下筐体部202は、上筐体部201と密着する面に防水パッキン202Aが設けられており、上筐体部201が下筐体部202に防水パッキン202Aを介してネジ(図示せず)螺着されるか、超音波融着されるので、上筐体部201と下筐体部202との間から内部空間に液体が侵入することを防止することができる。 The lower casing 202 is provided with a waterproof packing 202A on the surface that is in close contact with the upper casing 201, and the upper casing 201 is screwed to the lower casing 202 via the waterproof packing 202A (not shown). Since it is screwed or ultrasonically fused, it is possible to prevent liquid from entering the internal space from between the upper casing portion 201 and the lower casing portion 202.
 下筐体部202の上面には、充電アンテナ203が貼り付けられており、後述する充電器4(図21)から供給される電気を受電する。 The charging antenna 203 is affixed on the upper surface of the lower housing | casing part 202, and the electricity supplied from the charger 4 (FIG. 21) mentioned later is received.
 また下筐体部202の上面には、CPU(Central
Processing Unit)、RAM(Random Access Memory)、ROM(Read Only Memory)等の電気回路及びコントローラ3との間で信号を送受信するための通信アンテナ205が配置された基板部204が充電アンテナ203の上側に重ねて設けられる。
Further, on the upper surface of the lower housing section 202, a CPU (Central
A board unit 204 on which a communication antenna 205 for transmitting and receiving signals to and from an electrical circuit such as a processing unit (RAM), a random access memory (RAM), and a read only memory (ROM) and the controller 3 is disposed above the charging antenna 203. It is provided to overlap.
 さらに下筐体部202の上面には、充電アンテナ203から供給される電気により充電して駆動時に各部に電気を供給する充電池206が設けられる。 Furthermore, a rechargeable battery 206 is provided on the upper surface of the lower casing unit 202, which is charged by electricity supplied from the charging antenna 203 and supplies electricity to each unit during driving.
 さらに下筐体部202の上面には、薬液貯蔵送出部10の駆動用磁石138Cと対向する位置にモータ207、ギヤヘッド208及び動力伝達磁石209が上から順に重なるようにして設けられる。また下筐体部202の上面には、磁気センサ210が設けられる。 Further, the motor 207, the gear head 208, and the power transmission magnet 209 are provided on the upper surface of the lower casing unit 202 so as to overlap with each other in order from the top at a position facing the driving magnet 138C of the drug solution storage and delivery unit 10. A magnetic sensor 210 is provided on the upper surface of the lower housing unit 202.
 モータ207は、ギヤヘッド208を介して動力伝達磁石209を回転させる。動力伝達磁石209は、図12に示すように、薬液貯蔵送出部10と駆動制御部20とが密着された状態で駆動用磁石138Cと互いに引き付け合う極性となるように該駆動用磁石138Cと対向する配置される。 The motor 207 rotates the power transmission magnet 209 via the gear head 208. As shown in FIG. 12, the power transmission magnet 209 faces the drive magnet 138C so as to have a polarity that attracts the drive magnet 138C in a state where the chemical storage / delivery unit 10 and the drive control unit 20 are in close contact with each other. To be placed.
 動力伝達磁石209は、ギヤヘッド208を介してモータ207に回転されると、駆動用磁石138Cを磁力により引き付けながら自身の回転とともに回転させる。 When the power transmission magnet 209 is rotated by the motor 207 via the gear head 208, the power transmission magnet 209 rotates with its rotation while attracting the driving magnet 138C by magnetic force.
 従ってモータ207は、ギヤヘッド208、動力伝達磁石209及び駆動用磁石138Cを介して非接触により回転伝達部138を回転させて回転ねじ部137を回転させることで、ピストン132を回転させ、また左右方向へ移動させる。 Accordingly, the motor 207 rotates the piston 132 by rotating the rotation transmission portion 138 and rotating the rotation screw portion 137 in a non-contact manner via the gear head 208, the power transmission magnet 209, and the driving magnet 138C. Move to.
 ところでモータ207は動力伝達磁石209及び駆動用磁石138Cの磁力を介して回転伝達部138を非接触で回転させるため、モータ207の回転に追従して回転伝達部138が回転しているか否かを検出する必要がある。そこで回転伝達部138が回転していることを検出する磁気センサ210が、回転検出用磁石138Dが移動する円周上に対向して配される。 By the way, since the motor 207 rotates the rotation transmission unit 138 in a non-contact manner through the magnetic force of the power transmission magnet 209 and the driving magnet 138C, it is determined whether or not the rotation transmission unit 138 rotates following the rotation of the motor 207. It needs to be detected. Therefore, the magnetic sensor 210 that detects that the rotation transmitting unit 138 is rotating is disposed on the circumference where the rotation detecting magnet 138D moves.
 より具体的には、磁気センサ210が回転検出用磁石138Dの磁力を検出した後、再度、磁力を検出することにより回転伝達部138が1回転したことを検出する。 More specifically, after the magnetic sensor 210 detects the magnetic force of the rotation detection magnet 138D, it detects that the rotation transmitting unit 138 has made one rotation by detecting the magnetic force again.
 このようにして磁気センサ210は、回転伝達部138が回転していることを検出することにより、ピストン132の回転及び移動を検出することができる。尚、ここでは、一例として、回転数を1回転単位で検出するようになっているが、磁気センサ210の数を増やして回転数をより細かく検出するようにしてもよい。 In this manner, the magnetic sensor 210 can detect the rotation and movement of the piston 132 by detecting that the rotation transmitting unit 138 is rotating. Here, as an example, the number of rotations is detected in units of one rotation, but the number of magnetic sensors 210 may be increased to detect the number of rotations more finely.
 かくして詳しくは後述するように、マイクロコンピュータ220(図21)は、自身と同じ上筐体部201と下筐体部202で形成される空間内に設けられた磁気センサ210で、異なる空間である下筐体部101と上筐体部102で形成される空間内に設けられる送出部130の駆動を非接触で確認することができる。 Thus, as will be described in detail later, the microcomputer 220 (FIG. 21) is a magnetic sensor 210 provided in the same space formed by the upper housing portion 201 and the lower housing portion 202 and is a different space. It is possible to check the drive of the sending unit 130 provided in the space formed by the lower housing unit 101 and the upper housing unit 102 without contact.
 上筐体部201には、穿刺流路部30が密着する際に接触する凹部20Aの前面に、充電池206から穿刺流路部30に電気を供給し、また穿刺流路部30との間で各種信号を送受信するためのコネクタ部212が設けられる。コネクタ部212は、図13(A)及び(B)に示すように、電気及び各種信号を送受信するためのスプリングコネクタ212Cが複数本集められた電気コネクタ部212Aの外側を防水ゴム212Bで覆う構造でなる。 Electricity is supplied from the rechargeable battery 206 to the puncture channel unit 30 on the front surface of the recess 20A that comes into contact with the upper casing unit 201 when the puncture channel unit 30 is in close contact therewith. A connector unit 212 for transmitting and receiving various signals is provided. As shown in FIGS. 13A and 13B, the connector portion 212 has a structure in which a waterproof rubber 212B covers the outside of the electrical connector portion 212A in which a plurality of spring connectors 212C for transmitting and receiving electricity and various signals are collected. It becomes.
 またコネクタ部212と接続する穿刺流路部30のコネクタ部350(図15)も同様に電気及び各種信号を送受信するためのコネクタ部350Cが複数本集められた電気コネクタ部350Aの外側を防水ゴム350Bで覆う構造でなる。 Similarly, the connector part 350 (FIG. 15) of the puncture flow path part 30 connected to the connector part 212 also has a waterproof rubber outside the electric connector part 350A in which a plurality of connector parts 350C for transmitting and receiving electricity and various signals are collected. The structure is covered with 350B.
 これにより駆動制御部20では、コネクタ部212がコネクタ部350と接続される際に、防水ゴム212B及び350Bにより電気コネクタ部212A及び350Bに液体が触れることを防止することができる。また、コネクタの1ピンを利用して、穿刺流路部30を薬液貯蔵送出部10に挿入する場合に、挿入が許される限界(十分な挿入がされていない場合)にては接触されない長さのピンを設け、穿刺流路部30側でアースで電位に接続しておき、駆動制御部20側にてこのピンの電位がアース電位であるか無いかをチェックして、ア-ス電位でない場合には穿刺流路部30の挿入不足を警報表示して穿刺流路部の挿入状態を監視する。 Thereby, in the drive control unit 20, when the connector unit 212 is connected to the connector unit 350, the waterproof rubber 212B and 350B can prevent the liquid from touching the electrical connector units 212A and 350B. In addition, when inserting the puncture flow path section 30 into the drug solution storage / delivery section 10 using one pin of the connector, the length is not contacted at the limit where insertion is permitted (when sufficient insertion is not performed). This pin is provided and connected to the ground potential on the puncture flow path section 30 side, and it is checked whether the potential of this pin is the ground potential or not on the drive control section 20 side. In this case, the insertion of the puncture channel 30 is monitored by displaying an alarm indicating that the puncture channel 30 is insufficiently inserted.
〔2-3.穿刺流路部の構成〕
 穿刺流路部30は、図14及び図15に示すように、薬液貯蔵送出部10及び駆動制御部20が係合された状態で形成される凹部101H及び凹部20Aの空間に嵌合する前後方向に細長い形状でなる。穿刺流路部30は、外殻を形成する筐体部301の内部空間に各部が設けられる。なお図14(A)では外観構成を示し、図14(B)では内部構成を示す。また図15では、説明の便宜上、一部を断面で示す。
[2-3. (Configuration of puncture channel)
As shown in FIGS. 14 and 15, the puncture channel portion 30 is fitted in the space between the recess 101H and the recess 20A formed in a state where the drug solution storage / delivery unit 10 and the drive control unit 20 are engaged. It has an elongated shape. The puncture flow path part 30 is provided with each part in the internal space of the housing part 301 that forms the outer shell. 14A shows an external configuration, and FIG. 14B shows an internal configuration. Further, in FIG. 15, for convenience of explanation, a part is shown in cross section.
 筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合した際に、下筐体部101の底面101Aと同一平面上に位置する底面301Aと、上筐体部102の中央部102Cに隣接して対向する高さに位置する底面301Bとを有する。 When the puncture flow path unit 30 is fitted to the drug solution storage and delivery unit 10, the housing unit 301 includes a bottom surface 301 </ b> A located on the same plane as the bottom surface 101 </ b> A of the lower housing unit 101 and the center of the upper housing unit 102. A bottom surface 301B located at a height facing and adjacent to the portion 102C.
 筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合した際に上筐体部102の凹部102Dに嵌り込む凸部301Cが底面301Bにおける凹部102Dと対向する位置に設けられる。 The housing portion 301 is provided at a position where a convex portion 301C that fits into the concave portion 102D of the upper housing portion 102 when the puncture flow path portion 30 is fitted to the drug solution storage and delivery portion 10 faces the concave portion 102D in the bottom surface 301B. .
 また筐体部301は、薬液貯蔵送出部10の下筐体部101の突起部101I及び上筐体部102の突起部102A、下筐体部101の突起部101J及び上筐体部102の突起部102Bにそれぞれ係合する案内溝301D及び301Eが前後方向に沿って側面に形成される。 Further, the casing 301 includes a protrusion 101I of the lower casing 101 and a protrusion 102A of the upper casing 102, a protrusion 101J of the lower casing 101, and a protrusion of the upper casing 102. Guide grooves 301D and 301E that respectively engage with the portion 102B are formed on the side surfaces along the front-rear direction.
 筐体部301は、嵌合された薬液貯蔵送出部10及び駆動制御部20から穿刺流路部30を外す際に使用者の指を引っ掛けるための凹部301Qが上面301Fに設けられる。 The casing 301 is provided with a recess 301Q on the upper surface 301F for hooking a user's finger when removing the puncture channel 30 from the drug solution storage / delivery unit 10 and the drive controller 20 that are fitted.
 また筐体部301は、上面301Fから前面301Gにかけて湾曲されており、湾曲された湾曲面301Hに、詳しくは後述する角度調整機構340が設けられる。 The casing 301 is curved from the upper surface 301F to the front surface 301G, and an angle adjustment mechanism 340, which will be described in detail later, is provided on the curved surface 301H.
 また筐体部301は、穿刺流路部30が薬液貯蔵送出部10に嵌合された状態で、薬液貯蔵送出部10の弁体108と対向する位置に孔301Iが設けられ、弁体108に挿入されるノズル302が該孔301Iを貫通するようにして固着される。ノズル302は、孔301Iとの間で隙間が設けられることなく固着される。 In addition, the casing 301 is provided with a hole 301I at a position facing the valve body 108 of the chemical liquid storage / delivery section 10 in a state where the puncture flow path section 30 is fitted to the chemical liquid storage / delivery section 10. The nozzle 302 to be inserted is fixed so as to penetrate the hole 301I. The nozzle 302 is fixed without providing a gap with the hole 301I.
 ノズル302は、穿刺流路部30が薬液貯蔵送出部10に嵌合された状態で一端が弁体108に挿入されて流路管107と連通される。ノズル302は、他端に流水センサ303が接続される。 One end of the nozzle 302 is inserted into the valve body 108 in a state where the puncture flow path section 30 is fitted to the drug solution storage and delivery section 10 and communicates with the flow path pipe 107. The nozzle 302 is connected to a running water sensor 303 at the other end.
 流水センサ303は、通過する薬液が流れているか否かを検出するものであり、例えばサーミスタを定電流で加熱し、薬液の連続流によるサーミスタの温度変化を検出するもので、サーミスタ単体を加熱源と温度センサに用いる方式のほか、加熱源と温度センサを分離して用いる方式として、加熱源に抵抗器、ヒ-タ線、半導体、温度センサはサーモファイル、白金抵抗体、半導体などを組み合わせたものが適応可能である。 The flowing water sensor 303 is for detecting whether or not the passing chemical solution is flowing. For example, the thermistor is heated at a constant current to detect a temperature change of the thermistor due to the continuous flow of the chemical solution. In addition to the method used for the temperature sensor, the heating source and the temperature sensor are used separately. The heating source is a resistor, heater wire, semiconductor, and the temperature sensor is a thermo file, platinum resistor, semiconductor, etc. Things are adaptable.
 流水センサ303は、ノズル302が接続された端とは反対側の端に穿刺流路針304が接続され、ノズル302と穿刺流路針304とを連通させる。穿刺流路針304は、流水センサ303に接続された一端側がS字上に折り返され、そこから前後方向に沿って配され、他端側で底面301Aに到達するように曲げられる。なお穿刺流路針304は、金属製の部材でなるが、例えば28ゲージの中空管であり、容易に曲げられるようになされている。 The flowing water sensor 303 has a puncture channel needle 304 connected to the end opposite to the end to which the nozzle 302 is connected, and allows the nozzle 302 and the puncture channel needle 304 to communicate with each other. The puncture flow path needle 304 is bent so that one end side connected to the running water sensor 303 is folded back on the S-shape, is arranged along the front-rear direction therefrom, and reaches the bottom surface 301A on the other end side. The puncture channel needle 304 is made of a metal member, but is a 28 gauge hollow tube, for example, which can be easily bent.
 穿刺流路針304は、S字上に折り返された直後の位置で、筐体部301から内部に向かって突設される固定部305によって固定される。 The puncture channel needle 304 is fixed by a fixing portion 305 that protrudes inward from the housing portion 301 at a position immediately after being folded back on the S-shape.
 穿刺流路針304は、固定部305に固定された位置より前方側の一部(以下、これを弾性部とも呼ぶ)304Aが螺旋状に巻かれている。弾性部304Aは前後方向に伸縮自在である。 The puncture flow path needle 304 is spirally wound with a part (hereinafter also referred to as an elastic portion) 304A on the front side from the position fixed to the fixing portion 305. The elastic portion 304A is extendable in the front-rear direction.
 穿刺流路針304は、底面301Aに到達するように曲げられた他端側の先端の部分(以下、これを先端部とも呼ぶ)304Bが鋭く尖った形状でなる。 The puncture channel needle 304 has a sharply sharp shape at a tip portion (hereinafter also referred to as a tip portion) 304B that is bent so as to reach the bottom surface 301A.
 このような形状でなる穿刺流路針304は、流水センサ303から流れてきた薬液を内空を通して先端部304Bから外部に送出する。 The puncture flow path needle 304 having such a shape sends the drug solution flowing from the flowing water sensor 303 to the outside through the inner space from the distal end portion 304B.
 穿刺流路針304は、先端部304Bから弾性部304Aにかけて例えばシース部310に覆われる。 The puncture channel needle 304 is covered with, for example, the sheath portion 310 from the distal end portion 304B to the elastic portion 304A.
 シース部310は、例えばテフロン(デュポン株式会社の登録商標)(ポリテトラフルオロエチレン)やポリエチレンでなり、柔軟性を有するシース311と、例えばテフロン(デュポン株式会社の登録商標)やポリオレフィン、ポリウレタンでなり柔らかく、一度変形するとそのままの形状を維持して元の形状には戻ることがない特性(永久変形、塑性変形)を有している伸長部312とによって構成される。伸長部312として、柔らかくて変形しやすくて、元に戻らない特性を有する材料としては、熱収縮チューブなど高温化で紫外線により架橋されている材料が挙げられ、ポリオレフィン、テフロン(デュポン株式会社の登録商標)、シリコン、ポリ塩化ビニルポリフッ化ビニルデンなどを用いることができる。 The sheath portion 310 is made of, for example, Teflon (registered trademark of DuPont) (polytetrafluoroethylene) or polyethylene, and is made of a flexible sheath 311 and, for example, Teflon (registered trademark of DuPont), polyolefin, or polyurethane. It is composed of an elongated portion 312 that is soft and has a characteristic (permanent deformation, plastic deformation) that maintains the shape as it is once deformed and does not return to the original shape. Examples of the material that is soft and easily deformable and has an irreversible property as the extending portion 312 include a material that is crosslinked by ultraviolet rays at a high temperature such as a heat shrinkable tube. Polyolefin, Teflon (registered by DuPont) Trademark), silicon, polyvinyl chloride, polyvinylidene fluoride, and the like can be used.
 シース311は、穿刺流路針304の先端部304Bから弾性部304Aの前方までの大部分を覆っており、かつ穿刺流路針304に対して固定はされていない。 The sheath 311 covers most of the puncture channel needle 304 from the distal end 304B to the front of the elastic portion 304A, and is not fixed to the puncture channel needle 304.
 また伸長部312は、シース311の弾性部304A側の一端側の一部と重なる位置から弾性部304Aの直前まで穿刺流路針304を覆っており、固定部305側の一端が穿刺流路針304に固定され、他端がシース311に固定される。なお伸長部312は、固定された両端では隙間から液体を漏らすことがないように周方向に沿って穿刺流路針304及びシース311との隙間を密閉するようにして固定される。 The extending portion 312 covers the puncture channel needle 304 from a position overlapping one end side of the elastic portion 304A side of the sheath 311 to just before the elastic portion 304A, and one end on the fixed portion 305 side is the puncture channel needle. The other end is fixed to the sheath 311. The extending portion 312 is fixed so as to seal the gap between the puncture flow path needle 304 and the sheath 311 along the circumferential direction so that the liquid does not leak from the gap at both fixed ends.
 穿刺流路針304の弾性部304Aよりも先端部304B側の所定の位置に、該穿刺流路針304とシース311とをまとめて固定するカシメ306が設けられる。カシメ306は、例えばアルミニウムや銅のような一定の力が加えられると変形する材質でなる。 A caulking 306 that fixes the puncture flow path needle 304 and the sheath 311 together is provided at a predetermined position closer to the distal end portion 304B than the elastic portion 304A of the puncture flow path needle 304. The caulking 306 is made of a material that deforms when a certain force is applied, such as aluminum or copper.
 カシメ306は、リング形状である状態から、穿刺流路針304及びシース311がリング孔に挿通された後に左右方向から潰されて上下方向の一部が重なり合い、穿刺流路針304及びシース311を締め付けて固定する。これによりシース311は穿刺流路針304に対して滑らないように固定される。カシメ306は、シース311に対して接着されており、カシメ306の締め付けが緩んだ場合でもシース311とは離れることがない。 The caulking 306 is crushed from the left and right direction after the puncture flow path needle 304 and the sheath 311 are inserted into the ring hole from the state of the ring shape, and a part of the vertical direction overlaps, and the puncture flow path needle 304 and the sheath 311 are overlapped. Tighten and fix. Thereby, the sheath 311 is fixed so as not to slip with respect to the puncture flow path needle 304. The caulking 306 is bonded to the sheath 311 and does not leave the sheath 311 even when the caulking 306 is loosened.
 穿刺流路部30は、カシメ306の前方であって、該カシメ306から所定距離だけ離れた位置に移動制限部307が設けられる。この所定距離は、詳しくは後述するように、穿刺流路針304及びシース311が筐体部301の底面301Aから突出する距離、すなわち穿刺流路針304及びシース311を使用者に穿刺する深さ距離と同じ距離であり、本実施の形態では10mmに設定される。移動制限部307は、筐体部301に固定されており、中央に設けられた孔に穿刺流路針304とシース部310が接触することなく挿通するように配される。 The puncture flow path part 30 is provided in front of the caulking 306 and a movement restricting part 307 at a position away from the caulking 306 by a predetermined distance. As will be described later in detail, the predetermined distance is a distance at which the puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, that is, a depth at which the puncture flow path needle 304 and the sheath 311 are punctured to the user. It is the same distance as the distance, and is set to 10 mm in the present embodiment. The movement restricting portion 307 is fixed to the housing portion 301 and is arranged so that the puncture flow path needle 304 and the sheath portion 310 can be inserted into a hole provided in the center without contacting.
 穿刺流路部30は、カシメ306の後方であって伸長部312よりも前方の位置に穿刺機構320が設けられる。穿刺機構320は、固定板321、バネ322、支持板323及び押部324により構成される。 The puncture flow path section 30 is provided with a puncture mechanism 320 at a position behind the caulking 306 and ahead of the extension section 312. The puncture mechanism 320 includes a fixed plate 321, a spring 322, a support plate 323, and a pressing portion 324.
 固定板321は、筐体部301に固定されており、中央に設けられた孔に穿刺流路針304とシース部310が接触することなく挿通するように配される。 The fixing plate 321 is fixed to the housing part 301 and is arranged so that the puncture flow path needle 304 and the sheath part 310 can be inserted into a hole provided in the center without contact.
 固定板321の前方にはバネ322が配される。バネ322は、穿刺流路針304とシース部310が接触することなく内空を挿通するよう配されており、固定板321と支持板323に挟まれて自然長よりも圧縮された状態で配される。 A spring 322 is disposed in front of the fixed plate 321. The spring 322 is arranged so as to pass through the inner space without contact between the puncture flow path needle 304 and the sheath portion 310, and is arranged in a state where it is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length. Is done.
 支持板323は、穿刺流路針304とシース部310が接触することなく挿通するように配されており、バネ322が接する面とは反対側の面であって穿刺流路針304とシース部310より下側で押部324を支持する。また支持板323は、押部324を支持する面と同一面で押部324を支持する位置よりも下側の位置で穿刺リリース機構330により前方向に移動しないように保持される。 The support plate 323 is arranged so that the puncture flow path needle 304 and the sheath portion 310 are inserted without contacting each other, and is a surface on the opposite side to the surface where the spring 322 is in contact with the puncture flow path needle 304 and the sheath portion. The push portion 324 is supported below 310. The support plate 323 is held so as not to move forward by the puncture release mechanism 330 at a position lower than a position where the pressing portion 324 is supported on the same surface as the surface supporting the pressing portion 324.
 押部324は、図16に示すように、略円柱形状でなり、その先端が上下方向に長く左右方向に短いマイナス型(一文字型)となる形状でなる。押部324は、カシメ306の上下方向に延びた部分のうちの下側で重なり合っている部材同士の間に先端が位置するように支持板323に支持される。 As shown in FIG. 16, the pressing portion 324 has a substantially cylindrical shape, and has a negative shape (one character type) whose tip is long in the vertical direction and short in the horizontal direction. The pressing portion 324 is supported by the support plate 323 so that the tip is located between members overlapping on the lower side of the portion of the caulking 306 extending in the vertical direction.
 穿刺リリース機構330は、制限部331、バネ332及びアクチュエータ333により構成される。 The puncture release mechanism 330 includes a limiting portion 331, a spring 332, and an actuator 333.
 制限部331は、断面が略L字型となる形状となるように前後方向に延びた部分と上下方向に延びた部分とを有しており、前後方向に延びた部分の中央付近に設けられた回転軸331Aを中心に回動自在に保持される。制限部331は、上下方向に延びた部分の回転軸331A側の面で支持板323を支持するように配され、支持板323が前方向に移動しないように制限する。 The restricting portion 331 has a portion extending in the front-rear direction and a portion extending in the up-down direction so that the cross section has a substantially L shape, and is provided near the center of the portion extending in the front-rear direction. The rotary shaft 331A is held rotatably. The restricting portion 331 is disposed so as to support the support plate 323 with the surface on the rotating shaft 331A side of the portion extending in the vertical direction, and restricts the support plate 323 from moving in the forward direction.
 制限部331は、前後方向に延びた部分の回転軸331Aよりも前方向側の下面にバネ332が接続され、回転軸331Aより後側の上面にアクチュエータ333の突起部333Aが接する。 The restriction portion 331 has a spring 332 connected to the lower surface on the front side of the rotation shaft 331A of the portion extending in the front-rear direction, and the protrusion 333A of the actuator 333 is in contact with the upper surface on the rear side of the rotation shaft 331A.
 バネ332は、一端が制限部331に接続され、他端が筐体部301の底面301B側に接続されており、縮もうとする方向に常に力が加えられた状態で配される。 The spring 332 has one end connected to the restricting portion 331 and the other end connected to the bottom surface 301B side of the housing portion 301, and is arranged in a state in which a force is always applied in the direction of contraction.
 アクチュエータ333は、電力が供給されることにより突起部333Aを前後方向に移動させるようになされており、突起部333Aが制限部331に接する状態で配される。 The actuator 333 is configured to move the protruding portion 333A in the front-rear direction when electric power is supplied, and is disposed in a state where the protruding portion 333A is in contact with the limiting portion 331.
 なお、バネ322が固定板321と支持板323に挟まれて自然長よりも圧縮され、制限部331が支持板323と接し、アクチュエータ333の突起部333Aが制限部331に接する状態で配された状態を初期状態(図15、図17(A))とも呼ぶ。なお図17では説明の便宜上、穿刺流路針304及びシース311が曲げられていない真っ直ぐな状態で図示されているが、実際には上述したように、その一部が曲げられている。 The spring 322 is sandwiched between the fixed plate 321 and the support plate 323 and compressed more than the natural length, the limiting portion 331 is in contact with the support plate 323, and the projection 333A of the actuator 333 is disposed in contact with the limiting portion 331. The state is also referred to as an initial state (FIGS. 15 and 17A). In FIG. 17, for convenience of explanation, the puncture flow path needle 304 and the sheath 311 are illustrated in a straight state that is not bent, but in reality, a part thereof is bent as described above.
 初期状態において、アクチュエータ333が駆動して突起部333Aが後方向に移動されて該突起部333Aから制限部331が開放されると、制限部331がバネ332の自然長に戻ろうとする力により回転軸331Aを中心に反時計回りに回転されて支持板323から離れる。 In the initial state, when the actuator 333 is driven and the protrusion 333A is moved backward to release the restricting part 331 from the protrusion 333A, the restricting part 331 is rotated by the force of returning to the natural length of the spring 332 It is rotated counterclockwise around the shaft 331 </ b> A and moves away from the support plate 323.
 穿刺機構320では、制限部331が支持板323から離れると、縮んでいたバネ322が自然長に戻ろうとして伸びて支持板323及び押部324を前方向に押す。前方向に押された押部324は、カシメ306が移動制限部307に接するまで穿刺流路針304及びシース311と共にカシメ306を前方向に押す。 In the puncture mechanism 320, when the restricting portion 331 is separated from the support plate 323, the contracted spring 322 extends to return to the natural length and pushes the support plate 323 and the pressing portion 324 in the forward direction. The pushing portion 324 pushed in the forward direction pushes the caulking 306 forward together with the puncture channel needle 304 and the sheath 311 until the caulking 306 comes into contact with the movement restricting portion 307.
 このときカシメ306は、上下方向に延びた部分のうちの上側で重なり合っている部分が前後方向に延びるカシメガイド308に沿って穿刺流路針304及びシース311を挟んだまま前方向に移動する。 At this time, the caulking 306 moves in the forward direction while sandwiching the puncture channel needle 304 and the sheath 311 along the caulking guide 308 in which the upper portion of the portions extending in the vertical direction overlaps on the upper side.
 因みに、カシメガイド308の断面は下方が開口したコの字型でなり、カシメ306は、上下方向に延びた部分のうちの上側で重なり合っている部分がカシメガイド308の開口された方向から嵌るようにして保持される。 By the way, the cross section of the caulking guide 308 has a U-shape with an opening at the bottom, and the caulking 306 fits from the direction in which the caulking guide 308 is opened in the overlapping portion on the upper side. Is retained.
 カシメ306が前方向に移動する際、穿刺流路針304は弾性部304Aが伸びる(図17(B))。そして穿刺流路針304及びシース311は、筐体部301の底面301Aから突出し、先端部304Bが使用者を穿刺してシース311と共に使用者の体内に入り込む。 When the caulking 306 moves in the forward direction, the elastic portion 304A of the puncture channel needle 304 is extended (FIG. 17B). The puncture flow path needle 304 and the sheath 311 protrude from the bottom surface 301A of the housing 301, and the distal end 304B punctures the user and enters the user's body together with the sheath 311.
 穿刺機構320は、カシメ306が移動制限部307に接した後もバネ322が伸び続け、カシメ306の下方で重なり合っている部材同士の間に押部324の先端が入り込む。このとき押部324は、カシメ306の下方で重なり合っている部材を両側に開き、穿刺流路針304及びシース311に対するカシメ306の締め付けを緩める。 In the puncture mechanism 320, the spring 322 continues to extend even after the caulking 306 comes into contact with the movement restricting portion 307, and the tip of the pressing portion 324 enters between the members overlapping below the caulking 306. At this time, the pusher 324 opens the overlapping members below the caulking 306 on both sides, and loosens the tightening of the caulking 306 with respect to the puncture channel needle 304 and the sheath 311.
 カシメ306による締め付けが緩むことによって穿刺流路針304に対するカシメ306による固定が解除される。そうすると、穿刺流路針304は、弾性部304Aが自然長まで縮まり、先端部304Bが底面301Aの内側の初期位置まで戻る。 When the tightening by the caulking 306 is loosened, the fixation by the caulking 306 to the puncture channel needle 304 is released. Then, in the puncture channel needle 304, the elastic portion 304A contracts to the natural length, and the distal end portion 304B returns to the initial position inside the bottom surface 301A.
 このときシース部310では、シース311がカシメ306に固定されて移動できないので、弾性部304Aが縮むに連れて一端が穿刺流路針304に固定された伸長部312が伸びる。 At this time, in the sheath portion 310, the sheath 311 is fixed to the caulking 306 and cannot move, so the extension portion 312 having one end fixed to the puncture channel needle 304 extends as the elastic portion 304A contracts.
 そしてシース部310は、一端伸びた伸長部312が元の形状に戻ることがないことから、シース311の先端部が底面301Aから突出した状態に維持される(図17(C))。 The sheath portion 310 is maintained in a state in which the distal end portion of the sheath 311 protrudes from the bottom surface 301A because the elongated portion 312 that extends at one end does not return to the original shape (FIG. 17C).
 このように穿刺流路部30は、使用者を穿刺する際には先端部304Bが鋭利な金属製の穿刺流路針304で穿刺し、その後、柔軟性のあるシース311だけを体内に挿入し続け、金属製でなる穿刺流路針304を体外に戻すことができる。 In this way, when puncturing the user, the puncture channel section 30 punctures with the metal puncture channel needle 304 having a sharp tip 304B, and then inserts only the flexible sheath 311 into the body. Subsequently, the puncture channel needle 304 made of metal can be returned to the outside of the body.
 よって薬液投与装置2は、使用者が使用している最中は金属製の穿刺流路針304を体内に残しておくことがなく、柔軟性を有するシース311だけを体内に挿入し続けることができ、使用者に痛みや不快感を与えることを軽減でき、かくして使い勝手を向上することができる。 Therefore, the medicinal solution administration device 2 does not leave the metal puncture channel needle 304 in the body while the user is using it, and can continue to insert only the flexible sheath 311 into the body. It is possible to reduce pain and discomfort to the user, thus improving usability.
 これに対して従来の薬液投与装置では、シースの一端が針に対してパッキンを介して接続されており、針及びシースを皮膚に穿刺した後、針を体外に引き抜く際にシースをパッキン部分で滑らせてその位置に留まるようになされていた。 On the other hand, in the conventional drug solution administration device, one end of the sheath is connected to the needle through a packing, and after the needle and the sheath are punctured into the skin, the sheath is inserted into the packing portion when the needle is pulled out of the body. It was made to slide and stay in that position.
 従って従来の薬液投与装置では、針とシースの隙間をパッキンで塞いでいるので薬液が漏れてしまうか、また、シ-ルを強固にすると針とパッキンの摩擦が大きくなり針が十分な深さまで刺さらない可能性があった。 Therefore, in the conventional drug solution administration device, the gap between the needle and the sheath is sealed with the packing, so that the drug solution leaks, or when the seal is strengthened, the friction between the needle and the packing increases and the needle reaches a sufficient depth. There was a possibility not to sting.
 一方、薬液投与装置2は、伸長部312の一端で穿刺流路針304との隙間を設けることなく固定されているので、薬液が漏れてしまうことがない。また、パッキンと針との摩擦による穿刺動作への支障が発生しない。 On the other hand, since the medicinal solution administration device 2 is fixed without providing a gap with the puncture channel needle 304 at one end of the extending portion 312, the medicinal solution does not leak. In addition, there is no hindrance to the puncturing operation due to the friction between the packing and the needle.
 ところで穿刺流路部30(図14及び図15)は、移動制限部307より前方であって筐体部301の湾曲面301Hに、底面301Aに対する穿刺流路針304及びシース311の突出する角度(以下、これを突出角度とも呼ぶ)を調整する角度調整機構340が設けられる。この突出角度は、底面301Aが使用者の皮膚に当接されるので、穿刺流路針304及びシース311の使用者の皮膚に対する角度(以下、これを穿刺角度とも呼ぶ)と同じ角度となる。 By the way, the puncture flow path section 30 (FIGS. 14 and 15) is forward of the movement restricting section 307 and on the curved surface 301H of the housing section 301, the angle at which the puncture flow path needle 304 and the sheath 311 project with respect to the bottom surface 301A ( Hereinafter, an angle adjustment mechanism 340 for adjusting the projection angle is also provided. Since the bottom surface 301A is in contact with the user's skin, the protruding angle is the same as the angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's skin (hereinafter also referred to as the puncture angle).
 角度調整機構340は、図18に示すように、筐体部301に一端が固定されたL字型の円柱でなる支持部341に支持される。支持部341は、筐体部301に固定された一端とは反対側で左右方向に直交するように配される端面における同心円状で所定角度ごとに複数個(本実施例では4個)の凹部341Aが設けられる。なお、凹部341Aは、詳しくは後述するように、穿刺流路針304及びシース311の穿刺角度が20°~90°になるような位置に設けられる。 As shown in FIG. 18, the angle adjustment mechanism 340 is supported by a support portion 341 made of an L-shaped column whose one end is fixed to the housing portion 301. The support portion 341 is a concentric circular shape at the end surface arranged to be orthogonal to the left-right direction on the side opposite to the one end fixed to the housing portion 301, and a plurality of (four in this embodiment) concave portions at a predetermined angle. 341A is provided. The concave portion 341A is provided at a position where the puncture angle of the puncture channel needle 304 and the sheath 311 is 20 ° to 90 °, as will be described in detail later.
 角度調整機構340は、支持部341の端面と対向する位置に凹部341Aと同心円状で該凹部341Aに嵌るように凸部342Aが突設された中心部342が設けられる。中心部342は、バネ343及びバネ押板344を介してネジ345により支持部341に向かって押し付けられながら、突設された凸部342Aが凹部341Aに嵌る位置で支持部341に支持される。 The angle adjusting mechanism 340 is provided with a central portion 342 having a convex portion 342A projecting so as to be concentric with the concave portion 341A and fitted into the concave portion 341A at a position facing the end surface of the support portion 341. The central portion 342 is supported by the support portion 341 at a position where the protruding convex portion 342A fits into the concave portion 341A while being pressed toward the support portion 341 by the screw 345 through the spring 343 and the spring pressing plate 344.
 中心部342は、自身が回転する際の回転軸と直交する方向に、軸部346が設けられる。軸部346は、円柱形状でなり、一端が穿刺流路針304及びシース311を保持する保持部347と接続され、他端が使用者に角度を調整される際に持たれるツマミ部348に接続される。 The central portion 342 is provided with a shaft portion 346 in a direction orthogonal to the rotation axis when the center portion 342 rotates. The shaft portion 346 has a cylindrical shape, one end is connected to the holding portion 347 that holds the puncture channel needle 304 and the sheath 311, and the other end is connected to the knob portion 348 that is held when the angle is adjusted by the user. Is done.
 保持部347は、シース311の外形よりも太い内径を有する管であり、穿刺流路針304及びシース311が挿通され、穿刺流路針304及びシース311を固定することなく保持する。 The holding portion 347 is a tube having an inner diameter that is thicker than the outer shape of the sheath 311, and the puncture flow path needle 304 and the sheath 311 are inserted therethrough, and the puncture flow path needle 304 and the sheath 311 are held without being fixed.
 ツマミ部348は、図19に示すように、使用者に持たれるツマミ348Aと、該ツマミ348Aを支えるツマミ支持部348Bとからなる。ツマミ部348は、筐体部301の湾曲面301Hに設けられた開口301Jの左右両側が断面L字型となるレール部301K及び301Mに、ツマミ支持部348Bの両端が引っかかるようにして載置される。 As shown in FIG. 19, the knob portion 348 includes a knob 348A held by the user and a knob support portion 348B that supports the knob 348A. The knob portion 348 is placed so that both ends of the knob support portion 348B are hooked on rail portions 301K and 301M whose left and right sides of the opening 301J provided on the curved surface 301H of the housing portion 301 are L-shaped in cross section. The
 ツマミ支持部348Bは、筐体部301と該筐体部301の湾曲面301H上に設けられるパネル部349に挟まれるようにして載置される。パネル部349は、ツマミ348Aが湾曲面301Hに沿った方向(以下、これを湾曲方向とも呼ぶ)に移動し得るように開口し、かつレール部301K及び301Mよりも湾曲方向に沿って長い形状をしている。 The knob support portion 348B is placed so as to be sandwiched between the housing portion 301 and the panel portion 349 provided on the curved surface 301H of the housing portion 301. The panel portion 349 opens so that the knob 348A can move in a direction along the curved surface 301H (hereinafter also referred to as a curved direction), and has a shape that is longer in the curved direction than the rail portions 301K and 301M. is doing.
 なお、ツマミ支持部348Bの上面の縁には防水パッキン348Cが設けられており、該ツマミ支持部348Bとパネル部349との間から液体が筐体部301内に進入することを防止する。 A waterproof packing 348C is provided on the edge of the upper surface of the knob support portion 348B, and prevents liquid from entering the housing portion 301 from between the knob support portion 348B and the panel portion 349.
 このような構成でなる角度調整機構340は、ツマミ部348が使用者によって湾曲方向に移動されることにより、中心部342を中心とした軸部346の回転に応じて保持部347が回転される。 In the angle adjusting mechanism 340 having such a configuration, the holding portion 347 is rotated according to the rotation of the shaft portion 346 around the center portion 342 when the knob portion 348 is moved in the bending direction by the user. .
 これにより、角度調整機構340は、図20(A)及び(B)に示すように、保持部347で保持した穿刺流路針304及びシース311の底面301Aに対する突出角度を20°~90°の範囲で変更する。なお図20(A)は突出角度が90°の場合を示しており、図20(B)は突出角度が20°の場合を示している。 Accordingly, as shown in FIGS. 20 (A) and 20 (B), the angle adjusting mechanism 340 sets the protrusion angle of the puncture flow path needle 304 held by the holding portion 347 and the bottom surface 301A of the sheath 311 to 20 ° to 90 °. Change in range. 20A shows a case where the protrusion angle is 90 °, and FIG. 20B shows a case where the protrusion angle is 20 °.
 すなわち、角度調整機構340は、底面301Aと平行に配される使用者の表皮に対する穿刺流路針304及びシース311の穿刺角度を20°~90°の範囲で変更することができる。なお、穿刺角度によって先端部304Bと底面301Aとの距離が変化することにより先端部304Bが底面301Aより外に出ないように穿刺流路針304及びシース311を設定する。 That is, the angle adjusting mechanism 340 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis arranged in parallel with the bottom surface 301A in the range of 20 ° to 90 °. The puncture flow path needle 304 and the sheath 311 are set so that the tip 304B does not come out of the bottom 301A when the distance between the tip 304B and the bottom 301A changes depending on the puncture angle.
 なお、穿刺流路針304の先端部304B及びシース311の先端は、底面301Aに設けられた開口301Nを塞ぎかつシース311の外周に接するように配される例えばエラストマーでなる柔軟性を有する先端保持部309に保持される。 Note that the distal end portion 304B of the puncture channel needle 304 and the distal end of the sheath 311 are arranged so as to close the opening 301N provided in the bottom surface 301A and come into contact with the outer periphery of the sheath 311. Held by the unit 309.
 先端保持部309は、底面301Aの内側に設けたL字のリブにはめられており、両側が301の前面301G、背面301Vの内側に沿って前後方向にずれるようになっている。その柔軟性により、穿刺流路針304の先端部304B及びシース311の先端が角度調整機構340に移動されてもそれに追従でき、かつ開口301Nを塞ぎ続ける。よって筐体部301内に液体が進入することを防止することができる。 The tip holding portion 309 is fitted to an L-shaped rib provided inside the bottom surface 301A, and both sides are shifted in the front-rear direction along the inside of the front surface 301G and the back surface 301V of the 301. Due to the flexibility, even if the distal end portion 304B of the puncture flow path needle 304 and the distal end of the sheath 311 are moved to the angle adjusting mechanism 340, they can follow it and continue to close the opening 301N. Accordingly, liquid can be prevented from entering the housing portion 301.
 また、先端保持部309には、穿刺流路針304の先端部304Bのさらに先の位置で、穿刺流路針304の先端部304B及びシース311の先端に蓋をする形で、エアベントフィルタ309Aが設けられる。 The tip holding portion 309 includes an air vent filter 309A that covers the tip portion 304B of the puncture channel needle 304 and the tip of the sheath 311 at a position further ahead of the tip portion 304B of the puncture channel needle 304. Provided.
 従ってエアベントフィルタ309Aは、使用者が使用する前において穿刺流路針304を流れてきた薬液を外部に漏らすことなく、穿刺流路針304に始めから存在する空気だけを外部に排出することができる。 Therefore, the air vent filter 309A can discharge only the air present in the puncture channel needle 304 to the outside without leaking the drug solution flowing through the puncture channel needle 304 before use by the user. .
 このように薬液投与装置2では、角度調整機構340が使用者の操作に応じて穿刺流路針304及びシース311の底面301Aに対する突出角度を20°~90°の範囲で変更することができる。 Thus, in the drug solution administration device 2, the angle adjustment mechanism 340 can change the protrusion angle of the puncture flow path needle 304 and the bottom surface 301A of the sheath 311 with respect to the bottom surface 301A within a range of 20 ° to 90 ° according to the operation of the user.
 ところで人の体は、体表から1.5mm~4mm程度までに表皮及び真皮等の皮膚があり、その内部で体表から4mm~9mm程度までの深さの位置に皮下組織があり、さらに内側に筋肉などがある。 By the way, the human body has skins such as epidermis and dermis from about 1.5 mm to 4 mm from the body surface, and there is subcutaneous tissue at a depth of about 4 mm to 9 mm from the body surface inside, and further inside Have muscles.
 例えばインスリンを外部から投与する場合、使用者に対する負担や痛み、インスリンの吸収速度などが考慮され、表面から4mm~9mm程度の深さにある皮下組織に投与されることが一般的である。 For example, when insulin is administered from the outside, it is generally administered to a subcutaneous tissue at a depth of about 4 mm to 9 mm from the surface in consideration of burden on the user, pain, absorption rate of insulin, and the like.
 しかしながら皮下組織の深さはその位置及び年齢、体格、性別等の個人差により異なるものの、従来の薬液投与装置では決まった穿刺角度で決まった距離だけ穿刺されるため、一部の使用者にとっては皮下組織に対してインスリンを投与できなくなる可能性があった。 However, although the depth of the subcutaneous tissue varies depending on individual differences such as its position and age, physique, gender, etc., since conventional drug solution administration devices puncture a fixed distance at a fixed puncture angle, for some users Insulin could not be administered to the subcutaneous tissue.
 これに対して薬液投与装置2は、角度調整機構340により使用者の表皮に対する穿刺流路針304及びシース311の穿刺角度を20°~90°の範囲で変更することができるので、突出角度を調節させることにより任意の深さに穿刺することができ、全ての使用者にとって最適とされる皮下組織に確実に穿刺することができる。また、近年、真皮層に薬液を投与することにより、皮下に投与していたときに比べて少量の薬液で同等の薬効を得られることから、穿刺距離を真皮に設定することも可能である。かくして薬液投与装置2は、使い勝手を向上させることができる。 In contrast, the medicinal-solution administration device 2 can change the puncture angle of the puncture flow path needle 304 and the sheath 311 with respect to the user's epidermis within the range of 20 ° to 90 ° by the angle adjusting mechanism 340. By adjusting, it is possible to puncture to an arbitrary depth, and it is possible to reliably puncture the subcutaneous tissue that is optimal for all users. In recent years, by administering a drug solution to the dermis layer, it is possible to obtain the same medicinal effect with a small amount of drug solution compared to when administered subcutaneously, and therefore it is possible to set the puncture distance to the dermis. Thus, the medicinal solution administration device 2 can improve usability.
 ところで、筐体部301には、駆動制御部20が密着する際に該駆動制御部20のコネクタ部212と対向する位置に設けられた孔301Pに隙間なくコネクタ部350が接着される。コネクタ部350は、図13(A)及び(B)に示したように、電気及び各種信号を送受信するためのコネクタ部350Cが複数本集められた電気コネクタ部350Aの外側を防水ゴム350Bで覆う構造でなる。 By the way, when the drive control unit 20 is in close contact with the housing unit 301, the connector unit 350 is adhered to the hole 301P provided at a position facing the connector unit 212 of the drive control unit 20 without a gap. As shown in FIGS. 13A and 13B, the connector portion 350 covers the outside of the electrical connector portion 350A in which a plurality of connector portions 350C for transmitting and receiving electricity and various signals are collected with a waterproof rubber 350B. Constructed.
 このように薬液投与装置2は、使用者の皮膚を穿刺する穿刺流路針304が設けられる穿刺流路部30が、薬液が貯蔵される薬液バッグ110が設けられた薬液貯蔵送出部10及び送出部130を動作させるモータ207や基板部204が設けられた駆動制御部20に対して別体に設けられる。 Thus, the medicinal solution administration device 2 includes the puncture channel unit 30 provided with the puncture channel needle 304 for puncturing the user's skin, the medicinal solution storage and delivery unit 10 provided with the medicinal solution bag 110 for storing the medicinal solution, and the delivery. The drive control unit 20 provided with the motor 207 for operating the unit 130 and the substrate unit 204 is provided separately.
 従って薬液投与装置2では、例えば穿刺に失敗した場合であっても、また穿刺部位で炎症が起きた場合であっても、穿刺流路部30だけを取り替えさせるだけでよく、使い勝手がよい。 Therefore, in the drug solution administration device 2, for example, even when puncture fails or when inflammation occurs at the puncture site, it is only necessary to replace the puncture flow path section 30 and it is easy to use.
 これに対して従来の薬液投与装置では、使用者の皮膚を穿刺する針、薬液が貯蔵される薬液バッグ、モータ等が全て同一の筐体内に設けられているため、例えば穿刺に失敗した場合には装置全体を取り替えなくてはならず、使い勝手が悪いばかりか、経済的な負担も増えるという問題があった。 On the other hand, in the conventional liquid medicine administration device, since the needle for puncturing the user's skin, the liquid medicine bag for storing the liquid medicine, the motor, etc. are all provided in the same housing, for example, when puncture fails Had to replace the entire device, which was not only convenient, but also increased the economic burden.
〔3.薬液投与システムの回路構成等〕
 次に、薬液投与システム1の回路構成及び機能的構成を図21を用いて説明する。
[3. (Circuit configuration of chemical solution administration system etc.)
Next, the circuit configuration and functional configuration of the drug solution administration system 1 will be described with reference to FIG.
 コントローラ3は、マイクロコンピュータ361、電池362、電池監視部363、モードスイッチ364、数値設定スイッチ365、表示部366、送信部367、受信部368及び通信アンテナ369により構成される。 The controller 3 includes a microcomputer 361, a battery 362, a battery monitoring unit 363, a mode switch 364, a numerical value setting switch 365, a display unit 366, a transmission unit 367, a reception unit 368, and a communication antenna 369.
 マイクロコンピュータ361は、CPU、RAM、ROM等でなるコンピュータであり、CPUがROMに格納される基本プログラムをRAMに読みだして実行することにより全体を統括制御するとともに、CPUがROMに格納される各種プログラムをRAMに読みだして実行することにより各種処理を実行する。 The microcomputer 361 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.
 電池362は、各部に電源電力を供給する。電池監視部363は、電池362の有無や残量等を監視し、マイクロコンピュータ361に通知する。 The battery 362 supplies power to each unit. The battery monitoring unit 363 monitors the presence / absence and remaining amount of the battery 362 and notifies the microcomputer 361 of it.
 モードスイッチ364は、薬液を連続的に長時間投与するベーサルモードや薬液を一時的に投与するボーラスモードを設定するためのスイッチである。数値設定スイッチ365は、薬液の1時間当たりの投与量や投与時間などを設定するためのスイッチである。 The mode switch 364 is a switch for setting a basal mode in which a chemical solution is continuously administered for a long time and a bolus mode in which a chemical solution is temporarily administered. The numerical value setting switch 365 is a switch for setting the dose per hour and the administration time of the drug solution.
 マイクロコンピュータ361は、モードスイッチ364や数値設定スイッチ365に対する操作に応じた内容を表示部366に表示するとともに、その内容を示す信号を送信部367及び通信アンテナ369を介して薬液投与装置2に送信する。 The microcomputer 361 displays the contents corresponding to the operation on the mode switch 364 and the numerical value setting switch 365 on the display unit 366 and transmits a signal indicating the contents to the drug solution administration device 2 via the transmission unit 367 and the communication antenna 369. To do.
 また、マイクロコンピュータ361は、薬液投与装置2から送信された信号を通信アンテナ369で受信すると受信部368を介して取得し、閉塞警報や駆動部の異常等、該信号に応じた内容を表示部366に表示することにより使用者に通知するとともに、その内容に応じた処理を実行する。 In addition, when the microcomputer 361 receives the signal transmitted from the medicinal solution administration device 2 via the communication antenna 369, the microcomputer 361 acquires the signal via the receiving unit 368, and displays a content corresponding to the signal such as an occlusion alarm or a drive unit abnormality. In addition to notifying the user by displaying on 366, processing corresponding to the content is executed.
 一方、薬液投与装置2は、充電池206から供給される電源電力により電気回路が動作し、駆動制御部20に設けられるマイクロコンピュータ220が全体を統括制御する。 On the other hand, in the drug solution administration device 2, the electric circuit is operated by the power supply supplied from the rechargeable battery 206, and the microcomputer 220 provided in the drive control unit 20 performs overall control.
 マイクロコンピュータ220は、CPU、RAM、ROM等でなるコンピュータであり、CPUがROMに格納される基本プログラムをRAMに読みだして実行することにより全体を統括制御するとともに、CPUがROMに格納される各種プログラムをRAMに読みだして実行することにより各種処理を実行する。 The microcomputer 220 is a computer including a CPU, a RAM, a ROM, and the like. The CPU reads and executes a basic program stored in the ROM and executes the overall control, and the CPU is stored in the ROM. Various processes are executed by reading various programs into the RAM and executing them.
 マイクロコンピュータ220は、予めコントローラ3により設定され、送信された投与時間及び投与量を通信アンテナ205及び受信部222により受信してRAMに記憶させ、この投与時間及び投与量に応じて各部を動作させ、或いはコントローラ3から直接、受信部222を介して受信される投与量に応じて各部を動作させる。 The microcomputer 220 receives the administration time and the dose which are set in advance by the controller 3 and is stored in the RAM by the communication antenna 205 and the reception unit 222, and operates each part according to the administration time and the dose. Alternatively, each unit is operated directly according to the dose received from the controller 3 via the receiving unit 222.
 またマイクロコンピュータ220は、流水センサ303を送出部130の送液に同期させて動作させ、投与が正常に送られているか監視し、また磁気センサ210により送出部130が制御通り動作しているか監視して、異常と判断される場合には、閉塞、駆動部異常等の発生をコントローラ3に送信する。 Further, the microcomputer 220 operates the flowing water sensor 303 in synchronization with the liquid feeding of the delivery unit 130 to monitor whether the administration is normally delivered, and monitors whether the delivery unit 130 is operating as controlled by the magnetic sensor 210. If it is determined that there is an abnormality, the occurrence of a blockage, a drive unit abnormality, or the like is transmitted to the controller 3.
 使用者に薬液を投与する場合、具体的には、ボーラス投与時間及び投与量、並びにベーサル投与時間及び投与量がコントローラ3において設定され、薬液投与装置2に送信されることにより、当該薬液投与装置2に設定される。また、薬液バッグ110に対し、設定内容に応じた量の薬液が、当該薬液中に気泡が入らないように注入される。次に薬液投与装置2は、医師の指導の下で使用者に充填角度調整機構340を操作させることにより穿刺角度が調整され、当該使用者に貼付部103を介して貼り付けられる。 When administering a drug solution to a user, specifically, the bolus administration time and dose, and the basal administration time and dose are set in the controller 3 and transmitted to the drug solution administration device 2, thereby the drug solution administration device. 2 is set. In addition, an amount of the chemical solution corresponding to the set content is injected into the chemical solution bag 110 so that bubbles do not enter the chemical solution. Next, the puncture angle of the drug solution administration device 2 is adjusted by causing the user to operate the filling angle adjustment mechanism 340 under the guidance of the doctor, and the drug solution administration device 2 is attached to the user via the application unit 103.
 この状態でマイクロコンピュータ220は、穿刺実行信号がコントローラ3から供給されると、穿刺流路部30が駆動制御部20と接続されているか否かをコネクタ部212及び350の接続により確認する。そしてマイクロコンピュータ220は、穿刺リリース機構330を駆動して使用者に穿刺流路針304及びシース311を穿刺する。 In this state, when the puncture execution signal is supplied from the controller 3, the microcomputer 220 confirms whether or not the puncture flow path unit 30 is connected to the drive control unit 20 by connecting the connector units 212 and 350. The microcomputer 220 drives the puncture release mechanism 330 to puncture the user with the puncture channel needle 304 and the sheath 311.
 続いてマイクロコンピュータ220は、生体に穿刺されたシース内の空洞に薬液を満たすべく規定量の送液を行う。具体的にマイクロコンピュータ220は、あらかじめRAMに記憶されたベーサル投与時間又はボーラス投与時間になったか否かを監視し、何れかの投与時間になった時点で設定された投与量の薬液を投与する。またマイクロコンピュータ220は、コントローラ3からボーラス投与の指示を受信した場合には、受信した投与量の薬液を直ちに投与する。いずれの場合においてもマイクロコンピュータ220は、設定された薬液投与量及び投与速度で薬液を投与するために、モータ207を回転させて送出部130を駆動して使用者の体内に薬液を投与する。 Subsequently, the microcomputer 220 sends a prescribed amount of liquid to fill the cavity in the sheath punctured by the living body. Specifically, the microcomputer 220 monitors whether or not the basal administration time or the bolus administration time stored in advance in the RAM has been reached, and administers a drug solution of a set dose when any administration time is reached. . Further, when the microcomputer 220 receives a bolus administration instruction from the controller 3, the microcomputer 220 immediately administers the received dose of drug solution. In any case, the microcomputer 220 administers the drug solution into the user's body by rotating the motor 207 and driving the delivery unit 130 in order to administer the drug solution at the set drug solution dosage and administration speed.
 このとき薬液投与装置2では、注入部104を介して薬液バッグ110に予め貯蔵された薬液が、フィルタ部120、送出部130、流水センサ303、穿刺流路針304及びシース311などを介して使用者の体内に投与される。 At this time, in the drug solution administration device 2, the drug solution stored in advance in the drug solution bag 110 via the injection unit 104 is used via the filter unit 120, the delivery unit 130, the running water sensor 303, the puncture channel needle 304, the sheath 311, and the like. It is administered to the body of a person.
 薬液を投与している間、マイクロコンピュータ220は、モータ207の回転数をエンコーダ223を介して監視するとともに、流れ検出制御部224を介して薬液が流れているか否かを検出する。なお流れ検出制御部224は、流水センサ303のサーミスタを加熱するとともに、該サーミスタの温度変化を監視する。 During the administration of the chemical solution, the microcomputer 220 monitors the rotation speed of the motor 207 via the encoder 223 and detects whether or not the chemical solution is flowing via the flow detection control unit 224. The flow detection control unit 224 heats the thermistor of the flowing water sensor 303 and monitors the temperature change of the thermistor.
 またマイクロコンピュータ220は、磁気センサ210が検出する磁力に基づいて送出部130が駆動しているか否かを検出する。 Further, the microcomputer 220 detects whether or not the sending unit 130 is driven based on the magnetic force detected by the magnetic sensor 210.
 そしてマイクロコンピュータ220は、モータ207が正常に回転していない場合や、送出部130が正常に駆動していない場合、又は薬液が流れていない場合には、再び実施し、状態が変わらない場合、各部を停止させ、閉塞警報等その旨を送信部221及び通信アンテナ205を介してコントローラ3に送信する。 The microcomputer 220 performs again when the motor 207 is not rotating normally, when the delivery unit 130 is not normally driven, or when no chemical is flowing, and when the state does not change, Each unit is stopped, and a message such as a blocking alarm is transmitted to the controller 3 via the transmission unit 221 and the communication antenna 205.
 マイクロコンピュータ220は、充電池206を充電する際、受信・充電回路225を制御して充電器4から供給される電気を充電アンテナ203を介して受信して充電池206を充電する。なお充電池206には電池安全回路部226が設けられ、電池安全回路部226が充電中の過充電、温度変化を監視、過充電及び熱暴走の防止、また、使用中の過放電を防止する。 When charging the rechargeable battery 206, the microcomputer 220 controls the receiving / charging circuit 225 to receive the electricity supplied from the charger 4 through the charging antenna 203 to charge the rechargeable battery 206. The rechargeable battery 206 is provided with a battery safety circuit unit 226. The battery safety circuit unit 226 monitors overcharge during charging and temperature change, prevents overcharge and thermal runaway, and prevents overdischarge during use. .
 充電器4は、コンセント401、AC/DC変換器402、高周波変換部403及び送信アンテナ404を含む構成とされる。充電器4は、コンセント401から送られてくる交流をAC/DC変換器402で直流に変換し、送信アンテナ404で送信するために高周波変換部403で高周波に変換した後、送信アンテナ404を介して薬液投与装置2に電気エネルギーを送信する。 The charger 4 includes an outlet 401, an AC / DC converter 402, a high frequency converter 403, and a transmission antenna 404. The charger 4 converts alternating current sent from the outlet 401 into direct current by the AC / DC converter 402, converts it to high frequency by the high frequency conversion unit 403 for transmission by the transmission antenna 404, and then passes through the transmission antenna 404. Then, electric energy is transmitted to the drug solution administration device 2.
 従って薬液投与装置2では、薬液バッグ110を含む薬液貯蔵送出部10と、穿刺流路針304及びシース311を含む穿刺流路部30とが薬液を用いるという衛生上の観点から一度のみの使用であるのに対して、薬液を用いていない駆動制御部20は薬液貯蔵送出部10及び穿刺流路部30を着脱させることにより何度も使用することができる。このとき駆動制御部20の充電池206は充電器により充電されるので複数回の使用も行える。 Therefore, in the drug solution administration device 2, the drug solution storage and delivery unit 10 including the drug solution bag 110 and the puncture channel unit 30 including the puncture channel needle 304 and the sheath 311 are used only once from the hygiene viewpoint that the drug solution is used. On the other hand, the drive control unit 20 that does not use the chemical solution can be used many times by attaching and detaching the chemical solution storage and delivery unit 10 and the puncture flow path unit 30. At this time, since the rechargeable battery 206 of the drive control unit 20 is charged by the charger, it can be used multiple times.
〔4.他の実施の形態〕
 なお上述した実施の形態においては、各部の寸法や材料等を最適化することにより、回転ねじ部137のねじ部137A及びねじ受部135のねじ孔135Bの間に生じるねじ摩擦力をピストン132の外周側面132Bとシリンダ131の内周側面131Bとの間に生じる周側面摩擦力よりも高めるようにした場合について述べた。
[4. Other Embodiments]
In the embodiment described above, the screw friction force generated between the screw portion 137A of the rotary screw portion 137 and the screw hole 135B of the screw receiving portion 135 is optimized by optimizing the dimensions and materials of each portion. The case where the peripheral side frictional force generated between the outer peripheral side surface 132B and the inner peripheral side surface 131B of the cylinder 131 is increased is described.
 しかしながら本発明はこれに限らず、例えばスプリング等の付勢手段を用いて回転ねじ部137のねじ部137Aをねじ受部135のねじ孔135Bに付勢することにより、ねじ摩擦力を周側面摩擦力よりも高めるようにしても良い。 However, the present invention is not limited to this. For example, the screw friction force is applied to the peripheral side surface friction by urging the screw portion 137A of the rotating screw portion 137 to the screw hole 135B of the screw receiving portion 135 using an urging means such as a spring. You may make it raise rather than power.
 また上述した実施の形態においては、図示しない回転ねじ支持部により、左右方向、前後方向及び上下方向に関する位置を保ったまま自在に回転し得るよう、回転ねじ部137を支持する場合について述べた。 Further, in the above-described embodiment, the case where the rotation screw portion 137 is supported by the rotation screw support portion (not shown) so that the rotation screw portion 137 can freely rotate while maintaining the positions in the left-right direction, the front-rear direction, and the vertical direction has been described.
 しかしながら本発明はこれに限らず、周知の種々の機構又はその組み合わせでなる回転ねじ支持部により、左右方向、前後方向及び上下方向に関する位置を保ったまま自在に回転し得るように回転ねじ部137を支持するようにしても良い。 However, the present invention is not limited to this, and the rotating screw portion 137 can be rotated freely while maintaining positions in the left-right direction, the front-rear direction, and the up-down direction by a rotating screw support portion formed of various known mechanisms or combinations thereof. May be supported.
〔4-1.他の実施の形態1〕
 例えば図7及び図8と対応する図22及び図23に示すように、送出部130に代わる送出部630を構成することができる。
[4-1. Other Embodiment 1]
For example, as shown in FIG. 22 and FIG. 23 corresponding to FIG. 7 and FIG. 8, a sending unit 630 that replaces the sending unit 130 can be configured.
 送出部630は、図7の送出部130と比較して、ねじ受部135及び回転ねじ部137に代わるねじ受部635及び回転ねじ部637を有し、さらに中継ギヤ638及び回転ねじ支持部640を有する点が相違するものの、他の部分については同様に構成されている。 Compared with the delivery unit 130 of FIG. 7, the delivery unit 630 includes a screw receiver 635 and a rotary screw 637 that replace the screw receiver 135 and the rotary screw 137, and further includes a relay gear 638 and a rotary screw support 640. Although the point which has is different, it is comprised similarly about another part.
 ねじ受部635は、図24に示すように、ねじ受部135の爪部135A及びねじ孔135Bと同様の爪部635A及びねじ孔635Bを有すると共に、左側板の内面側に円環状の取付部635Cが立設されている。 As shown in FIG. 24, the screw receiving portion 635 has a claw portion 635A and a screw hole 635B similar to the claw portion 135A and the screw hole 135B of the screw receiving portion 135, and an annular mounting portion on the inner surface side of the left side plate. 635C is erected.
 取付部635Cの外周には、コイルばねでなるスプリング635Dが取り付けられている。スプリング635Dは、右方向へ向けて巻回され、その右端にキャップ635Eが取り付けられている。キャップ635Eは、取付部635Cと同様の円環状でなる635EAによりスプリング635Dに取り付けられており、また右側面の中央には、左方向へ突出した突出部635EBが形成されている。 A spring 635D made of a coil spring is attached to the outer periphery of the attachment portion 635C. The spring 635D is wound in the right direction, and a cap 635E is attached to the right end thereof. The cap 635E is attached to the spring 635D by an annular 635EA similar to the attachment portion 635C, and a protrusion 635EB protruding leftward is formed at the center of the right side surface.
 スプリング635Dは、自然長から伸長された状態でねじ受部635に取り付けられている。因みにスプリング635Dは、ピストン132が離隔位置にあり最も短縮されたときにも自然長までは戻らないよう、ばね係数や巻き数、或いはピッチ等が適宜選定されている。 The spring 635D is attached to the screw receiving portion 635 in a state extended from the natural length. Incidentally, the spring coefficient, the number of turns, the pitch, and the like of the spring 635D are appropriately selected so that the natural length is not returned even when the piston 132 is at the separation position and is shortened the most.
 回転ねじ部637は、回転ねじ部137のねじ部137Aと対応するねじ部637Aの右端部にルビー軸受637ABが埋め込まれている。ルビー軸受637ABは、右側面の中央部分に窪みが形成されていることにより、キャップ635Eの突出部635EBを受け止めるようになされている。 In the rotating screw portion 637, a ruby bearing 637AB is embedded in the right end portion of the screw portion 637A corresponding to the screw portion 137A of the rotating screw portion 137. The ruby bearing 637AB is configured to receive the protrusion 635EB of the cap 635E by forming a recess in the center portion of the right side surface.
 このためスプリング635Dは、ピストン132の位置に関わらず、常に自然長に戻ろうとする、すなわち短縮しようとする弾性力を作用させ、キャップ635Eを介して回転ねじ部637のねじ部637Aを左方向へ付勢するため、ねじ部637Aとねじ孔635Bとの間のねじ摩擦力を高めることができる。 Therefore, regardless of the position of the piston 132, the spring 635D applies an elastic force that always tries to return to the natural length, that is, shortens, and causes the screw portion 637A of the rotary screw portion 637 to move to the left via the cap 635E. Since the biasing is performed, the screw friction force between the screw portion 637A and the screw hole 635B can be increased.
 このように送出部630では、スプリング635Dの弾性作用によって回転ねじ部637のねじ部637Aをねじ受部635のねじ孔635Bへ付勢することにより、ねじ摩擦力を周側面摩擦力よりも高めることができる。 As described above, in the delivery portion 630, the screw friction force is made higher than the circumferential friction force by urging the screw portion 637A of the rotating screw portion 637 to the screw hole 635B of the screw receiving portion 635 by the elastic action of the spring 635D. Can do.
 ところで回転ねじ部637は、図7の回転ねじ部137のかさ歯車でなる歯車部137Cに代えて、平歯車でなる歯車部637Cが設けられている。この歯車部637Cは、中継ギヤ638の歯車部638Aと歯合している。 Incidentally, the rotating screw portion 637 is provided with a gear portion 637C made of a spur gear instead of the gear portion 137C made of a bevel gear of the rotating screw portion 137 of FIG. The gear portion 637C meshes with the gear portion 638A of the relay gear 638.
 中継ギヤ638は、円柱状の柱状部638Bの一端に平歯車でなる歯車部638Aが取り付けられ、他端にかさ歯車でなる歯車部638Cが取り付けられている。歯車部638Cは、回転ねじ部137の歯車部137Cと同様、回転伝達部138の歯車部138Aと歯合している。 In the relay gear 638, a gear portion 638A made of a spur gear is attached to one end of a cylindrical columnar portion 638B, and a gear portion 638C made of a bevel gear is attached to the other end. The gear portion 638 </ b> C meshes with the gear portion 138 </ b> A of the rotation transmission portion 138, similarly to the gear portion 137 </ b> C of the rotation screw portion 137.
 これにより中継ギヤ638は、回転伝達部138から回転駆動力が伝達されることにより回転し、さらにその回転駆動力を回転ねじ部637に伝達して回転させることができる。 Thus, the relay gear 638 can be rotated by transmitting the rotational driving force from the rotation transmitting portion 138, and the rotational driving force can be transmitted to the rotating screw portion 637 to be rotated.
 一方、回転ねじ支持部640(図23)は、左右方向に板面を向ける板状の基板641を中心に構成されている。基板641は、2箇所に孔部641A及び641Bが穿設されており、この孔部641A及び641Bにそれぞれ樹脂製の軸受642及び643が嵌め込まれている。 On the other hand, the rotating screw support portion 640 (FIG. 23) is configured around a plate-like substrate 641 that faces the plate surface in the left-right direction. The substrate 641 has holes 641A and 641B drilled in two places, and resin bearings 642 and 643 are fitted in the holes 641A and 641B, respectively.
 孔部641A及び641Bには、軸受642及び643を介して回転ねじ部637の中継部637B及び中継ギヤ638の柱状部638Bがそれぞれ挿通されている。 In the holes 641A and 641B, the relay portion 637B of the rotary screw portion 637 and the columnar portion 638B of the relay gear 638 are inserted through bearings 642 and 643, respectively.
 基板641の左側には、離隔板644が取り付けられている。離隔板644は、板状の部材が断面をU字状とするよう折り曲げられた形状となっており、基板641から左方向へ所定距離だけ離れた箇所に基板641とほぼ平行な底部644Aが形成されている。 A separation plate 644 is attached to the left side of the substrate 641. The separation plate 644 has a shape in which a plate-like member is bent so as to have a U-shaped cross section, and a bottom portion 644A substantially parallel to the substrate 641 is formed at a predetermined distance from the substrate 641 in the left direction. Has been.
 底部644Aにおける孔部641Aと対応する箇所、すなわち当該孔部641Aの左側には、孔部644Bが穿設されている。孔部644Bの左側及び右側には、それぞれスラスト玉軸受645及び646が取り付けられており、当該スラスト玉軸受646の左側には、円板637Dが当接している。 A hole 644B is formed in a portion corresponding to the hole 641A in the bottom 644A, that is, on the left side of the hole 641A. Thrust ball bearings 645 and 646 are respectively attached to the left and right sides of the hole 644B, and a disc 637D is in contact with the left side of the thrust ball bearing 646.
 かかる構成により回転ねじ支持部640は、左右方向、前後方向及び上下方向のいずれについてもその位置を変位させることなく、且つ滑らかに回転し得るよう、回転ねじ部637を支持することができる。 With this configuration, the rotating screw support portion 640 can support the rotating screw portion 637 so that it can rotate smoothly without displacing its position in any of the left-right direction, the front-rear direction, and the up-down direction.
〔4-2.他の実施の形態2〕
 また、例えば図7及び8並びに図22及び23とそれぞれ対応する図25及び図26に示すように、送出部130及び630に代わる送出部730を構成することもできる。
[4-2. Other Embodiment 2]
Further, for example, as shown in FIGS. 25 and 26 corresponding to FIGS. 7 and 8 and FIGS. 22 and 23, a sending unit 730 may be configured in place of the sending units 130 and 630.
 送出部730は、図23の送出部630と比較して、ねじ受部635、回転ねじ部637及び回転ねじ支持部640に代わるねじ受部135、回転ねじ部737及び回転ねじ支持部740を有し、さらにスプリング735を有する点が相違するものの、他の部分については同様に構成されている。 Compared with the delivery unit 630 of FIG. 23, the delivery unit 730 has a screw receiving unit 635, a screw receiving unit 135 instead of the screw receiving unit 635, the rotating screw supporting unit 640, a rotating screw supporting unit 740, and a rotating screw supporting unit 740. In addition, although the point of having a spring 735 is different, other parts are configured similarly.
 回転ねじ部737は、図23の回転ねじ部637からルビー軸受637AB(図24)が省略され、ねじ部637A、中継部637B、歯車部637C及び円板637Dとそれぞれ同様に構成されたねじ部737A、中継部737B、歯車部737C及び円板737Dを有し、さらにナイロンワッシャ737Eを有している。 In the rotating screw portion 737, the ruby bearing 637AB (FIG. 24) is omitted from the rotating screw portion 637 of FIG. 23, and the screw portion 737A configured similarly to the screw portion 637A, the relay portion 637B, the gear portion 637C, and the disc 637D. , Relay portion 737B, gear portion 737C and disk 737D, and further, nylon washer 737E.
 またねじ受部135の左側面と回転ねじ部737の歯車部737Cとの間には、ナイロンワッシャ737Eを挟んで、ねじ部737A及び中継部737Bの周囲を接触しないよう空間を空けて巻回するように、コイルばねでなるスプリング735が自然長から縮められた状態で挟み込まれている。 Further, a nylon washer 737E is sandwiched between the left side surface of the screw receiving portion 135 and the gear portion 737C of the rotating screw portion 737 so as to leave a space so as not to contact the periphery of the screw portion 737A and the relay portion 737B. Thus, the spring 735 which consists of a coil spring is pinched | interposed in the state shortened from natural length.
 因みにスプリング735は、ピストン132が当接位置にあり右方向に最も伸びたときにも自然長から縮められた状態にあり、またピストン132が離隔位置にあるときにも完全には短縮されないよう、ばね係数や巻き数等が適宜選定されている。 Incidentally, the spring 735 is in a state of being contracted from the natural length even when the piston 132 is in the abutting position and is most extended in the right direction, and is not completely shortened even when the piston 132 is in the separated position. The spring coefficient, the number of turns, etc. are selected as appropriate.
 このためスプリング735は、ピストン132の位置に関わらず、常に自然長に戻ろうとする、すなわち伸長しようとする弾性力を作用させ、回転ねじ部737のねじ部737Aを左方向へ付勢するため、送出部630の場合と同様、ねじ部737Aとねじ孔135Bとの間のねじ摩擦力を高めることができる。 Therefore, the spring 735 always applies an elastic force to return to the natural length regardless of the position of the piston 132, that is, to extend and urge the screw portion 737A of the rotating screw portion 737 to the left. As in the case of the delivery portion 630, the screw friction force between the screw portion 737A and the screw hole 135B can be increased.
 このように送出部730では、スプリング735の弾性作用によって回転ねじ部637のねじ部637Aをねじ受部135のねじ孔135Bへ付勢することにより、ねじ摩擦力を周側面摩擦力よりも高めることができる。 As described above, in the delivery portion 730, the screw friction force is made higher than the peripheral side friction force by urging the screw portion 637A of the rotary screw portion 637 to the screw hole 135B of the screw receiving portion 135 by the elastic action of the spring 735. Can do.
 一方、回転ねじ支持部740(図26)は、図23の回転ねじ支持部640と比較して、スラスト玉軸受645及び646に代わる軸受745を有する点が相違するものの、他の部分についてはほぼ同様に構成されている。 On the other hand, the rotating screw support portion 740 (FIG. 26) is different from the rotating screw support portion 640 of FIG. 23 in that it has a bearing 745 instead of the thrust ball bearings 645 and 646, but the other portions are almost the same. It is constituted similarly.
 軸受745は、軸受642及び643と同様、樹脂材料により構成されており、回転ねじ部737の中継部737Bに対する滑り摩擦が小さくなっている。 The bearing 745 is made of a resin material like the bearings 642 and 643, and the sliding friction of the rotating screw portion 737 with respect to the relay portion 737B is small.
 かかる構成により回転ねじ支持部740は、図23の回転ねじ支持部640と同様、左右方向、前後方向及び上下方向のいずれについてもその位置を変位させることなく、且つ滑らかに回転し得るよう、回転ねじ部637を支持することができる。 With this configuration, the rotating screw support portion 740 is rotated so as to be able to rotate smoothly without displacing its position in any of the left-right direction, the front-rear direction, and the up-down direction, similarly to the rotating screw support portion 640 of FIG. The threaded portion 637 can be supported.
〔4-3.他の実施の形態3〕
 さらに上述した実施の形態においては、流入口131E及び流出口131Fをそれぞれ左右方向に長い長孔状に形成することにより、ピストン移動範囲内のいずれの位置においても、外周側面口132BHと流入口131E又は流出口131Fとの接続状態を維持し、流通管132Cと流入管131C又は流出管131Dとの間で薬液を流入又は流出させるようにした場合について述べた。
[4-3. Other Embodiment 3]
Furthermore, in the embodiment described above, the inlet 131E and the outlet 131F are each formed in a long hole shape that is long in the left-right direction, so that the outer peripheral side surface port 132BH and the inlet 131E are located at any position within the piston movement range. Or the case where the connection state with the outflow port 131F was maintained and the chemical solution was allowed to flow in or out between the flow pipe 132C and the inflow pipe 131C or the outflow pipe 131D was described.
 しかしながら本発明はこれに限らず、外周側面口132BH並びに流入口131E及び流出口131Fの少なくとも一方を長孔状に形成することにより、ピストン移動範囲内のいずれの位置においても、外周側面口132BHと流入口131E又は流出口131Fとを接続するようにしても良い。この場合、ピストン132が当接位置及び離隔位置にあるとき外周側面口132BHと流入口131E又は流出口131Fとのずれがあったとしても重なり合う位置にあれば良い。 However, the present invention is not limited to this, and by forming at least one of the outer peripheral side surface port 132BH and the inflow port 131E and the outflow port 131F in the shape of a long hole, the outer peripheral side surface port 132BH The inlet 131E or the outlet 131F may be connected. In this case, when the piston 132 is in the contact position and the separation position, even if there is a deviation between the outer peripheral side surface port 132BH and the inflow port 131E or the outflow port 131F, it suffices if it is in an overlapping position.
 例えば図27に示す送出部830において、シリンダ131に代わるシリンダ831は、丸孔でなる流入口831E及び流出口831Fを有している。またピストン832は、丸孔でなる外周側面口132BHに代えて、長孔でなる孔部832BHを有している。 For example, in the delivery unit 830 shown in FIG. 27, a cylinder 831 instead of the cylinder 131 has an inflow port 831E and an outflow port 831F made of round holes. The piston 832 has a hole portion 832BH formed of a long hole instead of the outer peripheral side surface port 132BH formed of a round hole.
 この送出部830は、上述した送出部130と同様、ピストン移動範囲内のいずれの位置においても、孔部832BHと流入口831E又は流出口831Fとを接続し、流通管132Cと流入管131C又は流出管131Dとの間で薬液を流入又は流出させることができる。 This delivery part 830 connects the hole part 832BH and the inflow port 831E or the outflow port 831F at any position within the piston movement range as in the above-described delivery part 130, and connects the flow pipe 132C and the inflow pipe 131C or the outflow line. A chemical solution can flow in or out from the tube 131D.
〔4-4.他の実施の形態4〕
 さらに上述した実施の形態においては、左右方向、すなわち図8のピストン132の移動方向に関し、爪部135Aを短く構成すると共に、規制板136B及び136Cをピストン移動範囲以上の長さとするようにした場合について述べた。
[4-4. Other Embodiment 4]
Further, in the above-described embodiment, when the claw portion 135A is configured to be short with respect to the left-right direction, that is, the moving direction of the piston 132 in FIG. 8, the restriction plates 136B and 136C are set to be longer than the piston moving range. Said.
 しかしながら本発明はこれに限らず、左右方向に関し、ピストン132が当接位置及び離隔位置にあるとき爪部135Aと規制板136B及び136Cとが重なり合う位置にあれば良い。 However, the present invention is not limited to this, and the claw portion 135A and the restricting plates 136B and 136C only need to be in a position where the piston 132 is in the contact position and the separation position in the left-right direction.
 例えば図28に示すように、送出部930は、送出部730のねじ受部135及び規制部136に代わるねじ受部935及び規制部936を有している。ねじ受部935は、送出部730の爪部135Aと対応する爪部935Aにおける左右方向の長さがピストン移動範囲よりも長くなっている。一方、規制部936の規制板936B及び936Cは、左右方向の長さが爪部135Aと同程度に短くなっている。 For example, as shown in FIG. 28, the sending unit 930 includes a screw receiving unit 935 and a regulating unit 936 that replace the screw receiving unit 135 and the regulating unit 136 of the sending unit 730. In the screw receiving portion 935, the length in the left-right direction of the claw portion 935A corresponding to the claw portion 135A of the delivery portion 730 is longer than the piston movement range. On the other hand, the restricting plates 936B and 936C of the restricting portion 936 are as short as the length of the claw portion 135A in the left-right direction.
 この送出部930は、爪部935Aを規制板936B又は936Cと当接させることにより、ピストン132の回転範囲を約180°に規制することができ、またピストン132を左右方向に移動させる際にも、爪部935Aをガイドレールとして用いながら、当該爪部935Aを規制板936B又は936Cに摺動させることにより、その回転範囲を維持することができる。 The sending portion 930 can restrict the rotation range of the piston 132 to about 180 ° by bringing the claw portion 935A into contact with the restriction plate 936B or 936C, and also when moving the piston 132 in the left-right direction. While using the claw portion 935A as a guide rail, the rotation range can be maintained by sliding the claw portion 935A on the restriction plate 936B or 936C.
〔4-5.他の実施の形態5〕
 さらに上述した実施の形態においては、図23に示したようにピストン132と一体に回転するねじ受部135に1個の爪部135Aを設け、シリンダ131に固定された規制部136に2個の規制板136B及び136Cを設けるようにした場合について述べた。
[4-5. Other Embodiment 5]
Furthermore, in the above-described embodiment, as shown in FIG. 23, one claw portion 135A is provided in the screw receiving portion 135 that rotates integrally with the piston 132, and two restriction portions 136 fixed to the cylinder 131 are provided. The case where the restriction plates 136B and 136C are provided has been described.
 しかしながら本発明はこれに限らず、例えば図29(A)及び(B)に示す送出部1030のように、ねじ受部1035に2個の爪部1035A及び1035Bを設け、規制部1036に1個の規制板1036Bを設けるようにしても良い。 However, the present invention is not limited to this, and two claw portions 1035A and 1035B are provided in the screw receiving portion 1035, and one restriction portion 1036 is provided, for example, as in the delivery portion 1030 shown in FIGS. The restriction plate 1036B may be provided.
 この送出部1030は、送出部130と同様、ピストン132の回転範囲を約180°に規制すると共に、当該ピストン132がピストン移動範囲に渡って移動したときにもその回転範囲を規制し続けることができる。 Like the delivery unit 130, the delivery unit 1030 regulates the rotation range of the piston 132 to about 180 °, and can continue to regulate the rotation range even when the piston 132 moves over the piston movement range. it can.
〔4-6.他の実施の形態6〕
 さらに上述した実施の形態においては、図23に示したようにシリンダ131の前側に流入管131C及び流入口131Eを設けると共に後側に流出管131D及び流出口131Fを設け、内部空間131Sの前側及び後側にそれぞれ設けた規制板136B及び136Cにより、ピストン132の回転範囲を約180°に規制するようにした場合について述べた。
[4-6. Other Embodiment 6]
Further, in the above-described embodiment, as shown in FIG. 23, the inflow pipe 131C and the inflow port 131E are provided on the front side of the cylinder 131, and the outflow pipe 131D and the outflow port 131F are provided on the rear side, and the front side of the internal space 131S and The case where the rotation range of the piston 132 is restricted to about 180 ° by the restriction plates 136B and 136C provided on the rear side has been described.
 しかしながら本発明はこれに限らず、シリンダ131における任意の方向に流入管131C及び流入口131Eを設け、これと異なる方向に流出管131D及び流出口131Fを設けると共に、内部空間131S内におけるこれらと対応する方向に規制板136B及び136Cを設け、ピストン132の回転範囲を任意の角度に規制するようにしても良い。 However, the present invention is not limited to this, and the inflow pipe 131C and the inflow port 131E are provided in an arbitrary direction in the cylinder 131, and the outflow pipe 131D and the outflow port 131F are provided in different directions, and correspond to these in the internal space 131S. The restriction plates 136 </ b> B and 136 </ b> C may be provided in the direction in which the rotation of the piston 132 is restricted to an arbitrary angle.
 ただしこの場合、ピストン132の外周側面口132BHが流入口131E及び流出口131Fと同時に接続しないよう、流入管131C及び流入口131Eを設ける方向と、流出管131D及び流出口131Fを設ける方向とをある程度引き離すことが望ましい。 However, in this case, the direction in which the inlet pipe 131C and the inlet 131E are provided and the direction in which the outlet pipe 131D and the outlet 131F are provided to some extent so that the outer peripheral side surface port 132BH of the piston 132 is not connected simultaneously with the inlet 131E and outlet 131F. It is desirable to pull apart.
 例えば図30及び図31に示す送出部1230において、シリンダ1231の上側に流入管1231C及び流入口1231Eを設けると共に、規制部1236の規制板1236Bを内部空間131Sの上側に設けることにより、ピストン132の回転範囲を約90°に規制するようにしても良い。 For example, in the delivery part 1230 shown in FIGS. 30 and 31, the inflow pipe 1231C and the inflow port 1231E are provided on the upper side of the cylinder 1231, and the restriction plate 1236B of the restriction part 1236 is provided on the upper side of the internal space 131S. The rotation range may be restricted to about 90 °.
〔4-7.他の実施の形態7〕
 さらに上述した実施の形態においては、シリンダ131の底面131A及びピストン132の端面132Aをそれぞれ平面状に形成するようにした場合について述べた。
[4-7. Other Embodiment 7]
Furthermore, in the above-described embodiment, the case where the bottom surface 131A of the cylinder 131 and the end surface 132A of the piston 132 are formed in a planar shape has been described.
 しかしながら本発明はこれに限らず、それぞれ任意の形状とするようにしても良い。この場合、底面131A及び端面132Aを互いに対応する形状とすることにより、ピストン132が当接位置にあるときに貯留空間131Lの容積をほぼ0として内部の薬液を残すことなく流出できることが望ましい。 However, the present invention is not limited to this, and each may have an arbitrary shape. In this case, it is desirable that the bottom surface 131A and the end surface 132A have shapes corresponding to each other, so that when the piston 132 is in the contact position, the volume of the storage space 131L is substantially zero and can flow out without leaving the internal chemical.
〔4-8.他の実施の形態8〕
 さらに上述した実施の形態においては、駆動制御部20の動力伝達磁石209と送出部130の駆動用磁石138Cとを磁気的に結合することにより、モータ207の回転駆動力を非接触により回転ねじ部137へ伝達するようにした場合について述べた。
[4-8. Other Embodiment 8]
Furthermore, in the above-described embodiment, the rotational driving force of the motor 207 is non-contacted by the rotational screw portion by magnetically coupling the power transmission magnet 209 of the drive control unit 20 and the driving magnet 138C of the delivery unit 130. The case of transmitting to 137 has been described.
 しかしながら本発明はこれに限らず、例えば所定の歯車を歯合させることにより、モータ207の回転駆動力を接触により回転ねじ部137へ伝達するようにしても良い。 However, the present invention is not limited to this. For example, the rotational driving force of the motor 207 may be transmitted to the rotating screw portion 137 by contact with a predetermined gear.
〔4-9.他の実施の形態9〕
 さらに上述した実施の形態では、ピストン132の外周側面132BにOリング133を設けることにより、ピストン132とシリンダ131との間における気密性を高めるようにした場合について述べた。
[4-9. Other Embodiment 9]
Further, in the above-described embodiment, the case where the airtightness between the piston 132 and the cylinder 131 is improved by providing the O-ring 133 on the outer peripheral side surface 132B of the piston 132 has been described.
 しかしながら本発明はこれに限らず、例えばOリングに代えてXリングを設けるようにしても良く、またシリンダ131の内周側面131BにOリング又はXリングを設けるようにしても良く、さらにはピストン132にシリコンゴムやブタジエンゴムなどで構成されるピストンを取り付けるようにしても良い。 However, the present invention is not limited to this. For example, an X ring may be provided instead of the O ring, an O ring or an X ring may be provided on the inner peripheral side surface 131B of the cylinder 131, and a piston may be provided. A piston made of silicon rubber, butadiene rubber or the like may be attached to 132.
〔4-10.他の実施の形態10〕
 さらに上述した実施の形態においては、送出部130によりインスリン等の薬液を送出するようにした場合について述べた。
[4-10. Other Embodiment 10]
Furthermore, in the above-described embodiment, the case where a medicine such as insulin is delivered by the delivery unit 130 has been described.
 しかしながら本発明はこれに限らず、送出部130により種々の液体や種々の気体等、流動性を有する種々の物体(いわゆる流体)を送出するようにしても良い。 However, the present invention is not limited to this, and various objects (so-called fluids) having fluidity such as various liquids and various gases may be transmitted by the delivery unit 130.
 本発明は、例えば医療分野に適用することができる。 The present invention can be applied to the medical field, for example.
 1……薬液投与システム、2……薬液投与装置、3……コントローラ、4……充電器、10……薬液貯蔵送出部、20……駆動制御部、30……穿刺流路部、106、107……流路管、110……薬液バッグ、130……送出部、131……シリンダ、131A……底面、131B……内周側面、131C……流入管、131D……流出管、131E……流入口、131F……流出口、131L……貯留空間、131S……内部空間、132……ピストン、132A……端面、132AH……端面口、132B……外周側面、132BH……外周側面口、132C……流通管、135……ねじ受部、135A……爪部、135B……ねじ孔、136……規制部、136B、136C……規制板、137……回転ねじ部、137A……ねじ部、138……回転伝達部、X……中心軸
 
DESCRIPTION OF SYMBOLS 1 ... Chemical solution administration system, 2 ... Chemical solution administration apparatus, 3 ... Controller, 4 ... Charger, 10 ... Chemical solution storage and delivery part, 20 ... Drive control part, 30 ... Puncture flow path part, 106, 107... Channel pipe, 110... Chemical solution bag, 130... Delivery part, 131... Cylinder, 131 A .. Bottom surface, 131 B. ... Inlet, 131F ... Outlet, 131L ... Storage space, 131S ... Internal space, 132 ... Piston, 132A ... End face, 132AH ... End face port, 132B ... Outer peripheral side, 132BH ... Outer peripheral side , 132C... Distribution pipe, 135... Screw receiving portion, 135A .. claw portion, 135B... Screw hole, 136... Restricting portion, 136B and 136C. Threaded part 138 ...... rotation transmitting unit, X ...... central axis

Claims (8)

  1.  使用者の体表に貼着されて使用される薬液投与装置であって、
     薬液を貯蔵する薬液貯蔵部と、
     円筒状の内周側面及び所定形状の底面を有するシリンダと、
     前記薬液を供給するリザーバーと、
     前記リザーバーに接続される流入路を介して連通する、前記シリンダの前記内周側面に形成された流入口と、
     前記薬液を使用者の体内へ供給する中空の針まで所定の流出路を介して連通する、前記シリンダの内周側面に設けられ、前記シリンダの中心軸を中心に前記流入口から所定角度だけ回転した位置に形成された流出口と、
     前記シリンダの内周側面と接する外周側面と、前記薬液と接する端面と、該端面と対向する他端面と、前記外周側面に設けられた外周側面口及び前記端面とを接続する流通路とが設けられ、前記シリンダの前記内周側面と前記底面とで形成されるシリンダ内部空間を前記シリンダの中心軸方向に摺動するピストンと、
     前記ピストンの他端面側にねじ溝が形成されたピストンねじ部と、
     前記ピストンねじ部と螺合し、回転駆動部により前記シリンダの中心軸を中心として回転されると共に、当該回転される際に前記シリンダと前記ピストンとの間に生じる周側面摩擦力よりも大きいねじ摩擦力を前記ピストンねじ部との間に生じる回転ねじ部と、
     前記シリンダ内において前記ピストンが前記シリンダの中心軸を中心として回転する際に前記外周側面口が向く方位であるピストン方位を、前記外周側面口を前記流入口に接続させる流入方位と、当該流入方位から前記ピストンを回転され、前記外周側面口を前記流出口に接続させる流出方位とに挟まれた回転範囲内に規制する回転規制部と
     を具える
     ことを特徴とする薬液投与装置。
    A chemical liquid administration device that is used by being attached to the body surface of a user,
    A chemical storage section for storing the chemical,
    A cylinder having a cylindrical inner peripheral side surface and a bottom surface of a predetermined shape;
    A reservoir for supplying the drug solution;
    An inflow port formed on the inner peripheral side surface of the cylinder, which communicates via an inflow path connected to the reservoir;
    Provided on the inner peripheral side surface of the cylinder that communicates through a predetermined outflow path to a hollow needle that supplies the chemical solution to the user's body, and rotates by a predetermined angle from the inflow port about the central axis of the cylinder An outlet formed in the position,
    An outer peripheral side surface in contact with the inner peripheral side surface of the cylinder, an end surface in contact with the chemical solution, the other end surface facing the end surface, and an outer peripheral side surface port provided on the outer peripheral side surface and a flow path connecting the end surface are provided. A piston that slides in an inner space of the cylinder formed by the inner peripheral side surface and the bottom surface of the cylinder in the direction of the central axis of the cylinder;
    A piston thread portion in which a thread groove is formed on the other end surface side of the piston;
    A screw that is screwed into the piston screw portion and rotated about the central axis of the cylinder by the rotation driving portion, and larger than the peripheral side frictional force generated between the cylinder and the piston when the rotation is performed. A rotating screw portion that generates a frictional force between the piston screw portion,
    In the cylinder, when the piston rotates about the central axis of the cylinder, a piston orientation that is an orientation that the outer peripheral side port faces, an inflow direction that connects the outer peripheral side port to the inflow port, and the inflow direction And a rotation restricting portion that restricts the rotation within a rotation range sandwiched between an outflow direction that rotates the piston and connects the outer peripheral side surface port to the outflow port.
  2.  前記ピストンねじ部に対し前記回転ねじ部を前記ピストンが摺動する方向へ付勢させることにより、前記回転ねじ部が回転される際に前記周側面摩擦力よりも大きい前記ねじ摩擦力を生じさせるねじ付勢部
     をさらに具えることを特徴とする請求項1に記載の薬液投与装置。
    By energizing the rotary screw portion with respect to the piston screw portion in a direction in which the piston slides, the screw friction force larger than the peripheral side friction force is generated when the rotary screw portion is rotated. The drug solution administration device according to claim 1, further comprising a screw urging unit.
  3.  前記回転ねじ部及び前記回転規制部は、
     前記シリンダの中心軸に沿った方向に関し、前記ピストン方位が前記流入方位又は前記流出方位となるときに互いに係合する部分の長さの合計が、前記シリンダに対し前記ピストンが前記シリンダの中心軸に沿って移動する移動範囲以上である
     ことを特徴とする請求項1に記載の薬液投与装置。
    The rotating screw part and the rotation restricting part are:
    Regarding the direction along the central axis of the cylinder, the sum of the lengths of the portions that engage with each other when the piston orientation becomes the inflow direction or the outflow direction is calculated as follows. The medicinal-solution administration device according to claim 1, wherein the medicinal-solution administration device is not less than a moving range of moving along the line.
  4.  前記流入口及び前記流出口は、
     前記シリンダに対し前記ピストンが前記シリンダの中心軸に沿って移動する移動範囲以上に長い長孔でなる
     ことを特徴とする請求項3に記載の薬液投与装置。
    The inlet and the outlet are
    The medicinal-solution administration device according to claim 3, characterized in that the piston is a long hole longer than a moving range in which the piston moves along the central axis of the cylinder.
  5.  前記外周側面口は、
     前記シリンダに対し前記ピストンが前記シリンダの中心軸に沿って移動する移動範囲以上に長い長孔でなる
     ことを特徴とする請求項3に記載の薬液投与装置。
    The outer peripheral side opening is
    The medicinal-solution administration device according to claim 3, characterized in that the piston is a long hole longer than a moving range in which the piston moves along the central axis of the cylinder.
  6.  前記回転規制部は、
     前記ピストンに設けられ前記シリンダの中心軸から外方へ向けて周囲よりも突出したピストン側突出部と、
     前記シリンダに設けられ、前記ピストン方位が前記流入方位又は前記流出方位となるときに前記ピストン側突出部と係合するシリンダ側係合部と
     を具え、
     前記ピストン側突出部及び前記シリンダ側係合部は、
     前記ピストン方位が前記流入方位又は前記流出方位となり互いに係合し、前記回転ねじ部の回転により前記シリンダに対し前記ピストンが前記シリンダの中心軸に沿って移動するときに、互いに係合した状態を保持することにより前記ピストン方位を前記流入方位又は前記流出方位に維持する
     ことを特徴とする請求項1に記載の薬液投与装置。
    The rotation restricting portion is
    A piston side protruding portion provided on the piston and protruding outward from the center axis of the cylinder toward the outside;
    A cylinder-side engaging portion that is provided in the cylinder and engages with the piston-side protrusion when the piston orientation becomes the inflow orientation or the outflow orientation,
    The piston-side protruding portion and the cylinder-side engaging portion are
    When the piston azimuth becomes the inflow azimuth or the outflow azimuth and is engaged with each other, and the piston moves relative to the cylinder along the central axis of the cylinder by the rotation of the rotary screw portion, The medicinal-solution administration device according to claim 1, wherein the piston azimuth is maintained in the inflow azimuth or the outflow azimuth by holding.
  7.  前記ピストン側突出部及び前記シリンダ側係合部の少なくとも一方は、
     前記ピストン方位が前記流入方位又は前記流出方位となり前記シリンダに対し前記ピストンが前記シリンダの中心軸に沿って移動する移動範囲に渡り、前記シリンダの中心軸に沿った方向に関し一定の形状でなる箇所を相手方と当接させる
     ことを特徴とする請求項6に記載の薬液投与装置。
    At least one of the piston side protruding portion and the cylinder side engaging portion is:
    The piston azimuth is the inflow azimuth or the outflow azimuth, and the piston has a constant shape with respect to the direction along the central axis of the cylinder over a moving range in which the piston moves along the central axis of the cylinder with respect to the cylinder. The drug solution administration device according to claim 6, wherein the drug solution is brought into contact with the other party.
  8.  前記流入口及び前記流出口と前記外周側面口との少なくとも一方は、
     前記ピストンが摺動する方向に長い長孔である
     ことを特徴とする請求項1に記載の薬液投与装置。
     
    At least one of the inlet and the outlet and the outer peripheral side surface is
    The medicinal-solution administration device according to claim 1, wherein the piston is a long hole that is long in a sliding direction.
PCT/JP2013/001720 2012-03-16 2013-03-14 Drug administration device WO2013136802A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012060916 2012-03-16
JP2012-060916 2012-03-16

Publications (1)

Publication Number Publication Date
WO2013136802A1 true WO2013136802A1 (en) 2013-09-19

Family

ID=49160726

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2013/001720 WO2013136802A1 (en) 2012-03-16 2013-03-14 Drug administration device

Country Status (1)

Country Link
WO (1) WO2013136802A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184461B2 (en) 2013-09-18 2019-01-22 Smiths Medical Asd, Inc. Pump device and method therefor of conveying fluid, and method of manufacturing the pump device
WO2019018516A1 (en) * 2017-07-18 2019-01-24 Becton, Dickinson And Company Administration system, delivery device, and notification device for communicating status of a medical device
WO2021195338A1 (en) * 2020-03-26 2021-09-30 Waters Technologies Corporation Metering pump for liquid chromatography

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58137883U (en) * 1982-03-12 1983-09-16 西原 義晃 fluid discharge device
JPS6316176A (en) * 1986-07-09 1988-01-23 Nittec Co Ltd Vessel
JPS6441679A (en) * 1987-08-07 1989-02-13 Nippon Feeder Kogyo Kk Reciprocating pump
JPH07208325A (en) * 1994-01-05 1995-08-08 Toyo Ink Mfg Co Ltd No-valve reciprocation piston pump
JP2010501283A (en) * 2006-08-23 2010-01-21 メドトロニック ミニメド インコーポレイテッド Infusion medium delivery device and method using a drive device for driving a plunger in a storage container

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58137883U (en) * 1982-03-12 1983-09-16 西原 義晃 fluid discharge device
JPS6316176A (en) * 1986-07-09 1988-01-23 Nittec Co Ltd Vessel
JPS6441679A (en) * 1987-08-07 1989-02-13 Nippon Feeder Kogyo Kk Reciprocating pump
JPH07208325A (en) * 1994-01-05 1995-08-08 Toyo Ink Mfg Co Ltd No-valve reciprocation piston pump
JP2010501283A (en) * 2006-08-23 2010-01-21 メドトロニック ミニメド インコーポレイテッド Infusion medium delivery device and method using a drive device for driving a plunger in a storage container

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10184461B2 (en) 2013-09-18 2019-01-22 Smiths Medical Asd, Inc. Pump device and method therefor of conveying fluid, and method of manufacturing the pump device
WO2019018516A1 (en) * 2017-07-18 2019-01-24 Becton, Dickinson And Company Administration system, delivery device, and notification device for communicating status of a medical device
JP2020527420A (en) * 2017-07-18 2020-09-10 ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company Notification device to inform the status of administration system, administration device, and medical device
US11666704B2 (en) 2017-07-18 2023-06-06 Becton, Dickinson And Company Administration system, delivery device, and notification device for communicating status of a medical device
JP7295087B2 (en) 2017-07-18 2023-06-20 ベクトン・ディキンソン・アンド・カンパニー Notification devices for informing the status of dosing systems, dosing devices and medical devices
EP4241805A1 (en) * 2017-07-18 2023-09-13 Becton, Dickinson and Company Administration system, delivery device, and notification device for communicating status of a medical device
WO2021195338A1 (en) * 2020-03-26 2021-09-30 Waters Technologies Corporation Metering pump for liquid chromatography
US11774415B2 (en) 2020-03-26 2023-10-03 Waters Technologies Corporation Metering pump for liquid chromatography

Similar Documents

Publication Publication Date Title
WO2013047855A1 (en) Liquid-drug administration device, puncturing device, liquid-drug filling device, liquid-drug filling method, and liquid-drug filling system
KR101928297B1 (en) Medical fluid delivery device
JP5506780B2 (en) System, apparatus and method for delivering fluid
US20150352276A1 (en) Positive displacement pump
US20140074062A1 (en) Piston pump devices
JP2013192637A (en) Drug solution delivery device
BRPI0618320A2 (en) medical infusion system
CA3001887C (en) Systems for fluid delivery with wicking membrane
WO2013136802A1 (en) Drug administration device
US20210213192A1 (en) Drug Delivery System
JP2013192639A (en) Drug solution delivery device
JP2013070716A (en) Liquid-drug administration device
WO2023142368A1 (en) Integrated balanced plaster type liquid drug infusion system
JP5766082B2 (en) Puncture device and drug solution administration device
JP2013070713A (en) Medical fluid administration device
JP2013192640A (en) Drug solution delivery device
WO2013136801A1 (en) Drug administration device
JP2013070718A (en) Liquid-drug administration system and liquid-drug administration device
JP2013192638A (en) Drug solution delivery device
JP2013070717A (en) Liquid-drug filling device and liquid-drug filling method
JP2013070714A (en) Medical fluid administration device
JP2013070715A (en) Liquid-drug administration device
CN113577526B (en) Subcutaneous drug delivery device and subcutaneous drug delivery monitoring system
US20230173167A1 (en) Automated drug microinjection pump with wireless communication and method of use
US11918778B2 (en) Smart self-activating wearable device for automatically injecting medicines

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13760963

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 13760963

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP

NENP Non-entry into the national phase

Ref country code: DE